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i.  Abstract 
 
Mononuclear phagocytes are located throughout the body, and include DCs, 
macrophages and monocytes. One of their key functions is the detection of pathogens via an 
array of surface molecules. Determining the repertoire of surface molecules on each subset 
could reveal targets for DC-based vaccines and potential pathogen interactions. Furthermore, 
identifying which subsets are present in each of the anogenital tissues may increase 
understanding of the pathogenesis of various sexually transmitted infections, including HIV. 
To investigate the phenotype and frequency of mononuclear phagocytes in human skin 
and anogenital tissue, and their ability to transfer HIV to T cells, cells were isolated by 
collagenase digestion or after spontaneous migration, and examined by flow cytometry. 
Two previously undescribed epidermal DC-like subsets were identified in abdominal 
skin, as well as a novel langerin+ dermal DC. The surface expression of CLRs and Siglecs 
was observed to differ significantly between the epidermis and dermis, and also between the 
subsets that reside within each. CD141+ DCs were distinct from other DC subsets, which 
differed further from macrophage subsets. Greater differences were observed between the 
subsets isolated from skin compared to those derived in vitro, and between collagenase 
isolated cells (immature) and spontaneously migrated cells (mature). The subsets isolated 
from skin were also functionally distinct in their ability to transfer HIV to T cells. Importantly, 
the frequency of subsets in abdominal skin differed from those found in the anogenital tract, 
and significant differences in subset ratios were observed between different anogenital tissue 
types and sites. 
Therefore, each subset and site represent a unique barrier and/or target for invading 
pathogens. This work has significant implications for DC-based vaccine design and 
pathogenesis of infectious agents that interact with mononuclear phagocytes, including HIV 
and its sexual transmission. 
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Introductory remark: 
 This thesis summarises an investigation of dendritic cells (DCs) and macrophages in 
human skin and anogenital tissue, with a specific focus on transmission of Human 
Immunodeficiency Virus (HIV). This review of literature is divided into three parts. First to be 
reviewed is the anatomy and immune composition of skin and anogenital tissue, focussing on 
the tissues that potentially interact with HIV. A comprehensive review of what is currently 
known about human DC and macrophage subsets will follow. Last to be reviewed is what is 
known about how HIV is transmitted across the genital and anorectal tract, focussing in 
particular detail on the role of DCs and macrophages.  
 
 
1.1. Anatomy of the Skin and Anogenital Tissues 
The first line of defence against the external environment and potential pathogens is 
the skin and mucosae. Not only do these tissues form a physical barrier to repel incoming 
pathogens, they also have biochemical properties that inhibit pathogen entry, and contain 
various immune cell types that detect incoming pathogens and mediate the establishment of 
an appropriate immune response. 
 
1.1.1. Skin (Integumentary system) 
Covering the outermost surfaces of the body, the skin forms the body’s largest organ, 
which together with its normal appendages (e.g. hair, sweat glands and sebaceous glands) 
make up the integumentary system (Marieb and Hoehn, 2007b). Skin ranges in thickness from 
1 to 5mm and consists of two distinct regions: the superficial epidermis and the underlying 
dermis, which are connected by a basal lamina, also known as the basement membrane 
(Figure 1.1) (Marieb and Hoehn, 2007b; Nestle et al., 2009; Porth, 2007).   
 
1.1.1.1. Epidermis 
The epidermis forms the outermost protective barrier of skin and consists of 
keratinised, stratified squamous epithelium (Figure 1.1B). It contains 4 to 5 distinct layers 
depending on the skin’s thickness. Beginning with the outermost layers, these are: stratum 
corneum, stratum lucidum, stratum granulosum, stratum spinosum, and stratum basale (Heath 
and Carbone, 2013; Marieb and Hoehn, 2007b; Ross and Pawlina, 2006). Thick skin is found 
on the fingertips, palms of hands, and soles of feet and consists of all 5 layers. The stratum 
lucidium is absent from the thinner skin, that covers the remainder of the body, leaving four 
layers that are also thinner than those found in thick skin (Marieb and Hoehn, 2007b).  
Chapter 1: Literature Review  Rachel Botting 
4 
 
 
 
Chapter 1: Literature Review  Rachel Botting 
5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Skin epidermal and dermal layers. The skin (A) is split into two distinct regions, 
the epidermis and dermis, and contains multiple appendages, such as hair follicles and sweat 
and sebaceous glands. The epidermis (B) consists of 5 layers, which include the stratum 
corneum, stratum lucidum (only in thick skin), stratum granulosum, stratum spinosum and 
stratum basale. The layers are distinguishable by the various stages of keratinocyte 
differentiation, ranging from the deepest rapidly diving layer, to the superficial dead, enucleate 
layers. Interspersed between the keratinocytes are Langerhans cells, merkel cells and 
melanocytes. The epidermis is connected to the underlying dermis via the basement 
membrane.  The dermis (C) underlies the epidermis and consists of two layers, which include 
the papillary and reticular dermis, the topmost which, along with the basement membrane, 
enhances adherence of the epidermis to dermis.  The dermis consists mostly of connective 
tissue that houses blood and lymphatic vessels, nerves and the various skin appendages.  It 
also contains multiple innate immune cells, such as dendritic cells, macrophage and NK cells, 
and adaptive immune cells. Figure adapted from (THANC, 2015). 
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The epidermis is avascular and relies on nutrients diffusing in from the dermis. Diffusion limits 
are reached at the top two layers resulting in cell death, hence the top two layers are made of 
dead cells. The stratum corneum, or horny layer, is the thickest layer at 20 to 30 cells thick 
and consists of dead enucleate, keratin-filled cells with thickened plasma membranes that 
protect against penetration and abrasion (Marieb and Hoehn, 2007b; Porth, 2007; Storm and 
Elder, 2008). Glycolipids, produced in the stratum granulosum, fill the extracellular space 
providing a barrier against water loss (Feingold, 2012; Marieb and Hoehn, 2007b).  The 
stratum lucidium, only present in thick skin, is a thin layer consisting of 2 to 3 rows of flat, 
dead keratinocytes (Marieb and Hoehn, 2007b). The stratum granulosum is made up of 5 to 
7 layers of keratinocytes that are starting to die. As a result, the organelles degrade and 
produce keratin-secreting keratohyalin granules and glycolipid-secreting lamellated granules 
(lamellar bodies) (Feingold, 2012). The stratum spinosum consists of 5 to 7 cell layers of 
keratinocytes and an immune cell subset called Langerhans cells, which are interspersed with 
melanin granules that are produced in the underlying stratum basale. Here, the keratinocytes 
contain thick bundles of intermediate filaments, and are held together by desmosomes that 
hold tight during cell shrinkage resulting in irregularly shaped keratinocytes.  The deepest and 
thinnest layer of the epidermis is the stratum basale that consists of a single layer of cells, 
the majority of which are highly mitotic keratinocytes that continually and rapidly divide to 
renew the cell populations of the more superficial layers. Approximately 10 to 25% of the cells 
in this layer are melanocytes, which produce melanin granules and extend their processes 
between surrounding cells present in this layer and in the overlying stratum spinosum (Marieb 
and Hoehn, 2007b). Merkel cells, which are also occasionally present in this layer, function as 
mechanoreceptors and are closely associated with sensory nerve endings in the underlying 
dermis (Fradette et al., 2003; Marieb and Hoehn, 2007b; Moll et al., 2005; Storm and Elder, 
2008). Beneath the final epidermal layer is the basement membrane, which is composed of 
intracellular and extracellular matrices that aid adherence of the epidermis to the dermis 
(Marieb and Hoehn, 2007b; Storm and Elder, 2008). The basement membrane is also 
responsible for epithelial cell polarity (Storm and Elder, 2008). 
 
1.1.1.2. Dermis 
The dermis makes up the bulk of skin and mostly consists of connective tissue that is 
supplied with nerves, blood and lymphatic vessels, and also hosts the skin appendages.  The 
dermis has two layers, the superficial papillary layer and the deeper reticular layer (Figure 
1.1C) (Marieb and Hoehn, 2007b; Porth, 2007; Storm and Elder, 2008).  The papillary layer is 
a highly vascularised, thin layer of loosely arranged collagen and elastin fibres.  Its superficial 
edge has projections called dermal papillae, many of which house nerve endings, sensory 
receptors, and capillary loops (circulatory and lymphatic) (Fiore, 1967; Marieb and Hoehn, 
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2007b; Porth, 2007; Storm and Elder, 2008). Together with the basal lamina, the dermal 
papillae help to anchor the epidermis to the dermis (Marieb and Hoehn, 2007b; Porth, 2007; 
Storm and Elder, 2008). The largest proportion of the dermis is the reticular layer, which 
accounts for approximately 80% of the thickness (Fiore, 1967). The dense, irregular 
connective tissue of this layer contains collagen for strength and water retention, and elastin 
for elasticity, in the extracellular matrices. 
Importantly, the dermis contains many immune cell types including, fibroblasts, 
macrophages, DCs, mast cells and lymphocytes, which play various roles in the establishment 
of the host immune response (Figure 1.2). 
 
1.1.1.3. Appendages 
Skin appendages are derived from the epidermis and reside in the dermis (Fiore, 
1967). They include hair, hair follicles, sweat glands, sebaceous glands, and nails (Marieb and 
Hoehn, 2007b; Ross and Pawlina, 2006; Storm and Elder, 2008).  Hair is distributed across 
the entire skin surface, excluding parts of the external genitalia, lips, and thick skin (palms and 
soles), and stems from hair follicles (Marieb and Hoehn, 2007b; Storm and Elder, 2008).  Hair 
follicles fold down from the epidermal surface into the dermis and have been implicated as a 
passage for immune cells to gain access to the epidermis from the dermis (Gilliam et al., 1998; 
Heath and Mueller, 2012; Nagao et al., 2012).  Sebaceous glands are closely associated with 
hair follicles and produce sebum, an oily substance that lubricates the skin, helps prevent 
water loss and has bactericidal properties (Grice and Segre, 2011; Nakatsuji et al., 2010). 
Sweat glands are either eccrine or apocrine, the former being far more numerous and found 
on all but a few skin surfaces (Grice and Segre, 2011). Sweat secreted by eccrine sweat 
glands is 99% water (Grice and Segre, 2011) and, among other products, contains antibodies 
and dermcidin, a peptide microbicide (Schittek et al., 2001). Sweat secreted from apocrine 
sweat glands, which are largely confined to the axillary and anogenital areas, is similar to 
sweat from eccrine sweat glands with the addition of protein and fatty substances (Grice and 
Segre, 2011; Marieb and Hoehn, 2007b). 
 
1.1.1.4. The role of the skin in immunity 
The skin plays a crucial role as a physical, chemical and biological barrier against 
invading pathogens (Elias, 2007; Nestle et al., 2009). Layers of dead keratinocytes that are 
continually shed make it difficult for pathogens to establish residence on the surface of the 
skin (Grice and Segre, 2011), and the continuity and hardness of this keratinised layer also 
adds a significant challenge for penetration. Keratinocytes also express a number of 
antimicrobial proteins, both constitutively and in response to pathogenic and inflammatory 
stimuli (Feingold, 2012; Heath and Carbone, 2013; Nestle et al., 2009), which include RNases 
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(Harder and Schröder, 2002), S100 members (Zhu et al., 2013b), cathelicidins (Braff et al., 
2005) and β-defensins (Oren et al., 2003). Secretions from the sebaceous and sweat glands 
also contribute to the chemically hostile environment.  Sebum plays an important role in 
maintaining the continuity of skin by lubricating the skin and slowing dehydration, which 
prevents cracks and also acts as a shield.  Sebum also contains lipids and free-fatty acids 
(FFA) which are antimicrobial (Bibel et al., 1992; Elias, 2007; Fischer et al., 2012; Wille and 
Kydonieus, 2003). The lipids from sebum can also be metabolised to FFA by bacteria, which 
have antibiotic activity and also decrease the skin’s pH (Elias, 2007; Fluhr et al., 2001; Grice 
and Segre, 2011). Sweat too contributes to the acidity of skin, thereby slowing bacterial growth 
and replication (Borkowski and Gallo, 2011; Elias, 2007; Grice and Segre, 2011), and also 
has bactericidal properties through the action of dermcidin (Schittek et al., 2001). 
Further to the body’s defence mechanisms, are a vast array of commensal microbiota 
that are adapted to the skin’s hostile environment and outcompete pathogenic strains (Grice 
and Segre, 2011; Schloss, 2014).  The commensal microbiota may also play a role in priming 
epidermal and dermal immune cells against similar strains that are more pathogenic (Grice 
and Segre, 2011). 
 
1.1.1.5. Skin immune subsets 
Pathogens that penetrate the physical and chemical barriers of the skin encounter the 
various immune cell subsets residing in the epidermis and dermis which play diverse roles in 
pathogen detection and destruction, and in mounting an appropriate immune response or in 
inducing immune tolerance (Figure 1.2) (Nestle et al., 2009). In steady state, the predominant 
epidermal immune cell is the Langerhans cell, which accounts for 1-3% of the total cells and 
is most abundant in the stratum spinosum (Cooper et al., 1985; Foster et al., 1990; Storm and 
Elder, 2008). T cells have also been observed in the epidermis, but in very low numbers and 
most of which are CD8+ (Bos et al., 1987; Cooper et al., 1985; Foster et al., 1990). Langerhans 
cells are a subset of DC and are specialised in antigen detection and processing. They 
recognise and capture antigens via pattern recognition receptors (PRRs) such as Toll-like 
receptors (TLRs) and C-type lectin receptors (CLRs), which they then process and present to 
T cells (Flacher et al., 2006; Igyártó and Kaplan, 2013; Klechevsky et al., 2008; Romani et al., 
2003; Zaba et al., 2008). The T cells then become primed to either mount an appropriate 
immune response or to become tolerogenic (Romani et al., 2012). In states of inflammation, 
inflammatory dendritic epidermal cells (IDECs), which are distinct from Langerhans cells and 
dermal DCs, can also be observed in the epidermis (Wollenberg et al., 1996; Wollenberg et 
al., 2002a). The role of IDECs and Langerhans cells in immunity will be discussed in greater 
detail in section 1.2. 
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Figure 1.2. Immune subsets within skin. A variety of immune subsets reside within the skin 
to maintain homeostasis. Keratinocytes, Langerhans cells and CD8+ T cells reside within the 
epidermis. The underlying dermis contains a larger variety of immune subsets, including 
dermal dendritic cells (DCs), plasmacytoid dendritic cells (pDC), natural killer (NK) cells, 
fibroblasts, CD4+ T cells and γδ T cells. Figure adapted from (Nestle et al., 2009)  
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Keratinocytes constitute the majority of cells in the epidermis, and though they are not 
traditionally considered immune cells, they express many PRRs, including TLRs 1-6, 9 and 
10 (Lebre et al., 2006; Miller and Modlin, 2006), and in vitro have been shown to internalise 
bacteria, thereby having a direct role in innate immunity (Braff et al., 2005). In response to 
pathogenic stimuli and inflammation, keratinocytes also secrete an array of cytokines and 
chemokines, including chemokine (C-X-C motif) ligand (CXCL)9, CXCL10, CXCL11, 
chemokine (C motif) ligand (CCL)20, Tumour Necrosis Factor α (TNFα), Interleukin (IL)-1α, -
1β, -6, -8, -10, -18 and -33 (Heath and Carbone, 2013; Lebre et al., 2006; Nestle et al., 2009; 
Storm and Elder, 2008), that can assist in the recruitment of various immune subsets to the 
skin, as well as type I and type III interferons (IFNs) (Fujisawa et al., 1997; Howie et al., 1996; 
Lebre et al., 2006; Torseth et al., 1987).  
The dermis contains a far larger range of immune cells compared to the epidermis, 
most of which are located in the papillary layer at the dermoepidermal junction and traffic 
between the skin, lymph nodes and blood circulation for immune surveillance (Heath and 
Carbone, 2013; Nestle et al., 2009; Wang et al., 2014; Zhu et al., 2013a).  In steady state, the 
dermis contains several subsets of myeloid cells that are specialised in antigen detection and 
skin homeostasis such as macrophages and DCs (Hänsel et al., 2013; Heath and Carbone, 
2013; Nestle et al., 2009; van Furth et al., 1985; Wang et al., 2014), as well as natural killer 
(NK) cells (Batista et al., 2013; Ebert et al., 2006), mast cells (Heath and Carbone, 2013; 
Nestle et al., 2009; Storm and Elder, 2008) and several subsets of tissue resident T cells 
(Clark et al., 2006; Ebert et al., 2006; Zhu et al., 2013a).  These cells are preferentially located 
in close proximity to blood and lymphatic vessels or adjacent to hair follicles (Bos et al., 1987; 
Nestle et al., 2009; Wang et al., 2014). Dermal DCs and macrophages are dealt with in greater 
detail in section 1.2. 
The majority of T cells in normal skin express cutaneous cell-associated antigen (CLA) 
and have an effector memory phenotype (Clark et al., 2006; Zhu et al., 2013a). The majority 
are CD4+ T cells, although CD8+, γδ and T regulatory subsets are also present (Clark et al., 
2006; Heath and Carbone, 2013; Sanchez Rodriguez et al., 2014; Seneschal et al., 2012).  
NK cells are sparse in normal skin (Ebert et al., 2006), but infiltrate into the dermis from blood 
during inflammation (Batista et al., 2013), along with monocytes and plasmacytoid DCs 
(Batista et al., 2013; Hänsel et al., 2013; Nestle et al., 2005; Wollenberg et al., 2002b). In mice, 
infiltrating monocytes have been shown to differentiate into DCs and macrophages (Eidsmo 
et al., 2009; Higashi-Kuwata et al., 2009; León et al., 2007; Randolph et al., 1999; Rotta et al., 
2003), however in humans this has only been inferred after in vitro studies and transcriptomic 
comparison of monocyte-derived cells and cells isolated from skin (McGovern et al., 2014b; 
Randolph et al., 1998). 
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Similar to epidermal keratinocytes, dermal fibroblasts secrete numerous cytokines and 
chemokines, including TNF-α, IL-6, IL-8, CCL2, CCL5, CCL20, CXCL1 and CXCL12, which 
influence the surrounding immune subsets (Flavell et al., 2008; Rustemeyer et al., 2011). 
 
1.1.2. Mucosal surfaces 
Mucosae are the mucous membranes that line and protect the body cavities that are 
exposed to the external environment. Examples include the surfaces of the respiratory, 
digestive and urogenital tracts.  Mucosae are classified as either type I or type II, dependent 
on their function and anatomic features, which is reflected in their distinct epithelium.  
Underlying the epithelium of both mucosal types is the lamina propria, which is a layer of loose 
connective tissue. Table 1.1 summarises the most notable differences between skin and type 
I and II mucosae. 
 
1.1.2.1. Type I Mucosa 
Type I mucosal surfaces, found in the respiratory, digestive and upper female genital 
tracts, consist of a monolayer epithelium that is optimal for absorption, excretion and 
respiration (Iwasaki, 2007). The epithelium is mostly columnar cells joined by tight junctions, 
and is interlaced with mucous secreting columnar cells, which are called goblet cells in the 
intestines (Ross and Pawlina, 2006). Type I mucosal epithelium also expresses polymeric 
immunoglobulin receptor, which allows the secretion of Immunoglobulin (Ig)A (Iwasaki, 2010). 
The lamina propria that underlies type I mucosa often contains lymphoid aggregates forming 
mucosa-associated lymphoid tissue (MALT) which contain various lymphocyte populations 
and plasma cells (Iwasaki, 2010). Like the dermis, the lamina propria contains various immune 
cell subsets (Iwasaki, 2010), including lamina propria DCs that extend processes between the 
tight junctions of the epithelial monolayer and sample pathogens in the lumen (Cavarelli et al., 
2013; Patyka et al., 2015). 
 
1.1.2.2. Type II Mucosa  
Type II mucosal surfaces, found in the lower female genital tract, external male 
genitalia, and anal canal, contain a stratified squamous epithelium (Iwasaki, 2010). This 
surface functions as a physical barrier, however it does not contain the appendages found in 
skin and is covered in a layer of mucous (Iwasaki, 2007). The type II mucosa lacks the same 
level of keratinisation as skin, meaning it is easier for pathogens to penetrate (Hladik and 
McElrath, 2008; Iwasaki, 2007). Unlike type I mucosa, type II mucosa does not contain MALT, 
instead it drains to regional lymph nodes (Iwasaki, 2010).  Type II mucosal epithelium also 
lacks polymeric immunoglobulin receptor expression, thereby lacks the ability to secret IgA 
Chapter 1: Literature Review  Rachel Botting 
12 
 
but instead allows IgG to be released into the lumen via diffusion (Iwasaki, 2010). In general 
there are fewer immune cells in the lamina propria underlying Type II mucosa compared with 
Type I mucosa (Iwasaki, 2010). The immune subsets that survey these tissues are similar to 
those found in the skin (see section 1.1.1.5) and will be discussed further below in relation to 
their presence in specific anogenital tissues (see section 1.1.3.). 
 
1.1.3. Anogenital tissues and mucosal immunity 
The mucosal immune system, located near the body’s surfaces, represents the first 
line of defence against invading pathogens. The structure of mucosal surfaces is adapted for 
their function of gas exchange, nutrient absorption, sensation and reproduction, which also 
renders them susceptible to attack.  The anorectal tracts, including the anal canal and rectum, 
and female and male genital tracts (hereafter referred to as the anogenital tracts), form the 
mucosal immune system that protects against sexually transmitted infections (STIs). The 
mucosal immunity of the anogenital tracts needs to balance both tolerance and protection 
against the multitude of immunogenic stimuli, most of which is encountered during normal 
function (reproductive and digestive). Understanding the differences in these tissues and the 
immune subsets found within them is critical for the development of effective mucosal vaccines 
and microbicides to block transmission of STIs.  
The human anogenital tracts are comprised of multiple tissue types that each represent 
unique barriers and opportunities for the transmission of invading pathogens. These tissue 
types are either made up of skin or type I or type II mucosa. The type I mucosa of the 
endocervix and rectum is structurally weak but is protected with a mucous layer, which is 
acidic in the female genital tract (Lai et al., 2009b) but of neutral pH in the anorectal tract 
(Jannin et al., 2014; McNeil et al., 1987).  The type II mucosa of the vagina, ectocervix, inner 
foreskin and anal canal, represents a stronger physical barrier, and the skin that covers the 
labia, outer foreskin and exterior anus (perianal tissue surrounding the anal verge) represents 
a stronger physical barrier still due to the high level of keratinisation. The junction between 
type I and type II mucosal tissues, known as the squamocolumnar junction, represents a 
susceptible site for infection due to a monolayer epithelium and enrichment of immune cells 
(Pudney et al., 2005). The squamocolumnar junction occurs between the endo- and ectocervix 
of the female genital tract (Figure 1.3), and between the rectum and anal canal (also known 
as the pectinate or dentate line (Figure 1.5)).  
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Table 1.1. Comparison of skin and anogenital mucosae 
Feature Type I Mucosa Type II Mucosa Skin 
Tissues Endocervix, rectum, upper anal 
canal 
Vagina, ectocervix, labia minora, 
inner foreskin, lower anal canal, 
fossa navicularis 
External surfaces of the body, 
including the labia majora, penis 
(including glans penis), outer 
foreskin, urethral meatus 
Epithelia Single layer of columnar 
epithelium 
Stratified squamous epithelium 
with little to no keratinisation 
Keratinised, stratified squamous 
epithelium 
Submucosa Lamina propria  Lamina propria Dermis 
Mucous layer Present Present Absent 
Mucosa-associated 
lymphoid tissue 
Present Absent – drains to regional 
lymph nodes 
Absent – drains to regional 
lymph nodes 
Immune subset 
trends 
CD8+ T cells outnumber  
CD4+ T cells 
 
Few to no Langerhans cells 
CD8+ T cells outnumber  
CD4+ T cells 
 
Numerous Langerhans cells 
CD4+ T cells outnumber  
CD8+ T cells 
 
Langerhans cells present  
Adapted from (Iwasaki, 2010). 
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1.1.3.1. Mucosal immunity of the female genital tract 
The female genital tract is grossly split into the upper (fallopian tubes, uterus and 
endocervix) and lower (labia, vagina and ectocervix) tracts (Marieb and Hoehn, 2007c; Pudney 
et al., 2005; Reis Machado et al., 2014).  Its complexity is compounded with the hormonal 
changes that occur during the menstrual cycle, hormonal contraceptive use and pregnancy. 
Only the lower female genital tract and endocervix are commonly exposed to sexually 
transmitted infections, and therefore these tissues will be discussed in greater detail below. 
 
i. Labia 
The labia majora and labia minora form part of the external female genitalia (Porth, 
2007; Sabiston and Townsend, 2012).  The labia majora forms the outer borders of the vulva 
and consists of keratinised, stratified squamous epithelium containing normal skin 
appendages (hair follicles and glands) (Porth, 2007; Pudney et al., 2005; Sabiston and 
Townsend, 2012). Medial to the labia majora are the labia minora, which transitions from skin, 
similar to that of the labia majora excluding the hair follicles, to type II mucosa closer to the 
vaginal opening (Marieb and Hoehn, 2007c; Sabiston and Townsend, 2012).  The size and 
degree of folding and ridges varies between individuals and sites of the labia (Farage and 
Maibach, 2006), with a transition from ridged skin to smooth type II mucosa rich in sebaceous 
glands (Sloane, 1993). 
Very little is known regarding the immune cell subsets that reside within the skin and 
type II mucosa of the labia minora. One study by Edwards and Morris, revealed that 
Langerhans cells are present in the epithelium in high numbers, similar to those seen in the 
ectocervix (see below) (Edwards and Morris, 1985).  The same study reported CD4+ and CD8+ 
T cells in the underlying dermis/lamina propria, and CD8+ T cells at very low frequencies in 
the epidermal layer (Edwards and Morris, 1985).   
 
ii. Vagina 
The vagina is an 8-10cm fibromuscular tube that extends from the hymen to the cervix, 
connecting the internal and external genitalia (Lloyd et al., 2005; Marieb and Hoehn, 2007c; 
Porth, 2007; Sabiston and Townsend, 2012).  It is lined by type II mucosa with an average 
thickness of 200μm which alters in response to hormonal stimuli (Figure 1.3) (Bahamondes et 
al., 2000; Ildgruben et al., 2003; Mauck et al., 1999). The vaginal mucosa contains multiple 
ridges to allow extension during childbirth and intercourse (Fiore, 1967; Marieb and Hoehn, 
2007c; Pudney et al., 2005), and is further protected from friction by the stratified squamous 
epithelium (Fiore, 1967; Marieb and Hoehn, 2007c; Robboy et al., 2008; Shen et al., 2011).    
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Figure 1.3. Anatomy and histology of the female genital tract. The labia (labia minor and 
majora) (A) form part of the external female genital tract that frame the vagina. The internal 
female genital tract (B) consists of the uterus, fallopian tubes, ovaries, cervix and vagina.  The 
cervix is further divided into the endocervix, which forms the cervical canal that opens into the 
uterus and is lined with type I mucosa, and the ectocervix, which is lined with type II mucosa 
and is continuous with the vagina. The squamocolumnar junction (see insert) is the abrupt 
change from the type I mucosa in the endocervix to the type II mucosa in the ectocervix. Figure 
adapted from (Iwasaki, 2010). 
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The vaginal lamina propria is well supplied with small blood vessels (Fiore, 1967) and has 
distinct papillae that extend into the epidermis (Pudney et al., 2005). As a portal between the 
external and internal environments, the vaginal mucosa is exposed to pathogenic challenge.  
It is protected by mucous secreted by cervical glands, which is then acidified by local vaginal 
microflora providing an extra barrier against infection (Klebanoff and Coombs, 1991; Lai et al., 
2009b; Marieb and Hoehn, 2007c). Commensal microflora in the vagina also inhibits growth 
of pathogenic species through the production of hydrogen peroxide (Klebanoff and Coombs, 
1991; Quayle, 2002). 
The vaginal epithelium contains macrophages, Langerhans cells, and T cells (Duluc et 
al., 2013; Edwards and Morris, 1985; Hladik et al., 2007; Hussain and Lehner, 1995; Pudney 
et al., 2005; Reis Machado et al., 2014; Shen et al., 2014), while the underlying lamina propria 
contains DCs and aggregates of lymphocytes, including various subsets of T cells and NK 
cells, in greater diversity and numbers than those in the epithelium (Duluc et al., 2013; Mselle 
et al., 2007; Pudney et al., 2005; Reis Machado et al., 2014; Shen et al., 2014; Shen et al., 
2011). The number of immune subsets present in the epithelium increases from the distal to 
proximal vagina (Pudney et al., 2005). Unlike in dermis, CD8+ T cells are the predominant T 
cell in the lamina propria (Hladik et al., 2007; Ildgruben et al., 2003), γδ T cells are absent, 
and CD103+ (mucosa-associated) T cells are present in both the epithelium and lamina propria 
despite being scarce (Pudney et al., 2005). Similar to the skin, the majority of T cells are 
memory cells, but naïve T cells are also present (Pudney et al., 2005).   
 
iii. Cervix 
The cervix forms the neck of the uterus and the passage between the microbiota-
inhabited lower female genital tract and the sterile upper female genital tract (Fiore, 1967; 
Marieb and Hoehn, 2007c; Porth, 2007; Sabiston and Townsend, 2012). The ectocervix is 
continuous with the vagina, and the endocervix forms the cervical canal and opens into the 
uterus (Figure 1.3) (Fiore, 1967; Marieb and Hoehn, 2007c; Porth, 2007; Robboy et al., 2008; 
Sabiston and Townsend, 2012). The ectocervix is made up of type II mucosal tissue with 
similar features to the vaginal mucosa (Pudney et al., 2005; Shen et al., 2011); it consists of 
stratified squamous epithelium that does not contain glands, with a highly papillated lamina 
propria (Pudney et al., 2005). The immune cells of the ectocervix are similar to those in the 
vagina, including CD8+ and CD4+ T cells, NK cells, macrophages and Langerhans cells, but 
are present in greater numbers (Greenhead et al., 2000; Hussain and Lehner, 1995; Mselle et 
al., 2007; Patterson et al., 1998; Patyka et al., 2015; Pudney et al., 2005; Shen et al., 2011). 
The epithelium of the ectocervix transitions to the type I mucosal tissue of the endocervix at 
the squamocolumnar junction (Figure 1.3) (Fiore, 1967; Pudney et al., 2005; Robboy et al., 
2008). The lamina propria underlying the squamocolumnar junction is especially enriched with 
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immune cells which, together with its fragile single layered epithelium, contributes to its 
vulnerability to some STIs such as HIV and human papilloma virus (Pudney et al., 2005). In 
particular this region of lamina propria contains the highest concentrations of macrophages, 
and T cells, including CD4+, CD8+ and CD103+ cells, in the female genital tract, and it also 
contains numerous granulocytes (Pudney et al., 2005). Langerhans cells are present in 
numbers comparable to the ectocervix, while there are very few NK cells (Pudney et al., 2005).  
The endocervix consists of a single layer of mucous-secreting and ciliated, non-
mucous secreting columnar epithelial cells connected by tight junctions (type I mucosa) 
underlain with glandular lamina propria (Fiore, 1967; Marieb and Hoehn, 2007c; Porth, 2007; 
Pudney et al., 2005; Quayle, 2002; Robboy et al., 2008; Shen et al., 2011). The epithelium of 
the endocervix produces mucous that is distributed by the ciliated columnar epithelial cells to 
protect the uterus and vagina, a dynamic function that changes with the ovarian cycle (Marieb 
and Hoehn, 2007c; Robboy et al., 2008; Sabiston and Townsend, 2012). Mucous in the female 
genital tract is acidic and can play a crucial role as a biochemical barrier against invading 
pathogens (Porth, 2007), therefore the changes in consistency that occur at various stages of 
the ovarian cycle could greatly alter susceptibility. IgG and IgA secreted by B cells in the lamina 
propria, also add a protective layer to mucous in the female genital tract (Hirbod et al., 2011; 
Pudney et al., 2005; Reis Machado et al., 2014). The endocervical lamina propria also 
contains granulocytes, DCs, macrophages and lymphocytes, including NK cells, and CD4+ 
and CD8+ T cells (Hirbod et al., 2011; Mselle et al., 2007; Patyka et al., 2015; Pudney et al., 
2005). Of the lamina propria immune subsets, macrophages and T cells are also present in 
the epithelium (Hirbod et al., 2011; Patyka et al., 2015; Pudney et al., 2005). Studies have 
reported conflicting results regarding the presence (Patyka et al., 2015; Prakash et al., 2004) 
and absence (Pudney et al., 2005) of Langerhans cells in the endocervix, which may be due 
to differences in isolation and detection as well as scarcity of these cells (Hirbod et al., 2011; 
Patyka et al., 2015). 
 
iv. Hormonal effects on the female genital mucosa 
The female genital mucosa is dynamic in response to hormonal stimuli that occurs 
naturally during pregnancy and menstruation (Patton et al., 2000), and pharmacologically 
through hormone replacement and contraceptives (Wira et al., 2015).  The two main hormones 
are oestrogen and progesterone, the latter being predominant in contraceptives.  Oestrogen 
stimulates proliferation and maturation of vaginal epithelium and the production of clear 
permissible mucous (Robboy et al., 2008; Sabiston and Townsend, 2012).  Progesterone 
induces opposing effects, inhibiting epithelial maturation, and stimulating the production of 
thick mucus that plugs the cervical canal (Robboy et al., 2008; Sabiston and Townsend, 2012).  
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During the normal menstrual cycle, the vaginal epithelium increases and decreases in 
thickness, although at increments small enough to not be considered clinically significant 
(Patton et al., 2000), and is generally increased with the use of hormonal contraceptives 
(Ildgruben et al., 2003). The number and distribution of Langerhans cells, and other immune 
subsets, is unchanged during normal menstruation (Ildgruben et al., 2003; Patton et al., 2000), 
however, the number of T cells increases with hormonal contraceptive use, which is more 
prominent in the CD4+ population (Ildgruben et al., 2003). Various studies show conflicting 
results regarding the influence of hormonal contraceptives on Langerhans cell numbers, in 
which no change (Ildgruben et al., 2003; Mauck et al., 1999) and an increase have been 
observed (Wieser et al., 2001). 
 
1.1.3.2. Mucosal immunity of the male genital tract 
The male genital tract consists of various ducts and accessory glands including the 
epididymis and prostate, and the testicles, urethra, penis and foreskin (Iwasaki, 2010; Marieb 
and Hoehn, 2007c). Of the male genital tract, the penis, foreskin and urethra are the parts 
most commonly exposed to sexually transmitted infections (Dinh et al., 2015; Ganor and 
Bomsel, 2011; Ganor et al., 2010; Zhou et al., 2011), and will therefore be covered further 
below. 
 
i. Penis 
The penis consists of the shaft that attaches to the body at the root, and the glans 
penis that forms the distal point at the end of the shaft (Figure 1.4) (Marieb and Hoehn, 2007c). 
The skin covering the shaft is loose and extends to the foreskin that covers the glans penis 
(Iwasaki, 2010; Marieb and Hoehn, 2007c). The epithelium covering the glans penis is 
keratinised squamous epithelium devoid of hair follicles, and is underlain with very little dermis 
(Ganor et al., 2013; Marieb and Hoehn, 2007c). The erectile bodies in the underlying 
submucosa are composed of fibroelastic connective tissue and smooth muscle, and contain 
extensive vasculature (Marieb and Hoehn, 2007c).  
The level of keratinisation on the penis forms a significant barrier against invading 
pathogens (Ganor et al., 2013), and is further protected by immune subsets within the 
epidermis and dermis. The epidermis contains numerous Langerhans cells (Ganor et al., 
2013; McCoombe and Short, 2006) that extend their dendrites toward the epithelial surface 
(McCoombe and Short, 2006), while macrophages are confined to the underlying dermis 
(Ganor et al., 2013; McCoombe and Short, 2006). Both CD4+ and CD8+ T cells are present in 
the epidermis and dermis, although the CD4+ T cells are generally located in the dermis 
(McCoombe and Short, 2006), and the majority of T cells are CD8+ with a memory phenotype 
(Ganor et al., 2013).   
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Figure 1.4. Anatomy and histology of the external male genital tract. The external male 
genital tract consists of the penis (shown here) and the scrotum. The external portion of the 
penis is the penile shaft and the distal glans penis. The loose skin that covers the penile shaft 
terminates with the foreskin that covers the glans penis. The outer foreskin consists of 
keratinised, stratified squamous epithelium, which is similar to the covering of the glans penis, 
while the inner foreskin consists of type II mucosa.  The penile (spongy) urethra runs through 
the penile shaft, while the portion that runs through the glans penis is the fossa navicularis 
and is lined with type II mucosa. The distal terminal end of the urethra is the urethal meatus, 
which is lined with skin continuous with that of the glans penis. Figure adapted from (Iwasaki, 
2010). 
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ii. Urethra 
The urethra consists of three regions, including the prostatic urethra and membranous 
urethra, which sit inside the body cavity, and the spongy urethra, which runs through the shaft 
of the penis (Marieb and Hoehn, 2007c). The spongy urethra can be further divided into the 
bulbous and pendulous urethra, which run through the shaft and are lined with stratified or 
pseudostratified columnar epithelium, and the fossa navicularis, which runs through the glans 
penis and is lined with type II mucosa (Figure 1.4) (Dinh et al., 2015; Fiore, 1967; Ganor et al., 
2013; McCoombe and Short, 2006; Pudney and Anderson, 1995). The urethral epithelium 
abruptly changes from type II mucosa at the urethral meatus, which is the end of the penile 
urethra and is lined with keratinised skin that is continuous with that of the glans penis 
(McCoombe and Short, 2006; Pudney and Anderson, 1995). The urethral mucosa is thrown 
into multiple folds that contain glands and mucous-secreting cells within them (Fiore, 1967; 
Marieb and Hoehn, 2007c; Pudney and Anderson, 1995). 
The immune subsets in the mucosa of the penile urethra differ from those in the 
mucosa and skin of the fossa navicularis and urethral meatus respectively. The most abundant 
immune subset in the penile urethra are memory T cells, including CD4+, CD8+ and  T cells 
located in the lamina propria, the majority of which are CD8+, which are also present in the 
epithelium (Dinh et al., 2015; Ganor et al., 2013; Pudney and Anderson, 1995). Macrophages 
are also present in both the epithelium and lamina propria (Dinh et al., 2015; Ganor et al., 
2013; Pudney and Anderson, 1995). Langerhans cells are absent (Dinh et al., 2015; Ganor et 
al., 2013; Pudney and Anderson, 1995), and B cells, NK cells and granulocytes are rarely 
observed (Pudney and Anderson, 1995). Similar to the penile urethra, the urethral meatus and 
fossa navicularis contain abundant memory T cells located in the lamina propria and 
epithelium, and lack B cells and NK cells (Dinh et al., 2015; Ganor et al., 2013; Pudney and 
Anderson, 1995). In contrast, the urethral meatus does not contain macrophages, but similar 
to the glans penis contains DCs in the lamina propria and Langerhans cells in the epithelium 
(McCoombe and Short, 2006; Pudney and Anderson, 1995). Similar to the penile urethra and 
unlike the urethral meatus, the fossa navicularis contains numerous granulocytes within the 
lamina propria and epithelium, and also contains macrophages although predominantly in the 
lamina propria (Ganor et al., 2013; Pudney and Anderson, 1995). Inversely, the fossa 
navicularis has Langerhans cells in the epithelium, much like the urethral meatus although 
less abundant (Ganor et al., 2013; Pudney and Anderson, 1995). Thus, the fossa navicularis 
contains the largest variety of immune subsets with a profile that combines that of the penile 
urethra and urethral meatus. 
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ii. Foreskin 
The foreskin, or prepuce, is a section of skin and type II mucosa that covers the glans 
penis, and consists of an exposed portion named the ‘outer foreskin’ and an inner portion that 
folds over the glans penis named the ‘inner foreskin’ (Dinh et al., 2015).  Both the inner and 
outer foreskin consist of stratified squamous epithelium, however the inner foreskin is more 
like type II mucosa than the skin of the outer foreskin (Figure 1.4) (Ganor and Bomsel, 2011; 
Iwasaki, 2010). There is controversy as to the level of keratinisation observed between the 
inner and outer foreskin, which may be attributed to racial differences (Ganor and Bomsel, 
2011; Liu et al., 2014).  Some studies have reported no significant difference in keratinisation 
(Dinh et al., 2012; Dinh et al., 2010), while others report significantly less keratinisation in the 
inner foreskin compared to the outer foreskin (Ganor and Bomsel, 2011; Lemos et al., 2014; 
McCoombe and Short, 2006; Patterson et al., 2002).  
Similar to the controversy in the comparable degree of keratinisation, there are also 
mixed reports in the comparable abundance of immune cells in the inner and outer foreskin. 
The inner and outer foreskin both contain Langerhans cells in the epidermis (Dinh et al., 2015; 
Ganor et al., 2010; McCoombe and Short, 2006; Patterson et al., 2002; Szabo and Short, 
2000; Zhou et al., 2011) and, in the dermis, macrophages and DCs (Donoval et al., 2006; Liu 
et al., 2014; McCoombe and Short, 2006; Patterson et al., 2002). In one study, dendrites of 
Langerhans cells were observed to extend through the epithelial cells to within 4.8µm of the 
epithelial surface of the inner foreskin, compared to the outer foreskin in which the dendrites 
only reached within 20µm of the surface due to the increased level of keratinisation 
(McCoombe and Short, 2006). Similar to the glans penis, CD4+ and CD8+ T cells are also 
present in the dermis, most of which are memory CD8+ T cells, which are also present in the 
epidermis (Donoval et al., 2006; Ganor et al., 2010; Liu et al., 2014; McCoombe and Short, 
2006; Patterson et al., 2002; Prodger et al., 2014; Szabo and Short, 2000; Zhou et al., 2011). 
Whilst some studies have reported no difference in the abundance of Langerhans cells 
between the inner and outer foreskin (Dinh et al., 2015; Liu et al., 2014), the majority have 
reported significantly more in the former (Donoval et al., 2006; Ganor et al., 2010; Liu et al., 
2014; McCoombe and Short, 2006; Patterson et al., 2002). As well as Langerhans cells, there 
are also more epidermal CD4+ T cells in the inner foreskin compared to the outer foreskin 
(Dinh et al., 2015; Lemos et al., 2014; Liu et al., 2014). There are slightly more lymphoid 
aggregates in the inner foreskin compared to the outer (Liu et al., 2014; Patterson et al., 2002), 
which are also located closer to the epithelium (Liu et al., 2014). The differences in epithelium 
and immune subsets between inner and outer foreskin may contribute to differences in 
susceptibility of each site to sexually transmitted infections (Dinh et al., 2015; Liu et al., 2014).  
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1.1.3.3. Mucosal immunity of the anorectal tract 
The distinction between the anal canal and rectum differs between a surgical and 
anatomic perspective.  The ‘surgical’ anal canal extends from the anal verge, which lies just 
within the border of the external anus, to the anorectal ring, a palpable ring indicated by the 
end of the internal sphincter muscle (Nivatvongs et al., 1981; Sabiston and Townsend, 2012).  
The ‘anatomic’ anal canal separates the rectum from the anal canal based on their distinct 
epithelium and embryologic origin, endoderm and proctodeum respectively, and extends from 
the anal verge to the dentate line (Nivatvongs et al., 1981; Sabiston and Townsend, 2012).  
As the majority of published studies on the rectum and anal canal use the surgical definition, 
for consistency with the literature henceforth ‘anal canal’ will refer to the surgical definition 
(Figure 1.5). Furthermore, this reflects our collaboration with the surgeons who provided our 
rectum and anal specimens. 
The anorectal tract is exposed to numerous infectious and inflammatory stimuli, not all 
of which requires a response.  As a result, the immune cells in the mucosa need to act in a 
delicate balance between mounting a response against invading pathogens and inducing 
tolerance against the commensal microbiota. 
 
i. Rectum 
The rectum extends from the sigmoid colon to the anorectal ring, spanning 12 to 15cm 
in length (Mahadevan, 2014; Yun et al., 2008).  The rectal mucosa contains three sublayers, 
the epithelium, lamina propria and muscularis mucosa, which is folded into deep crypts, or 
intestinal glands (Fiore, 1967; Mahadevan, 2014; Marieb and Hoehn, 2007a; Porth, 2007; 
Prasad, 2007; Ross and Pawlina, 2006).  The muscularis mucosae is a thin smooth muscle 
layer that contributes to the folding of the rectal mucosa (Marieb and Hoehn, 2007a; Ross and 
Pawlina, 2006).  The mucosa and underlying submucosa is further folded into rectal columns 
(Fiore, 1967).  The luminal surface of the rectum is lined with Type I mucosa (Iwasaki, 2010). 
The epithelium consists of simple columnar cells, most of which are mucous-secreting goblet 
cells (Mahadevan, 2014; Marieb and Hoehn, 2007a; Porth, 2007; Prasad, 2007; Ross and 
Pawlina, 2006).  Unlike in the vagina (see section 1.1.3.1.), the mucous secreted by rectal 
goblet cells is of a neutral pH (McNeil et al., 1987), but contains antimicrobial agents (Romas 
et al., 2014).  Furthermore, the epithelial cells have rapid turnover (Porth, 2007), which 
increases the difficulty of inhabitation by microbes.  The lamina propria underlying the 
epithelium sits between the glands and consists of loose areolar connective tissue that is rich 
with capillaries and lymphoid follicles (Iwasaki, 2010; Mahadevan, 2014; Marieb and Hoehn, 
2007a).  
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Figure 1.5. Anatomy and histology of anorectal tract. The anorectal tract consists of the 
proximal rectum and distal anal canal.  The anal canal extends from the proximal anorectal 
ring to the distal anal verge, and consists of three regions: the colorectal zone, anal transitional 
zone (AZT), and the squamous zone.  The colorectal zone is lined with type I mucosa, which 
is continuous with that of the rectum, that abruptly changes in the anal transitional zone to 
type II mucosa (anoderm), which lines the squamous zone. The colorectal zone and anal 
transitional zone contain multiple anal columns and the anal sinuses between them. The distal 
termination of the anal columns is marked with the pectinate line, which also marks the 
termination of type II mucosal tissue. Figure adapted from (Iwasaki, 2010) and (Seidel et al., 
2011). 
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The majority of studies on the immune subsets of the large intestine are conducted on 
colon, and as a result little is known about the immune subsets within the rectum. The few 
studies that have looked at the immune subsets in the rectum have observed T cells in the 
epithelium and lamina propria (McElrath et al., 2013; Patyka et al., 2015), some of which were 
CD4+ (Patyka et al., 2015).  The same studies observed DCs and macrophages in the lamina 
propria (Hussain and Lehner, 1995; Patyka et al., 2015), and in one, DCs were observed to 
extend their dendrites into the lumen (Patyka et al., 2015), similar to what has been observed 
in colon (Cavarelli et al., 2013). 
 
ii. Anal canal 
The anal canal is approximately 4cm in length and extends from the distal anal verge, 
which lies just inside the exterior anus, to the proximal anorectal ring (Mahadevan, 2014; 
Nivatvongs et al., 1981). It can be divided into three zones of roughly equal length according 
to the distinct epithelium found in each (Ross and Pawlina, 2006). From the anorectal ring to 
the anal verge, these regions are the colorectal zone, the anal transitional zone, and the 
squamous zone (Figure 1.5) (Ross and Pawlina, 2006). The colorectal zone consists of Type 
I mucosa that is indistinguishable from that in the rectum (Iwasaki, 2010; Mahadevan, 2014; 
Ross and Pawlina, 2006). This zone contains vertical folds that form the anal columns, and 
the anal sinuses and valves which are the recesses between (Mahadevan, 2014; Marieb and 
Hoehn, 2007a; Prasad, 2007; Ross and Pawlina, 2006). Within the anal sinuses are the 
openings of anal glands, which are ducts lined with stratified columnar epithelium that secrete 
mucous onto the surface (Mahadevan, 2014; Marieb and Hoehn, 2007a; Ross and Pawlina, 
2006). The lamina propria underlying the colorectal zone contains numerous lymphoid 
aggregates, which form part of the MALT, and are often found surrounding the anal glands 
(Iwasaki, 2010; Prasad, 2007; Ross and Pawlina, 2006). The anal transitional zone 
accommodates the transition from the simple columnar epithelium in the colorectal zone to 
the squamous epithelium in the squamous zone, with an area of stratified columnar or cuboidal 
epithelium (see Figure 1.5) (Ross and Pawlina, 2006). The lower line of the anal transitional 
zone is marked with a narrow line called the pectinate line (see Figure 1.5), which also marks 
the termination of intestinal glands and the lower margins of the anal sinuses (Marieb and 
Hoehn, 2007a; Prasad, 2007; Sabiston and Townsend, 2012). The squamous zone is lined 
with type II mucosa, termed anoderm, which merges with the true skin at the anal verge (Fiore, 
1967; Iwasaki, 2010; Mahadevan, 2014; Marieb and Hoehn, 2007a; Ross and Pawlina, 2006; 
Sabiston and Townsend, 2012). 
Similar to rectum, little is known about the immune subsets that reside within the anal 
canal, and less still on the specific regions. Gervaz et al. 1995 identified DCs and T cells in 
the epidermis (Langerhans cells) and dermis. Of the T cells, CD8+ cells were more abundant 
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in the epithelium, while there were similar numbers of CD4+ cells and CD8+ cells in the lamina 
propria (Gervaz et al., 1995).  
 
1.1.4. Concluding remarks 
Human skin has been studied extensively in regards to its role in immunity, including 
the immune subsets that reside within its layers and how they survey for invading pathogens. 
Mucosal surfaces, such as those that line the anogenital tracts, are structurally weaker barriers 
than skin but are exposed to a far greater array of pathogens. The tissues that make up the 
anogenital tract differ between region (genital and anorectal) and gender, and are exposed to 
very different environments, which is reflected in the differences in their mucosal surfaces. 
Furthermore, the delicate balance between tolerance and immunity is dictated by the various 
immune subsets that reside within these mucosal sites. Due to the difficulty in obtaining 
healthy human tissue from anogenital tracts, other than the female genital tract, these tissues 
have not been extensively studied in regard to their immune subset profile, especially the 
rectum and anal canal. A more comprehensive study of the immune subsets, especially DCs 
and macrophages, in the anogenital tract could prove invaluable in understanding the 
susceptibility of this area to invading pathogens, specifically sexually transmitted infections. 
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1.2. The Human Mononuclear Phagocyte System 
 The mononuclear phagocyte system consists of a group of leukocytes that are 
specialised for antigen processing and presentation, and are therefore often referred to as 
antigen presenting cells (Guilliams et al., 2014; Haniffa et al., 2015a; van Furth et al., 1985). 
Mononuclear phagocytes, including DCs, macrophages and monocytes play a crucial role in 
homeostasis, inflammation, immunity, tolerance and development (Haniffa et al., 2015a; 
Natsuaki et al., 2014; Schlitzer et al., 2015). The mononuclear phagocyte system was 
originally used to classify macrophages and monocytes, with DCs being included later. It was 
first believed that macrophages and DCs were derivatives of monocytes, however 
transcriptomic and ontogeny studies have shown that they cluster and develop separately 
(Haniffa et al., 2012; Harman et al., 2013a; Lundberg et al., 2013; McGovern et al., 2014b; 
Miller et al., 2012), and will be discussed further in section 1.2.1.2.  
DCs are bone-marrow derived cells found in blood, lymphoid and non-lymphoid 
tissues, including skin, intestines, liver, lung and tonsils. They were first identified in 1868 by 
Paul Langerhans, who mistakenly took epidermal Langerhans cells for a nerve cell due to their 
dendrite-like processes (Langerhans, 1868). It was over a century later that Inga Silberberg 
showed that they played a role in immunity (Silberberg, 1973) and seminal work in mice by 
Nobel laureate Ralph Steinman established them as a class of antigen presenting cells 
(Steinman and Cohn, 1973, 1974; Steinman et al., 1974). DCs express a wide variety of 
surface molecules that they use to capture pathogens, which they subsequently process and 
present to lymphocytes. Different DC subsets express a unique repertoire of surface protein 
and cytokine secretion profiles, which is reflected in their unique function in regards to the 
magnitude, type (immunogenic or tolerogenic) and specificity of the immune response elicited. 
The key characteristics that have been used to distinguish DCs from macrophages (Haniffa et 
al., 2009; McGovern et al., 2014b; Segura et al., 2013b) and monocytes (Cros et al., 2010) 
are their ability to prime naïve T cells, migratory capacity and morphology (Angel et al., 2006; 
Haniffa et al., 2015a; Haniffa et al., 2015b; Lenz et al., 1993; Nestle et al., 1993; Schlitzer et 
al., 2015; Wang et al., 2014).  
Monocytes are highly plastic cells, which, depending on the stimulation they receive, 
are recruited to tissues where they can differentiate into a variety of immune subsets (Ginhoux 
and Jung, 2014; Ziegler-Heitbrock, 2014). Blood monocytes are frequently used to generate 
model systems of macrophages (monocyte-derived macrophages; MDMs) and DCs 
(monocyte-derived DCs; MDDCs) using GM-CSF alone or together with IL-4, respectively 
(Becker et al., 1987; Randolph et al., 1998; Randolph et al., 1999; Sallusto and Lanzavecchia, 
1994; Zhou and Tedder, 1996). Infiltrating blood monocytes contribute to the tissue 
macrophage population, but are distinct from tissue-resident macrophages. 
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Macrophages reside in every tissue throughout the body and in some cases have 
unique names and specific functions depending on the tissue in which they reside, for example 
Kupffer cells in the liver, microglia in the brain, and osteoclasts in the skeletal system 
(Mantovani et al., 2013; Varol et al., 2015). Unlike DCs, macrophages do not tend to migrate 
out of tissue, and are therefore considered fixed tissue residents (Wang et al., 2014). They 
have an enhanced ability to phagocytose apoptotic and necrotic cells and pathogens, but are 
inefficient antigen presenters (Varol et al., 2015). They are also able to produce a range of 
immune modulatory molecules (Schultze et al., 2015). Macrophages are highly plastic cells 
that are able to change their functional properties depending on the local signals they receive 
(Mantovani et al., 2013; Sica and Mantovani, 2012; Varol et al., 2015). This is evident in the 
two main subsets of macrophages, ‘classically’ and ‘alternatively’ activated M1 and M2 
macrophages, respectively. M1/M2 macrophages are generally distinguished by their 
differential cytokine secretion profile, with IFNγ and TNFα indicative of pro-inflammatory M1, 
and IL-4, IL-10 and glucocorticoids indicative of anti-inflammatory M2 (Martinez and Gordon, 
2014). 
Much of what is currently known about the mononuclear phagocyte system was first 
shown in mice, and similarities to humans found later or inferred. In humans, most work has 
been carried out using blood and skin, as these are more readily accessible. As this thesis is 
focused on human tissues and the DCs and macrophages that reside within them, the 
following review will focus on human DCs and macrophages, unless otherwise stated. 
 
1.2.1. Nomenclature and classification 
DCs, monocytes and macrophages have often been grouped according to location, 
phenotype and function (Guilliams et al., 2014); however, recent characterisation techniques 
have included transcriptomic analysis, which in some cases has resulted in re-classification of 
subsets and conflict/controversy in the literature as to the correct naming of a cell as a DC, 
macrophage or monocyte. This is further compounded by subsets possessing characteristics 
from more than one cell type, for example there is a CD14 expressing dermal subset that 
displays features attributed to both DCs and macrophages (McGovern et al., 2014b), and a 
subset of blood CD16 expressing cells that displays features of both DCs and monocytes 
(Hänsel et al., 2011). Characteristics can also converge due to the activation state of the cell 
or method of isolation/detection. This is especially apparent in states of inflammation, during 
which resident mononuclear phagocytes undergo phenotypic changes and, in the case of 
tissue, other mononuclear phagocytes infiltrate.  
The mononuclear phagocyte system can be split into three compartments: blood, 
lymphoid tissue (e.g. lymph nodes and spleen) and non-lymphoid tissue (e.g. skin and 
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mucosal surfaces).  The various mononuclear phagocyte subsets will be discussed further 
below in relation to their compartments, and are summarised in Table 1.2. 
 
1.2.1.1. Blood 
Mononuclear phagocytes comprise approximately 10-30% of peripheral blood 
mononuclear cells, and represent the human leukocyte antigen (HLA)-DR positive cells that 
are negative for lineage markers CD3 (T cells), CD19/20 (B cells) and CD56 (NK cells) 
(Ziegler-Heitbrock et al., 2010). They can also be distinguished from other HLA-DR+Lin- cells 
by their positive expression of CD4 (Jardine et al., 2013). The vast majority of these are 
monocytes, which are divided into three main groups based on their relative expression of 
CD14 and CD16: CD14+CD16- ‘classical’ monocytes (85% blood monocytes), CD14lowCD16+ 
‘non-classical’ monocytes (10% blood monocytes) and CD14+CD16+ ‘intermediate’ monocytes 
(5% blood monocytes) (Cros et al., 2010; Ziegler-Heitbrock et al., 2010). Within the non-
classical monocyte fraction is a major subset that is positive for the 6-sulpho LacNAc (Slan) 
carbohydrate modification of the P selectin glycoprotein ligand 1 (PSGL-1) (Hänsel et al., 
2013; Schäkel et al., 2002). These cells were originally termed ‘DCs’ because they share 
morphological and T cell stimulatory characteristics attributed to DCs (Schäkel et al., 1998), 
however recent transcriptomic comparisons revealed they were more similar to monocytes 
(Cros et al., 2010), which was supported by their relatively poor ability to present antigen 
compared to classical DCs (Cros et al., 2010; Schäkel et al., 2006). Here they will be referred 
to as Slan+ cells.  
Blood DCs comprise <1% of mononuclear cells, and as well as being HLA-DRhighLin-, 
they are also negative for monocytes markers CD14 and CD16 (MacDonald et al., 2002). They 
consist of plasmacytoid DCs (pDCs), which can be identified by expression of CD123 (IL-3R), 
CD303 (Blood DC antigen 2 (BDCA2); CLEC4C) and CD304 (BDCA4; neurophilin), and 
‘classical’ or ‘myeloid’ DCs (Dzionek et al., 2000; Haniffa et al., 2012; MacDonald et al., 2002; 
Robinson et al., 1999). Classical DCs can be distinguished from pDCs by their positive 
expression of CD11c and can be further divided into two subsets based on their expression of 
CD141/BDCA3 (hereafter blood CD141+ DCs) and CD1c/BDCA1 (hereafter CD1c+ DCs) 
(Dzionek et al., 2000; Haniffa et al., 2012; MacDonald et al., 2002; Ziegler-Heitbrock et al., 
2010). 
Recently, a unified nomenclature was proposed based on ontogeny first and then on 
function, phenotype and location (Guilliams et al., 2014). This has aimed to aid comparison 
between human and animal models as well as comparing mononuclear phagocytes from 
different tissues and compartments. It proposed that blood CD141+ DCs and CD1c+ DCs, 
along with their tissue counterparts, be termed classical DC1 (cDC1) and cDC2 respectively. 
However, this naming system fails to account for tissue subsets that are not present in blood 
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or subsets of the proposed cDC1 and cDC2s that are examined in the experiments described 
in this study, and therefore has not been used in this thesis. 
 
1.2.1.2. Non-lymphoid tissue 
Unlike blood myeloid DCs, which express CD1c or CD141, mononuclear phagocytes 
found in tissue can display significantly different surface expression profiles in steady and 
inflamed states, which can often lead to misinterpretation of specific DC subsets (Durand and 
Segura, 2015). Langerhans cells are characterised by localisation to the epidermal layer, 
presence of intracellular Birbeck granules and expression of CD1a, langerin, E-cadherin and 
EpCAM (Angel et al., 2006; Haniffa et al., 2009; Zaba et al., 2007). Dermal mononuclear 
phagocytes represent the CD45+HLA-DR+Lineage- cell population, and consist of multiple 
subsets that have traditionally been discriminated based on their expression of CD1a, CD14 
or CD141 (Haniffa et al., 2012; Lenz et al., 1993; Nestle et al., 1993). Unlike blood, CD1c is 
not exclusively expressed on one tissue mononuclear phagocyte subset, therefore CD1a and 
relative expression of CD11c have been used to define the CD1c+ DC equivalent in tissue 
(hereafter referred to as CD1a+ DCs) (Haniffa et al., 2012). A subpopulation of Langerin+ 
CD1a dermal DCs has recently been described, which are distinct from migrating Langerhans 
cells that express higher levels of CD1a (Bigley et al., 2015).  
Dermal CD14+ cells can be subdivided into at least three populations based on 
differential expression of CD1c and the transglutaminase factor XIIIa (FXIIIa), and presence 
or absence of autofluorescence. Tissue resident macrophages can be distinguished from 
other CD14+ dermal cells by their high autofluorescence and high expression of FXIIIa 
(Haniffa et al., 2009; McGovern et al., 2014b; Wang et al., 2014). CD14+Autofluorescent- cells 
were traditionally referred to as CD14+ DCs, however these have recently been subdivided 
into two populations based on CD1c expression (Durand and Segura, 2015; McGovern et al., 
2014b). The CD14+CD1c- population has been shown to cluster genotypically and functionally 
with monocytes and macrophages, and have therefore been termed monocyte-derived 
macrophages (MDMs) (McGovern et al., 2014b), while the CD14+CD1c+ population will 
hereafter be referred to as CD14+ DCs. 
The tissue equivalent of a blood CD141+ DC was relatively recently described (Haniffa 
et al., 2012), but their identification was made difficult by their low frequency (Haniffa et al., 
2012), and the expression of CD141 on endothelium (Jongbloed et al., 2010) and other dermal 
DCs upon maturation and migration (Chu et al., 2012; Haniffa et al., 2012; Jongbloed et al., 
2010), as well as upregulation of CD1a on maturing CD141+ DCs (Chu et al., 2012; Haniffa 
et al., 2012). Hereafter referred to as CD141+ DCs, these cells can be distinguished by their 
lower expression levels of CD11c and absence of CD14, and therefore represent the 
CD141highCD14-CD11clow cell population. CD141+ DCs can also be identified by their unique 
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expression of C-type lectin receptor domain family 9 member A (CLEC9A) (Huysamen et al., 
2008; Poulin et al., 2012) and XCR1 (Carpentier et al., 2016; Crozat et al., 2010), unfortunately 
the lack of a reliable human XCR1 antibody has hindered its use as a marker. 
Inflammatory DCs and monocyte-like cells, that are distinct from their steady state 
counterparts, can also be found in inflamed skin and synovial and ascitic fluids.  These cells 
include inflammatory dendritic epidermal cells (IDECs) in the epidermis, and TNFα and 
inducible nitric oxide synthase (iNOS) producing DCs (Tip-DCs) and Slan+ cells (Lowes et al., 
2005; Segura et al., 2013b; Zaba et al., 2009) in the dermis. In mice, MDDCs have also been 
observed, which are derived from infiltrating monocytes (León et al., 2007; Rotta et al., 2003), 
and MDDCs can also be generated in vitro from human CD14+ monocytes (Randolph et al., 
1998; Sallusto and Lanzavecchia, 1994; Zhou and Tedder, 1996), however human MDDCs 
have yet to be described in vivo. IDECs can be distinguished from Langerhans cells by their 
absence of Birbeck granules and higher expression of CD206 (mannose receptor; MR) 
(Wollenberg et al., 2002a). Slan+ cells have been observed in steady state, however are 
present in far greater numbers during inflammation (Günther et al., 2012). As with Slan+ cells, 
pDCs, which are rarely observed in healthy skin, have been observed in high numbers in 
inflamed tissues (Nestle et al., 2005; Wollenberg et al., 2002b).  
 Recently four new DC subsets were identified in human intestine based on their 
relative expression of CD103 (integrin αE) and SIRPα (CD172a) (Watchmaker et al., 2014). 
The three most abundant subsets, CD103+SIRPα+, CD103+SIRPα-, CD103-SIRPα+ show 
similarities to CD1a+ DCs, CD141+ DCs and MDMs respectively (Watchmaker et al., 2014), 
and may be their intestinal counterparts, hence highlighting the need for unified nomenclature 
across various tissues and compartments. However, it is of note that CD14-expressing cell 
populations were excluded from this analysis despite the clear evidence in the literature of 
CD14 and DC-SIGN expressing DCs in both the small intestine (Shen et al., 2010), colon 
(Cavarelli et al., 2013) and rectum (Gurney et al., 2005). 
 
1.2.1.3. Lymphoid tissue 
The mononuclear phagocyte population in lymphoid tissues is made up of resident and 
migratory cells. Resident lymphoid mononuclear phagocytes were identified in lymphoid 
tissues that lack afferent lymph nodes (tonsils and spleen) (Haniffa et al., 2012; Mittag et al., 
2011; Segura et al., 2012), and can be distinguished from migratory cells that express higher 
HLA-DR and CD11c (Haniffa et al., 2012). Migratory CD141+ DCs can also be distinguished 
from their resident counterparts by their expression of CD1a and CD1c (Haniffa et al., 2012). 
Resident mononuclear phagocytes include pDCs (Cox et al., 2005; Segura et al., 2012), 
CD1c/CD1a DCs and CD141 DCs (Jongbloed et al., 2010; Mittag et al., 2011; Poulin et al., 
2010; Segura et al., 2012; Summers et al., 2001). CD14+ DCs are not a large contributor to 
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migrating DCs (Haniffa et al., 2012), rather the majority of CD14+ cells in lymph nodes are 
likely to be blood-borne (Jongbloed et al., 2010; Mittag et al., 2011; Poulin et al., 2010; Segura 
et al., 2012; Summers et al., 2001). Migrating Langerhans cells can be identified in skin 
draining lymph nodes by langerin and higher CD1a expression (Angel et al., 2006). 
 
1.2.2. Blood dendritic cells 
1.2.2.1. CD1c+ dendritic cells 
 CD1c+ DCs are 10 times more abundant in blood than CD141+ DCs, comprising 
approximately 45% of blood DCs (MacDonald et al., 2002). They are identified by their surface 
expression of CD1c, CD11b, CD11c, CD13, CD33, CD45RO and SIRPα (Cella et al., 1999; 
MacDonald et al., 2002; Mittag et al., 2011). CD1c+ DCs express a diverse range of receptors 
that aid pathogen uptake, processing and presentation.  They express TLRs 1-10 (Harman et 
al., 2013a; Hémont et al., 2013; Lundberg et al., 2013), CLEC6A (Dectin-2) and CLEC7A 
(Dectin-1) (Harman et al., 2013a; Lundberg et al., 2013), as well as DEC205 (CD205; 
CLEC13B) and MR (CD206; CLEC13D) (Harman et al., 2013a; Segura et al., 2012; Zaba et 
al., 2007). Upon stimulation they secrete IL-1α, IL-1β, IL-6, IL-8, IL-10, IL-12 (p40 and p70), 
IL-23, CCL3, CCL4, CCL5, CXCL10, TNFα and IFNβ (Haniffa et al., 2012; Hémont et al., 
2013; Morelli et al., 2005; Nizzoli et al., 2013; Schlitzer et al., 2013). CD1c+ DCs efficiently 
stimulate naïve CD4+ T cells, more so than other blood DCs (MacDonald et al., 2002), but are 
inferior to blood CD141+ DCs at cross-presenting to CD8+ T cells (Bachem et al., 2010; Crozat 
et al., 2010; Haniffa et al., 2012; Jongbloed et al., 2010; Mittag et al., 2011).  
 
1.2.2.2. Blood CD141+ dendritic cells 
 Blood CD141+ DCs comprise approximately 10% of blood classical DCs, and are most 
commonly identified by their high expression of CD141 (Dzionek et al., 2000). They can also 
be identified by their unique expression of CLEC9A (Caminschi et al., 2008; Huysamen et al., 
2008; Poulin et al., 2012; Sancho et al., 2009) and chemokine XC receptor 1 (XCR1) (Bachem 
et al., 2010; Crozat et al., 2010; Dorner et al., 2009), which are conserved across 
compartments and species along with expression of cell adhesion molecule 1 (CADM1) 
(Galibert et al., 2005; Poulin et al., 2010) and IRF8 (Dutertre et al., 2014). 
Blood CD141+ DCs are often referred to as cross-presenting DCs due to their 
enhanced capacity to cross-present to CD8+ T cells in vitro (Crozat et al., 2010; Haniffa et al., 
2012; Joffre et al., 2012; Jongbloed et al., 2010; Poulin et al., 2010). They have also been 
shown to cross-present viral antigens from HIV (Crozat et al., 2010), hepatitis B (Haniffa et al., 
2012), and cytomegalovirus (Bachem et al., 2010) to other DCs. Blood CD141+ DCs can take 
up and present cell-associated material from dead and necrotic cells via CLEC9A (Bachem et 
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al., 2010; Sancho et al., 2009), and through the expression of TLRs 1, 2, 3, 6, 8 and 10 
(Hémont et al., 2013) can sense a variety of stimuli including viral nucleic acids. Depending 
on the stimulation, they produce IL-1α, IL-6, IL-8, IL-12p70, CCL3, CCL4, CCL5, CXCL10, 
TNFα (Haniffa et al., 2012; Hémont et al., 2013; Jongbloed et al., 2010; Nizzoli et al., 2013; 
Poulin et al., 2010), IFNβ and IFNλ (Hémont et al., 2013; Lauterbach et al., 2010; Yoshio et 
al., 2013). Blood CD141+ DCs are also efficient at activating CD4+ T cells (Jongbloed et al., 
2010) and are able to induce Th1 (Hémont et al., 2013; Jongbloed et al., 2010) and Th2 
responses (Yu et al., 2014). 
  
1.2.2.3. Plasmacytoid dendritic cells 
 pDCs were first identified as a result of their ability to secrete high levels of type I 
interferons in response to viruses (Siegal et al., 1999), and represent approximately 45% of 
blood DCs (Dzionek et al., 2000; MacDonald et al., 2002). They can be distinguished from the 
classical DCs by the absence of CD11c, as well as the expression of CD123 (IL-3R), BDCA2 
(CD303; CLEC4C) and BDCA4 (CD304) (Dzionek et al., 2000; MacDonald et al., 2002). They 
comprise a similar percent of blood mononuclear cells as CD1c+ DCs (MacDonald et al., 
2002), but unlike CD1c+ tissue equivalent DCs, they are rare in non-lymphoid tissues unless 
inflamed (Nestle et al., 2005; Wang et al., 2014; Wollenberg et al., 2002b; Zaba et al., 2007). 
pDCs are rapidly recruited to sites of inflammation and constitute approximately 20% of HLA-
DR+ cells in lymph nodes (Cox et al., 2005). They express TLRs 1, 6, 8, and 10 (Hémont et 
al., 2013),  as well as high levels of TLR7 and TLR9 which gives them an enhanced ability to 
recognise viral single-stranded RNA and DNA (Gilliet et al., 2008). Therefore, pDCs play an 
important role in anti-viral immune responses (McGovern et al., 2014a). As well as production 
of type I interferons, pDCs also produce IL-1α, IL-6, IL-8, CCL3, CCL4, CXCL10 and TNFα. 
As with CD1c+ DCs and blood CD141+ DCs, pDCs can cross-present (Di Pucchio et al., 2008; 
Hoeffel et al., 2007; Segura et al., 2013a; Tel et al., 2013). They are able to induce both pro-
inflammatory (Th1 and Th2) (Rissoan et al., 1999) and tolerogenic responses (Ito et al., 2004; 
Martín-Gayo et al., 2010; Moseman et al., 2004). 
 
1.2.3. Non-lymphoid tissue macrophages and dendritic cells 
1.2.3.1. Langerhans cells 
 Langerhans cells reside in the epidermal layer of skin and type II mucosal surfaces, 
and unlike CD1a+ DCs and CD14+ DCs/MDMs, possess self-renewal capacity (Czernielewski 
and Demarchez, 1987; Kanitakis et al., 2011; Kanitakis et al., 2004) and remain donor derived 
for months to years after stem cell and limb transplantation respectively (Collin et al., 2006; 
Kanitakis et al., 2011; Kanitakis et al., 2004). This, together with high CD1a expression and  
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Table 1.2. Comparison of human mononuclear phagocytes 
 Blood Skin 
 CD1c DCs CD141 DC pDC LC CD1a DC CD141 DC CD14DC/MDM Macrophage 
Identifying 
markers 
CD1c+ 
CD11b+ 
CD11c+ 
CD141- 
 
HLA-DRmid 
CD1c- 
CD11clow 
CLEC9A+ 
XCR1+ 
CD11c- 
CD123+ 
BDCA2+ 
BDCA4+ 
CD11clow 
CD1ahigh 
EpCAM+ 
CD1c+ 
E-
cadherin+ 
Langerin+ 
CD1a+ 
CD11c+ 
CD141- 
SIRPα+ 
CD141+ 
CD1c-/low 
CD11clow 
CD14- 
HLA-DRlow 
CD1c+ (DCs) 
CD1c-/low (MDMs) 
CD11b+ 
CD11c+ 
CD14+ 
CD16- 
Auto-fluorescence- 
Auto-
fluorescence+ 
CD14+ 
FXIIIahigh 
Surface 
expression 
CD13+ 
CD45RO+ 
Siglec-3+ 
SIRPα+ 
 
CXCR3+ 
CADM1+ 
SIRPα- 
 
  CCR7+ 
CD40+ 
CD80+ 
CD83+ 
CD86+ 
subset of 
langerin+ 
CD103+ in 
intestine 
CXCR3+ 
CADM1+ 
CD40+ 
CD80+ 
CD86+ 
CCR7+ 
CD103+ in 
intestine 
SIRPα-/low 
CD80low 
CD86low 
CD141+ on activation 
DC-SIGN+ 
CD163+ 
CX3CR1+ 
SIRPα+ 
 
CD64+ 
DC-SIGN+ 
SIRPα+ 
 
TLRs 1-10 1, 2, 3, 6, 8, 
10 
1, 6, 7, 8, 9, 
10 
1, 2, 3, 6, 
10 
1-9 3 1-9 ND 
Cytokine and  
Chemokine 
secretion 
IL-1 
IL-6 
IL-8 
IL-10 
IL-12 
IL-23 
CCL3 
CCL4 
CCL5 
CXCL10 
TNFα 
IFNβ 
IL-1α 
IL-6 
IL-8 
IL12 
CCL3 
CCL4 
CCL5 
CXCL10 
TNFα 
IFNβ 
IFNλ 
IL-1α 
IL-6 
IL-8 
CCL3 
CCL4 
CXCL10 
IFNα 
TNFα 
IL-8 
CXCL10 
IL-1β 
IL-6 
IL-8 
IL-10 
IL-23 
CXCL10 
TNFα 
 
IL-1β 
IL-6 
IL-8 
IL-10 
IL-23 
CXCL10 
TNFα 
 
IL-1β 
IL-6 
IL-8 
IL-10 
IL-1 
IL-6 
IL-10 
IL-23 
TNFα 
DC, dendritic cell; IL, Interleukin; LCs, Langerhans cells; MDM, monocyte-derived macrophage; ND, not determined; pDCs, plasmacytoid dendritic cells; TLR, 
Toll-like Receptor 
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Birbeck granules distinguishes Langerhans cells from langerin+CD1a+ DCs in the dermis (see 
section 1.2.3.3) (Bigley et al., 2015).  
Langerhans cells are highly immunogenic, with the ability to polarise Th1, Th2 (Furio 
et al., 2010; Morelli et al., 2005), Th17 (Mathers et al., 2009) and Th22 (Fujita et al., 2009) 
responses, but also show tolerogenic properties, including stimulation of regulatory T cells 
(Tregs) (Seneschal et al., 2012). They express TLRs 1, 2, 3, 5, 6 and 10 (Flacher et al., 2006), 
and produce high amounts of IL-8 and CXCL10, but little to no IL-1β, IL-6 and IL-10 (Haniffa 
et al., 2012). Langerhans cell persistence and self-renewal in skin has also lead to the belief 
by some that Langerhans cells should be classified as macrophages rather than DCs 
(Guilliams et al., 2014), which is supported by their relative inefficiency at cross-presentation 
(Haniffa et al., 2012; van der Vlist et al., 2011). 
 
1.2.3.2. CD1a+ Dendritic Cells 
CD1a+ DCs are present in lymphoid tissue, including spleen and lymph nodes, and 
other non-lymphoid tissue such as liver, gut, lung and skin (Haniffa et al., 2012; Mittag et al., 
2011; Segura et al., 2012; Wang et al., 2014). In skin, they are the most abundant dermal DC 
(Haniffa et al., 2012; Wang et al., 2014). Similar to blood CD1c+ DCs, they express CD1c, 
CD11c and SIRPα (MacDonald et al., 2002; Schlitzer et al., 2013; Segura et al., 2012), but 
downregulate the tissue homing receptor CLA (Haniffa et al., 2012). In the intestine there is a 
subset of DCs that cluster with CD1a+ DCs and also express CD103 (Watchmaker et al., 
2014). Tissue CD1a+ DCs are more activated than their blood counterparts, showing higher 
expression of co-stimulatory and maturation markers CD40, CD80, CD83, and CD86 (Angel 
et al., 2007; Haniffa et al., 2012; McLellan et al., 1998; Watchmaker et al., 2014), and lymph 
node homing receptor CCR7 (Angel et al., 2006; Haniffa et al., 2012). The proposed intestinal-
equivalent CD1a+ DCs (CD103+SIRPα+ population) also express CCR6, which has been 
implicated in intestinal homing (Watchmaker et al., 2014). They are distinct from Langerhans 
cells that express CD1a at higher levels and also express EpCAM.   
Similar to blood CD1c+ DCs, CD1a+ DCs express TLRs 1-9, however lack TLR 10 
(Harman et al., 2013a; Lundberg et al., 2013), and produce IL-1β, IL-6, IL-8, IL-10, IL-23, 
CXCL10 and TNFα (Haniffa et al., 2012). In non-lymphoid tissue CD1a+ DCs are inferior to 
CD141+ DCs at cross-presentation (Haniffa et al., 2012; Yu et al., 2013), unlike lymph node 
resident CD1a+ DCs that have equivalent cross-presenting ability as CD141+ DCs (Segura et 
al., 2013a). CD1a+ DCs express IRF4 (Schlitzer et al., 2013) and are able to polarise Th1, 
Th2 and Th17 responses (McGovern et al., 2014b; Persson et al., 2013; Schlitzer et al., 2013; 
Watchmaker et al., 2014), and those found in intestine have also been shown to stimulate 
Tregs (Watchmaker et al., 2014). CD1a+ DCs have been observed in lymphatic vessels of 
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explant tissue (Wang et al., 2014), and in mesenteric (Watchmaker et al., 2014) and skin 
draining lymph nodes (Haniffa et al., 2012; Segura et al., 2012).   
 
1.2.3.3. Langerin+CD1a+ dermal dendritic cells 
 Traditionally langerin has been used to distinguish epidermal Langerhans cells from 
CD1a+ DCs, but a langerin-expressing subset of CD1a+ DCs was proposed by Harman et al. 
after gene comparison (Harman et al., 2013a), and recently identified and characterised as a 
subset distinct from Langerhans cells and CD1a+ DCs (Bigley et al., 2015). In comparison to 
Langerhans cells, langerin+CD1a+ DCs express lower levels of CD1a and langerin, which by 
microscopy is diffuse in comparison to the bright perinuclear staining observed in Langerhans 
cells (Bigley et al., 2015). Langerin+CD1a+ DCs cluster with CD1a+ DCs by gene expression 
and phenotype (Bigley et al., 2015; Harman et al., 2013a), showing positive expression of 
CD11b, CD11c and CD13, which are low to negative on Langerhans cells (Bigley et al., 2015). 
 Langerin+CD1a+ DCs follow similar replacement kinetics as CD1a+ DCs following 
haematopoietic stem cell transplantation (HSCT), which are distinct from Langerhans cells 
that are slow to replace (Bigley et al., 2015). They are also absent alongside CD1a+ DCs in 
DC deficiency syndromes in which Langerhans cells persist (Bigley et al., 2011; Bigley et al., 
2015). These cells have also been observed in mucosal tissues including the lung (Bigley et 
al., 2015) and intestine (Welty et al., 2013), in which Langerhans cells are not usually present. 
As such, these cells are unlikely to be a migrating subset of Langerhans cells, but rather 
represent a distinct subset closely resembling CD1a+ DCs (Bigley et al., 2015). 
 
1.2.3.4. CD141+ dendritic cells 
 Cross presenting DCs similar to blood CD141+ DCs can also be found in lymphoid 
tissue, including lymph nodes, bone marrow, spleen and tonsils (Jongbloed et al., 2010; Mittag 
et al., 2011; Poulin et al., 2012; Segura et al., 2012), and non-lymphoid tissue such as the 
liver, skin, gut and lung (Haniffa et al., 2012; Schlitzer et al., 2013; Watchmaker et al., 2014). 
As mentioned in section 1.2.1.2., correct identification of CD141+ DCs is reliant on the 
differential expression of a variety of makers, including positive expression of CLEC9A, XCR1, 
CADM1 and in intestine CD103 (Watchmaker et al., 2014), and low to negative expression of 
CD1c, CD11b, CD11c, CD14 and SIRPα (Haniffa et al., 2012; Watchmaker et al., 2014). 
CD141+ DCs have a similar surface expression profile to blood CD141+ DCs, but have a more 
activated phenotype, displayed in the expression of co-stimulatory markers CD40, CD80 and 
CD86 (Haniffa et al., 2012; Watchmaker et al., 2014). CD141+ DCs also upregulate lymphoid 
homing receptors CCR7 and CXCR3 (Haniffa et al., 2012; Watchmaker et al., 2014). 
Enhanced cross-presentation that is observed in blood CD141+ DCs is conserved in skin 
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CD141+ DCs (Haniffa et al., 2012), however lymphoid resident DC subsets have similar cross-
presentation abilities (Segura et al., 2013a). CD141+ DCs produce IL-1β, IL-6, IL-8, IL-10, IL-
23, CXCL10 and TNFα, but unlike blood CD141+ DCs do not produce IL-12 (Haniffa et al., 
2012). Intestinal CD141+ DCs have also been shown to weakly induce a Treg response in 
vitro (Watchmaker et al., 2014). 
 
1.2.3.5. CD14+ dendritic cells and monocyte-derived macrophages 
 CD14+ non-autofluorescent cells present in tissue (Haniffa et al., 2009) were classified 
as DCs until recent studies showed that these consist of two separate populations, 
CD14+CD1c+ DCs and CD14+CD1c-/low monocyte-derived macrophages (McGovern et al., 
2014b). Because these two populations have been grouped together and have yet to be 
studied as separate cells types, very little is known about the functional differences between 
them. This may partly explain why this mixed population display characteristics representative 
of DCs, monocytes and macrophages. Here, ‘CD14+ DCs/MDMs’ will be used to refer to the 
mixed population of cells. CD14+ DCs/MDMs express high levels of HLA-DR and CD11c 
typical of DCs, but also display expression typical of macrophage and monocyte markers such 
as CD11b, CD163, CX3CR1, DC-SIGN (CD209) and FXIIIa (Angel et al., 2007; de Gruijl et 
al., 2006; Klechevsky et al., 2008; McGovern et al., 2014b; Ochoa et al., 2008). Similar to 
CD1c+ DCs, CD14+ DCs/MDMs are SIRPα+ and express TLRs 1-9 (Matthews et al., 2012). 
Upon migration from skin explants these cells upregulate CD141 expression (Chu et al., 2012), 
thereby adding to the difficulty of distinguishing CD141+ DCs from other dermal DCs. In 
response to stimulation they secrete IL-1β, IL-6, IL-8 and IL-10 (Chu et al., 2012; Haniffa et 
al., 2012; Klechevsky et al., 2008; Matthews et al., 2012), displaying a more tolerogenic 
phenotype. 
CD14+ DCs/MDMs are less activated than CD1a+ DCs, with lower expression of co-
stimulatory markers CD80 and CD86 and an absence of CD83 (Angel et al., 2007; de Gruijl 
et al., 2006; Haniffa et al., 2009; Haniffa et al., 2012). This is reflected in their lower efficiency 
in stimulating naïve T cells (Angel et al., 2007; Haniffa et al., 2009; Klechevsky et al., 2008; 
Penel-Sotirakis et al., 2012). CD14+ DCs/MDMs are also able to induce B cell activation and 
T follicular helper polarisation of CD4+ T cells (Klechevsky et al., 2008; Matthews et al., 2012).  
Despite being first identified in migratory skin cultures, which contributed to their initial 
classification as a DC (Haniffa et al., 2009; McGovern et al., 2014b; Nestle et al., 1993), 
CD14+ DCs/MDMs are similar to macrophages in that they lack CCR7 and have yet to be 
observed in lymph of lymphatic vessels (McGovern et al., 2014b; Morandi et al., 2013). It is 
also difficult to determine whether they contribute to the CD14+DC-SIGN+ population in lymph 
nodes, or whether these are macrophages or blood-derived cells (Angel et al., 2009; Segura 
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et al., 2012). Despite differing in migratory function from DCs, CD14+ DCs/MDMs are rapidly 
replaced following HSCT, which is characteristic of DCs (Haniffa et al., 2009). 
Recently identified intestinal CD103-SIRPα+ cells transcriptionally align with MDMs, but 
lack CD14 and CD64, and are able to potently induce T cell proliferation (Watchmaker et al., 
2014), therefore highlighting the influence of microenvironments on the function of these cells. 
However, the exclusion of CD14+ cells from this analysis is intriguing and makes proper 
conclusions about alignment of these cell types questionable. 
 
1.2.3.6. Macrophages 
Macrophages are highly phagocytic cells that reside in tissue and play a crucial role in 
scavenging and destroying microbes and dead cells. Similar to CD14+ DCs/MDMs, they 
express CD14, CD11b, SIRPα, DC-SIGN, FXIIIa, CD163 (Haniffa et al., 2009; Zaba et al., 
2007) and CD64 (McGovern et al., 2014b). Unlike dermal DCs, macrophages do not express 
CCR7 and are not found to migrate from tissue explants (Haniffa et al., 2009; Schlitzer et al., 
2013), nor are they observed in lymphatic vessels (Wang et al., 2014). Macrophages are also 
poor stimulators of naïve CD4+ T cells, and depending on stimulation, they secrete IL-1, IL-6, 
IL-10, IL-23 and TNFα (Haniffa et al., 2009). Unlike CD14+ DCs/MDMs, macrophages are 
also slow to replace ablated cells in stem cell transplant recipients (Haniffa et al., 2009). 
 
1.2.3.7. Inflammatory mononuclear phagocytes 
 In states of inflammation, various mononuclear phagocytes have been observed that 
are distinct from those present in steady state (Fujita et al., 2011; Haniffa et al., 2015b; Hänsel 
et al., 2011; Lowes et al., 2005; Segura et al., 2013b; Serbina et al., 2003; Wollenberg et al., 
1996). All the inflammatory cells so far described express high levels of HLA-DR and CD11c, 
and can be found in the epidermis (Wollenberg et al., 1996), dermis (Hänsel et al., 2011; 
Lowes et al., 2005; Segura et al., 2013b), and synovial and ascites fluid (Segura et al., 2013b). 
At least three subsets have so far been identified and include inflammatory epidermal DCs 
(IDECs) (Wollenberg et al., 1996), TNFα and inducible nitric oxide synthase (iNOS)-producing 
DCs (TIP-DCs) (Lowes et al., 2005; Serbina et al., 2003) and Slan+ cells (Hänsel et al., 2013; 
Hänsel et al., 2011). Tip-DCs and Slan+ cells have been observed in psoriatic skin lesions 
(Hänsel et al., 2011; Lowes et al., 2005), and the latter are also observed in lupus 
erythematosus (Hänsel et al., 2013) and steady state skin (Günther et al., 2012). An 
accumulation of Slan+ cells has also been observed in cerebrospinal fluid and brain lesions in 
multiple sclerosis (Thomas et al., 2014). Slan+ cells respond rapidly to inflammatory stimuli 
and secrete IL-6 and IL-23, and large amounts of TNFα, IL-1β and IL-12 (Hänsel et al., 2013; 
Hänsel et al., 2011; Schäkel et al., 2002; Schäkel et al., 2006). Tip-DCs and Slan+ cells are 
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both CD14-CD1c-, which distinguishes them from a CD14+CD1c+ inflammatory DC that was 
recently observed in inflamed synovial and ascites fluid (Segura et al., 2013b). CD14+CD1c+ 
inflammatory DCs express CD1a, CD11b, MR, SIRPα and FcεR1 (Segura et al., 2013b). 
IDECs, which were observed in the skin of patients with atopic dermatitis, express CD1a, 
CD11b, MR and FcεR1 in common with CD14+CD1c+ inflammatory DCs, and also express 
CD11c and DC-SIGN (CD209) (Wollenberg et al., 1996; Wollenberg et al., 2002a). Tip-DCs, 
Slan+ cells and CD14+CD1c+ inflammatory DCs, but not IDECs drive Th17 responses (Hänsel 
et al., 2011; Lowes et al., 2005; Segura et al., 2013b).  
 In mice, infiltrating monocytes differentiate into MDDCs and macrophages (Eidsmo et 
al., 2009; León et al., 2007; Rotta et al., 2003), however this has not yet been confirmed in 
humans. 
 
1.2.4. Dendritic cell and macrophage lineage 
 DCs, macrophages and monocytes are derived from haematopoietic stem cells in 
bone marrow; specifically, they arise from bone marrow precursors (Haniffa et al., 2009), 
including granulocyte macrophage progenitors (GMPs) and multi-lymphoid progenitors 
(MLPs) (Doulatov et al., 2010). The recent discovery of distinct progenitor subsets in cord 
blood and bone marrow has indicated that DCs, monocytes and macrophages arise in a step-
wise manner from progenitors that become increasingly restricted (Lee et al., 2015), 
diagrammatically represented in Figure 1.6. Granulocyte-monocyte-DC progenitors (GMDPs) 
give rise to granulocytes and monocyte-DC-restricted progenitor (MDP) (Lee et al., 2015). 
MDPs in turn develop into monocytes and a DC-restricted progenitor (common DC progenitor; 
CDP) (Lee et al., 2015). CDPs are restricted to the development of pDCs and blood myeloid 
DCs, and also give rise to a circulating myeloid DC progenitor (pre-common DC; pre-CDC) 
(Breton et al., 2015; Lee et al., 2015). Unlike GMDPs, MDPs and CDPs, which are restricted 
to bone marrow and cord blood (Lee et al., 2015), pre-CDCs are also found in blood and 
lymphoid organs, and are restricted to the production of myeloid DCs (Breton et al., 2015). 
GMDPs, MDPs and CDPs are included in GMPs, but are distinct from MLPs (Lee et al., 2015). 
Blood DCs and monocytes may also serve as the precursors for non-lymphoid DCs and 
macrophages, as is evident in DC deficiencies (Bigley et al., 2011), bone marrow transplants 
(Haniffa et al., 2009), and supported by gene arrays (Haniffa et al., 2012; McGovern et al., 
2014b; Watchmaker et al., 2014).  
DC deficiency syndromes have been crucial in identifying key factors necessary for 
DC development, including the gene GATA2 and transcription factor, IFN regulatory factor 
(IRF) 8 (Bigley et al., 2011; Hambleton et al., 2011). Tissue and blood DCs and monocytes 
are absent in DC, monocyte, B, and NK lymphoid (DCML) deficiency syndrome, in which 
individuals are heterozygous for mutations in the transcription factor GATA2 (Bigley et al., 
Chapter 1: Literature Review  Rachel Botting 
39 
 
2011; Dickinson et al., 2011). Similar, IRF8 mutations have been linked to the absence of 
blood and tissue DCs, however monocyte and CD14+ cells persist although at reduced 
numbers (Hambleton et al., 2011). DCML patients also exhibit an absence of multi-lymphoid 
progenitors and reduced numbers of granulocyte macrophage precursors in the bone marrow, 
which supports their role as DC and monocyte precursors (Bigley et al., 2011). Patients with 
DCML retained some Langerhans cells and macrophages (Bigley et al., 2011), suggesting 
these may arise from different progenitors. In mice it has been shown that Langerhans cells 
are derived from embryonic foetal liver monocytes and yolk sac-derived macrophages (Hoeffel 
et al., 2012). If the same is true of human Langerhans cells, it may explain why a subset of 
Langerhans cells remain detectable, independent of GATA2 mutations (Bigley et al., 2011). In 
vitro culture studies have also identified other factors that influence mononuclear phagocyte 
development.  For example, TGFβ and bone morphogenic protein 7 (BMP7) are key factors 
in the differentiation of Langerhans cell-like cells from CD34+ haemopoietic progenitors (Bauer 
et al., 2012; Yasmin et al., 2013). However, their role in vivo has yet to be determined. 
  
Chapter 1: Literature Review  Rachel Botting 
40 
 
  
Chapter 1: Literature Review  Rachel Botting 
41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6. Lineage of human blood and tissue dendritic cells. Blood and tissue DCs are 
derived from bone marrow precursors that arise from haematopoietic stem cells (HSC). 
Granulocyte-macrophage progenitors (GMPs) are a mixed population that include DC 
precursors that give rise to DCs in an increasingly restricted stepwise manner. Development 
is as follows: granulocyte-macrophage-DC progenitors (GMDPs), give rise to granulocytes 
(not shown) and macrophage-DC-restricted progenitors (MDPs). MDPs give rise to monocytes 
and a common DC-restricted progenitor (CDP), which in turn gives rise to plasmacytoid DCs 
(pDCs) and myeloid DCs. CDPs also give rise to pre-common/myeloid DC progenitors (pre-
CDCs), which unlike the other progenitors can be found in blood and are restricted to 
development of CD1c+ DC and CD141+ DC. Monocytes differentiate to macrophages and 
monocyte-derived DCs (MDM) in tissue, while blood CD1c+ DCs and CD141+ DCs are 
believed to be the pre-cursor for dermal CD1a+ DCs and CD141+ DCs, respectively. The 
lineage of dermal CD14+ DCs remains unknown. Full arrows indicate known pathways; 
dashed arrows have yet to be confirmed. 
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1.3. DC and Macrophage Pathogen Recognition Receptors 
 DCs and macrophages are equipped with an array of receptors on their surface for the 
recognition of self and non-self (Pillai et al., 2012; Sancho and Sousa, 2012). Two families of 
receptors that will be discussed further are C-type lectin receptors (CLRs) and sialic acid-
binding IgG-like lectins (Siglecs). Both are widely expressed on immune cells where they are 
involved in regulating the immune system in both health and disease (Pillai et al., 2012; 
Sancho and Sousa, 2012). Here, I will focus on receptors expressed on DCs and 
macrophages, and those known to play a role in pathogen binding, in particular those shown 
to bind HIV-1.  
 CD4, CCR5 and CXCR4 were the first HIV receptors and co-receptors to be identified 
(reviewed in Borggren and Jansson, 2015). Subsequently, members of the CLR and Siglec 
families have shown HIV-binding capacity, and therefore are potential HIV co-receptors 
(Borggren and Jansson, 2015; Zou et al., 2011). 
 
1.3.1. C-type lectin receptors 
 C-type lectins comprise a superfamily of proteins that are identified by the presence of 
one or more C-type lectin-like domains (Drickamer, 1999; Zelensky and Gready, 2005). The 
family consists of more than 1000 proteins that are further divided into 17 subgroups based 
on structure and phylogeny (Zelensky and Gready, 2005). Some C-type lectins act as 
receptors (C-type lectin receptors; CLRs) that recognise carbohydrates, proteins and lipids 
from pathogens (e.g. MR and DC-SIGN) and damaged cells (e.g. CLEC9A), which 
subsequently trigger endocytosis, phagocytosis, microbicidal activity and an array of other 
immune and homeostatic functions (Sancho and Sousa, 2012; Zelensky and Gready, 2005). 
As such, some CLRs function as pattern recognition receptors to activate immune responses, 
while others trigger signalling pathways that inhibit immune responses (Osorio and 
Reis e Sousa, 2011; Sancho and Sousa, 2012). Furthermore, CLRs, such as DEC-205, 
CLEC9A and CLEC12A, have shown potential as targets for DC-targeted vaccine designed 
due to their ability to present antigen to T cells and stimulate a subsequent immune response 
(Caminschi et al., 2009; Caminschi et al., 2008; Lahoud et al., 2009). Two C-type lectin domain 
families (CLECs) are of particular relevance to this thesis as they contain multiple members 
that bind HIV, and will be discussed in further detail below. These are the CLEC4 family, which 
contain a single carbohydrate recognition domain (CRD), and CLEC13 family, which contain 
multiple CRDs (Borggren and Jansson, 2015; Sancho and Sousa, 2012). A more 
comprehensive list of CLRs is detailed in Table 1.3.. 
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Table 1.3. C-type lectin receptors involved in pathogen recognition 
Family Common 
name 
Gene 
Symbol 
Cell Specificity Pathogens 
recognised 
References 
 
CLEC1 
CLEC-1, 
CLEC1A 
CLEC1A DCs, 
macrophages, 
monocytes, 
platelets 
ND (Colonna et al., 2000; 
Sobanov et al., 2001) 
CLEC-2, 
CLEC1B 
CLEC1B DCs, 
macrophages, 
monocytes, 
platelets 
HIV-1, snake 
venom 
 (Chaipan et al., 2006; 
Colonna et al., 2000; 
Sobanov et al., 2001; 
Suzuki-Inoue et al., 
2006) 
 
CLEC4 
DCIR, 
CLEC4A, 
CD367 
CLEC4A Myeloid and 
tissue DCs, 
macrophages, 
monocytes, 
granulocytes, B 
cells 
HIV-1 (Klechevsky et al., 
2010; Lambert et al., 
2011; Lambert et al., 
2008) 
BDCA2, 
CD303, 
CLEC4C,  
CLEC4C pDCs HIV-1 (Dzionek et al., 2000; 
Dzionek et al., 2001; 
Martinelli et al., 2007) 
MCL, 
CLECSF8, 
CLEC4D, 
CD368 
CLEC4D monocytes, 
macropahges, 
neutrophils 
ND (Arce et al., 2004; 
Graham et al., 2012) 
Mincle, 
CLEC4E 
CLEC4E monocytes, 
neutrophils, 
myeloid DCs,  
B cells 
C. albicans,  
M. tuberculosis 
 
(Bugarcic et al., 2008; 
Furukawa et al., 2013; 
Vijayan et al., 2012) 
LSECtin, 
CLEC4G 
CLEC4G DCs, 
macrophages, 
endothelial cells 
Coronaviruses, 
Ebola 
(Gramberg et al., 
2005; Powlesland et 
al., 2008) 
Langerin, 
CD207, 
CLEC4K 
CD207 Langerhans cells, 
langerin+CD1a+ 
DCs 
HIV-1, measles 
virus, Candida 
spp. M. leprae, 
Saccharomyces 
spp., Malassezia 
furfur 
(de Jong et al., 2010c; 
de Witte et al., 2007; 
Hunger et al., 2004; 
Nasr et al., 2014; 
Turville et al., 2003; 
van der Vlist et al., 
2011) 
DC-SIGN, 
CLEC4L 
CD209 DCs, 
macrophages, 
liver sinusoidal 
endothelium 
HIV-1, measles 
virus, SARS, 
dengue virus, 
CMV, HCV, C. 
albicans, bacteria, 
filoviruses 
(Cambi et al., 2003; de 
Witte et al., 2006; 
Gringhuis et al., 
2009a; Halary et al., 
2002; Lai et al., 2006; 
Marzi et al., 2004; 
Marzi et al., 2007; 
Tassaneetrithep et al., 
2003) 
L-SIGN, 
DC-
SIGNR, 
CLEC4M, 
CD299 
CD299 Liver sinusoidal 
endothelium 
HIV-1, HCV, 
SARS, filoviruses 
(Gardner et al., 2003; 
Jeffers et al., 2004; Lai 
et al., 2006; Marzi et 
al., 2004; Marzi et al., 
2007; Snyder et al., 
2005) 
 
CLEC5 
MDL-1, 
CLEC5A 
CLEC5A Monocytes, 
macrophages,  
Dengue virus (Bakker et al., 1999; 
Chen et al., 2008; 
González-Domínguez 
et al., 2015; Inui et al., 
2009) 
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CMV, Cytomegalovirus; DC, dendritic cell; DCAL, DC-associated lectin; DCIR, DC immunoreceptor; 
DC-SIGN, DC-specific ICAM-3-grabbing non-integrin;DEC-205, DC and epithelial cell, 205kDa; 
Dectin, DC-associated C-type lectin; DNGR, DC, NK lecctin group receptor, HBV, Hepatitis B virus; 
HCV, Hepatitis C virus; LOX-1, Lectin-like oxidised low density lipid receptor; LSECtin, Liver 
sinusoidal endothelial cells lectin; L-SIGN, Liver/lymph node-specific ICAM-3-grabbing non-integrin; 
MAH, macrophage antigen H; MCL, Macrophage-restricted C-type lectin; MDDC, monocyte-derived 
DC; MDL, Myeloid DAP12-associating lectin; MDM, monocyte-derived macrophage; MGL, 
macrophage galactose C-type lectin; MICL, Myeloid inhibitory C-type lectin-like receptor; Mincle, 
macrophage-inducible C-type lectin; MR, mannose receptor; ND, not determined; SARS, severe 
acute respiratory syndrome. Common names used throughout this thesis are in bold.    
Family Common 
name 
Gene 
Symbol 
Cell Specificity Pathogens 
recognised 
References 
 
CLEC6 
Dectin-2, 
CLEC6A 
CLEC6A DCs, monocytes, 
macrophages 
Fungi, 
mycobacteria, 
house dust mite 
allergens 
(Barrett et al., 2009; 
McGreal et al., 2006; 
Saijo et al., 2010; Sato 
et al., 2006) 
 
CLEC7 
Dectin-1, 
CLEC7A, 
CD369 
CLEC7A DCs, 
macrophages, 
monocytes, mast 
cells, B cells, 
neutrophils, 
eosinophils 
Fungi, 
Mycobacterium 
spp. 
(Brown, 2006; 
Goodridge et al., 2007; 
Olynych et al., 2006; 
Palma et al., 2006) 
 
CLEC8 
LOX-1, 
CLEC8A 
ORL1 Myeloid DCs, 
monocytes, 
macrophages, B 
cells, in vitro  
MDDCs 
Dead cells (Delneste et al., 2002; 
Mehta and Li, 2002; 
Parlato et al., 2010) 
 
CLEC9 
CLEC9A, 
DNGR-1, 
CD370 
CLEC9A CD141+ DCs 
(blood and tissue) 
Dead cells (Caminschi et al., 
2008; Huysamen et al., 
2008; Sancho et al., 
2009; Schreibelt et al., 
2012) 
 
CLEC10 
MGL, 
CD301, 
CLEC10A 
CLEC10A in vitro MDDCs, 
in vitro MDMs, 
CD1a+ DCs 
ND (Fehres et al., 2015; 
Raes et al., 2005; van 
Vliet et al., 2007) 
 
CLEC12 
MICL, 
DCAL-2, 
CLEC12A, 
CD371 
CLEC12A DCs, monocytes, 
macrophages, 
granulocytes 
ND (Chen et al., 2006; 
Lahoud et al., 2009; 
Marshall et al., 2004) 
CLEC12B, 
MAH 
CLEC12B in vitro MDMs ND (Hoffmann et al., 2007) 
CLEC13 DEC-205, 
CD205, 
CLEC13B 
LY75 Widely 
expressed, incl. 
DCs, 
macrophages, 
monocytes, B 
cells, NK cells, T 
cells 
HIV-1 (Hatsukari et al., 2007; 
Kato et al., 2006; 
Mahnke et al., 2000; 
Wu and KewalRamani, 
2006) 
MR, 
CD206, 
CLEC13D 
MRC1 DCs, 
macrophages, 
endothelium 
HIV-1, dengue 
virus, HBV, fungi, 
M. tuberculosis, 
parasites 
(Cambi et al., 2008; 
Kang et al., 2005; 
Kooij et al., 2015; 
Martinez-Pomares, 
2012; Mercier et al., 
2013; Miller et al., 
2008; Op den Brouw et 
al., 2009; Wollenberg 
et al., 2002a; Wu and 
KewalRamani, 2006; 
Zhang et al., 2004) 
ND DCAL-1 CLECL1 DCs, germinal 
center B cells 
ND (Ryan et al., 2002) 
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1.3.1.1. C-type lectin domain family 4 (CLEC4) 
i. DCIR/CLEC4A 
 Dendritic cell immunoreceptor (DCIR, CD367) is expressed on DCs, macrophages, 
monocytes, granulocytes and B cells (Bates et al., 1999; Fehres et al., 2015; Klechevsky et 
al., 2010; Lundberg et al., 2014), and is downregulated in response to activation signals (Bates 
et al., 1999; Meyer-Wentrup et al., 2008). Antibodies that bind DCIR trigger antigen 
presentation (Meyer-Wentrup et al., 2008) and cross-presentation (Klechevsky et al., 2010), 
and inhibition of IFNα production in pDCs (Meyer-Wentrup et al., 2008), but little is known 
about natural ligands that it binds (Sancho and Reis e Sousa, 2013). Lambert et al. identified 
HIV-1 as a ligand for DCIR, in which DCIR acts as an attachment factor and contributes to 
transfer of virus to CD4+ T cells (Lambert et al., 2011; Lambert et al., 2008). Expression of 
DCIR was observed on CD4+ T cells from HIV-1-positive individuals, and can be recapitulated 
in vitro where DCIR expression was observed on infected and bystander CD4+ T cells 
(Lambert et al., 2010).  Furthermore, subsequent binding of HIV-1 to DCIR on CD4+ T cells 
enhances infection (Lambert et al., 2011). Therefore, due to its expression on multiple HIV-1 
target cells, role in attachment and transfer, and ability to enhance infection, DCIR may play 
a crucial role in HIV infection and pathogenesis, and represents a potential target for 
microbicides. 
 
ii. BDCA2/CLEC4C 
 BDCA2 (CD303) is exclusively expressed on pDCs (Dzionek et al., 2000). Binding to 
BDCA2 has been shown to trigger antigen internalisation and inhibition of type I IFN production 
(Dzionek et al., 2001; Martinelli et al., 2007). HIV gp120 is one of the few known ligands for 
BDCA2, and upon binding is able to inhibit TLR9-mediated secretion of IFNα and inflammatory 
cytokines (Martinelli et al., 2007). Therefore, binding of HIV to BDCA2 on pDCs may impair 
the immune response not only to HIV, but also to subsequent viral infections. 
 
iii. Mincle/CLEC4E 
 Macrophage-inducible C-type lectin (Mincle; CLEC4E) is predominantly expressed on 
monocytes and neutrophils, but is also detectable on myeloid DCs and B cells as well as in 
vitro derived MDMs and MDDCs (Vijayan et al., 2012). Mincle ligands have been identified in 
C. albicans (Bugarcic et al., 2008; Vijayan et al., 2012) and M. tuberculosis (Furukawa et al., 
2013; Yamasaki et al., 2009). Furthermore, binding of C. albicans to Mincle triggers the 
production of proinflammatory cytokines IL-1β and TNFα (Vijayan et al., 2012). 
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iv. LSECtin/CLEC4G 
 Liver sinusoidal endothelial cells lectin (LSECtin, CD368), is expressed on 
macrophages (Domínguez-Soto et al., 2009) and myeloid DCs (Dominguez-Soto et al., 2007), 
as well as endothelial cells in the liver and lymph node sinusoids (Liu et al., 2004). Known 
ligands include proteins in filoviruses (Gramberg et al., 2005; Powlesland et al., 2008) and 
SARS coronavirus (Gramberg et al., 2005), and upon binding may contribute to virus uptake 
and subsequent infection (Dominguez-Soto et al., 2007; Gramberg et al., 2005). 
 
v. DC-SIGN/CLEC4L 
 Dendritic cell specific ICAM-3-grabbing nonintegrin (DC-SIGN; CD209) is expressed 
on DCs (Engering et al., 2002b; Lundberg et al., 2014), macrophages (Ochoa et al., 2008) 
and liver sinusoidal endothelium (Bashirova et al., 2001; Lai et al., 2006). DC-SIGN has 
typically been reported as a DC marker, due to its expression on in vitro MDDCs (Geijtenbeek 
et al., 2000b; Mercier et al., 2013; Soilleux et al., 2002) and CD14+ DCs (Fehres et al., 2015; 
McGovern et al., 2014b), which were one of the first tissue DCs identified (Nestle et al., 1993). 
This has led to the use of DC-SIGN as an identifier of DCs in tissues (Cavarelli et al., 2013; 
Jameson et al., 2002; Liu et al., 2014), however this approach is misleading as DC-SIGN is 
also expressed on tissue-resident macrophages (McGovern et al., 2014b; Ochoa et al., 2008) 
and is not expressed by the major CD1a-expressing tissue DC subset (Turville et al., 2002). 
Therefore, DC-SIGN expression may be restricted to macrophages and CD14-derived cells. 
DC-SIGN has a diverse range of pathogenic ligands, including fungi (Cambi et al., 
2003), bacteria (Geijtenbeek et al., 2003; Gringhuis et al., 2009a), and viruses such as 
hepatitis C virus (Lai et al., 2006), measles virus (de Witte et al., 2006), filoviruses (Marzi et 
al., 2004; Marzi et al., 2007), SARS (Marzi et al., 2004), cytomegalovirus (Halary et al., 2002), 
dengue virus (Tassaneetrithep et al., 2003), and HIV (type 1 and 2) (Geijtenbeek and van 
Kooyk, 2003; Gringhuis et al., 2009a; Gringhuis et al., 2010; Pöhlmann et al., 2001a). Binding 
to DC-SIGN mediates internalisation of ligands, which are directed to the endolysosomal 
pathway for degradation and subsequent antigen presentation (Engering et al., 2002a).  
DC-SIGN+ cells are present in close proximity to HIV-exposures sites, including the 
vagina (Jameson et al., 2002), cervix (Hirbod et al., 2011; Hirbod et al., 2009), foreskin (Hirbod 
et al., 2010) and rectum (Jameson et al., 2002). In the case of the rectum, DC-SIGN+ cells 
been shown to efficiently transfer HIV (Gurney et al., 2005), which was also observed in the 
intestine (Shen et al., 2010) and colon (Cavarelli et al., 2013), in which DC-SIGN+ cells 
extended their dendrites into the lumen to capture virus (Cavarelli et al., 2013). HIV binding to 
DC-SIGN results in retention of some of the virions in early endocytic compartments (Kwon et 
al., 2002), thereby delaying degradation, and productive infection of DCs (Burleigh et al., 2006; 
Harman et al., 2009; Nobile et al., 2005). Binding of HIV-1 to DC-SIGN also promotes the 
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formation of an immunological synapse with T cells (Hijazi et al., 2011; Hodges et al., 2007) 
and subsequent transfer of virus (Burleigh et al., 2006; de Witte et al., 2008; Geijtenbeek et 
al., 2000a; Kwon et al., 2002). Blocking of DC-SIGN has also been shown to inhibit HIV 
infection in cervical explants (Berzi et al., 2012) and transfer to T cells using DC-SIGN-
expressing cell lines (Sattin et al., 2010), however there may exist a redundancy in markers 
that would require blocking of multiple receptors to prevent HIV transmission. 
 
vi. L-SIGN/CLEC4M 
 Liver/lymph node-specific ICAM-3-grabbing nonintegrin (L-SIGN, CD299), also known 
as DC-SIGNR, is closely related to DC-SIGN (Soilleux et al., 2000) and is expressed on 
endothelial cells in the lymph nodes, liver and placenta (Engering et al., 2004; Pöhlmann et 
al., 2001b). Its pathogenic ligands include hepatitis C virus (Gardner et al., 2003), SARS 
(Jeffers et al., 2004; Marzi et al., 2004), filoviruses (Marzi et al., 2004; Marzi et al., 2007) and 
HIV-1 (Snyder et al., 2005). L-SIGN functions not only to capture HIV-1 (Snyder et al., 2005), 
but can also enhance infection of T cells (Bashirova et al., 2001). 
 
vii. Langerin/CLEC4K 
 Langerin (CD207) is a DC-specific receptor that was originally thought to be uniquely 
expressed on epidermal Langerhans cells, but it has recently been shown to be expressed on 
a subset of dermal CD1a+ DCs (Bigley et al., 2015; Romani et al., 2010) and on an intestinal 
DC subset (Watchmaker et al., 2014; Welty et al., 2013). Langerin expression can also be 
induced on blood CD1c+ DCs after in vitro culture or treatment with TGFβ (Milne et al., 2015). 
The langerin CRD has high affinity for multiple carbohydrates that are present in many 
microorganisms, including mycobacteria, fungi, and viruses, specifically HIV-1 and measles 
virus (de Jong et al., 2010c; de Witte et al., 2007; van der Vlist et al., 2011). As well as binding 
pathogens, langerin has also been shown to play a crucial role in presentation of antigens to 
T cells (Hunger et al., 2004).  
 The effect of langerin-virus binding is specific to the virus. Capture of the measles virus 
by langerin results in transfer of viral peptides to CD4+ T cells without productive infection of 
Langerhans cells (van der Vlist et al., 2011). Binding of HIV-1 to langerin on Langerhans cells 
promotes internalisation of the virus into Birbeck granules where it is subsequently degraded 
(de Witte et al., 2007), however, it also results in productive infection and transfer of whole 
virus to CD4+ T cells, which can be inhibited through the use of soluble langerin (Kawamura 
et al., 2008; Nasr et al., 2014; Peressin et al., 2011). Therefore, langerin on Langerhans cells 
plays a key role in infection and transmission of HIV-1. 
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1.3.1.2. C-type lectin domain family 13 (CLEC13) 
i. DEC-205/CLEC13B 
 Dendritic cell and epithelial cell, 205kDa (DEC-205; CD205) is expressed on a wide 
range of cells, including DCs, macrophages and monocytes (Kato et al., 2006; Lundberg et 
al., 2014). Binding to DEC-205 results in internalisation, degradation and presentation on MHC 
molecules (Jiang et al., 1995), specifically MHC-II (Mahnke et al., 2000). DEC-205 is also 
expressed on renal cells, where in the absence of CD4, CCR5 and CXCR4, DEC-205 acts as 
a receptor and mediates internalisation of HIV-1 (Hatsukari et al., 2007). Therefore, it may 
also act as a receptor for HIV-1 on DCs and macrophages. 
 
ii. Mannose Receptor/CLEC13D 
 Mannose Receptor (MR; CD206) is expressed on DCs, macrophages and a variety of 
endothelia (Fehres et al., 2015; Le Cabec et al., 2005; Lundberg et al., 2014; Martinez-
Pomares, 2012). Binding to MR results in endocytosis (Le Cabec et al., 2005; Schweizer et 
al., 2000), but not phagocytosis (Le Cabec et al., 2005), and can trigger the production of anti-
inflammatory cytokines IL-1β and IL-10 (Chieppa et al., 2003). MR contains multiple CRDs 
that bind a variety of structures found on self- and non-self-molecules (Largent et al., 1984; 
Martinez-Pomares, 2012; Sancho and Sousa, 2012). Pathogenic ligands include fungi (Cambi 
et al., 2008; Gazi et al., 2011; Tachado et al., 2007; Zhang et al., 2004), bacteria (Kang et al., 
2005), parasites (Kooij et al., 2015), and viruses such as dengue virus (Miller et al., 2008), 
hepatitis B virus (Op den Brouw et al., 2009), and HIV-1 (Fanibunda et al., 2011; Lai et al., 
2009a; Nguyen and Hildreth, 2003; Trujillo et al., 2007; Wu and KewalRamani, 2006). 
 The expression profile and binding capacity of MR has identified it as an important 
receptor in HIV transmission. MR is expressed by HIV-target cells, including those in sites of 
exposure such as the vagina (Fanibunda et al., 2011), in which low expression has been 
correlated to lower rates of transmission (Jadhav et al., 2012). Binding of HIV-1 to MR can 
lead to degradation and presentation of viral antigens (Trujillo et al., 2007), and in vitro has 
been shown to mediate transmission of HIV-1 to T cells (Nguyen and Hildreth, 2003).  
Therefore, MR is an important player in HIV-1 transmission and presents itself as an ideal 
target to prevent transmission. 
 
1.3.1.3. Other C-type lectin receptors 
i. CLEC1B/CLECL1 
 CLEC1B (also known as CLEC-2) gene expression has been detected in multiple 
myeloid cells, including DCs, macrophages and monocytes (Colonna et al., 2000), however 
surface expression has only been observed on platelets (Gitz et al., 2014; Suzuki-Inoue et al., 
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2006). Binding of self-ligand, podoplanin, and snake vemon promotes coagulation of platelets 
(Suzuki-Inoue et al., 2006). HIV-1 has been shown to bind CLEC1B on platelets (Chaipan et 
al., 2006), which is a result of the incorporation of podoplanin into the HIV-1 virion (Chaipan 
et al., 2010; Suzuki-Inoue et al., 2006). Furthermore, HIV-1 captured on platelets has been 
shown to survive for several days, potentially contributing a source of spread of the virus in 
the circulation (Chaipan et al., 2006).  
 
ii. CLEC5A/MDL-1 
 CLEC5A, also known as Myeloid DAP12-associating lectin (MDL-1), is expressed on 
macrophages and monocytes (Bakker et al., 1999; Chen et al., 2008; González-Domínguez 
et al., 2015). Initially it was shown to play a role in activating myeloid cells (Bakker et al., 1999), 
but has since been shown to be a pathogen-binding receptor for dengue virus (Chen et al., 
2008; Tung et al., 2014), which induced the production of TNFα (Chen et al., 2008). 
 
iii. CLEC6A/Dectin-2 
 CLEC6A, also known as DC-associated C-type lectin 2 (Dectin-2) is expressed on 
DCs, monocytes and macrophages (Lundberg et al., 2014; Robinson et al., 2009; Taylor et 
al., 2005), and has high affinity for ligands found in fungal cell walls (McGreal et al., 2006; 
Saijo et al., 2010), mycobacteria (Yonekawa et al., 2014) and house dust mites (Barrett et al., 
2009). Binding to CLEC6A results in endocytosis, phagocytosis and presentation of antigens 
(Sato et al., 2006), and has been shown to prime Th2 (Barrett et al., 2011) and Th17 immune 
responses (Gringhuis et al., 2011; Robinson et al., 2009; Saijo et al., 2010). 
 
iv. CLEC7A/Dectin-1 
 CLEC7A, also known as Dectin-1, is expressed on a large number of immune cells 
including DCs, monocytes and macrophages (Fehres et al., 2015; Lundberg et al., 2014; 
Olynych et al., 2006; Willment et al., 2005). It recognises ligands present in fungi and 
mycobacteria (Brown, 2006; Goodridge et al., 2007; Palma et al., 2006), as well as self-ligand 
expressed on T cells (Ariizumi et al., 2000). Binding to CLEC7A results in phagocytosis as 
well as initiating a signalling cascade (Brown and Gordon, 2001; Rogers et al., 2005; Underhill 
et al., 2005). In DCs, binding to CLEC7A induces maturation and, depending on the signalling 
pathway induced, secretion of cytokines, including IL-1β, IL-2, IL-6, IL-10, IL-12, IL-23 and 
TNF-α (Gringhuis et al., 2009b; Gringhuis et al., 2011; LeibundGut-Landmann et al., 2007). 
As a result it has been shown to prime Th1 (Gringhuis et al., 2009b) and Th17 responses 
(Gringhuis et al., 2011). 
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v. CLEC10A/MGL 
 CLEC10A, also known as macrophage galactose C-type lectin (MGL) is expressed on 
in vitro MDMs (Raes et al., 2005) and MDDCs (Higashi et al., 2002; van Vliet et al., 2007), and 
tissue CD1a+ DCs (Fehres et al., 2015). Binding to CLEC10A, targets its ligands to the 
phagolysosomal compartment, where they are degraded and subsequently presented on 
MHC-II (van Vliet et al., 2007). Therefore, CLEC10A may act as a pathogen binding receptor, 
however, although pathogen binding has been observed in mice, it has yet to be observed for 
human CLEC10A (Sancho and Sousa, 2012). 
 
1.3.2. Sialic acid-binding IgG-like lectins 
 Sialic acid-binding IgG-like lectins (Siglecs) are a family of receptors predominantly 
expressed on cells of the haematopoietic and immune system, where they act as regulators 
of innate and adaptive immunity (Crocker et al., 2007; Lock et al., 2004; Pillai et al., 2012). 
Siglecs are divided into two families based on structural homology. The first group contains 
Siglecs that are conserved across mammalian species, and includes Siglec-1, -2, -4, and -15 
(Crocker et al., 2007). The second group, CD33-related Siglecs, differ between species but 
share 50-99% sequence identity within the group, and includes Siglec-3, -5 to 14, and -16 
(Crocker et al., 2007). Siglecs play various roles in the modulation on immune responses 
through cell-cell adhesion, including inflammation, T cell function, and B cell tolerance 
(Crocker et al., 2007; Pillai et al., 2012). They have also been shown to be involved in adhesion 
and phagocytosis of pathogens, including HIV-1 (Macauley et al., 2014). 
 A number of Siglecs have been shown to bind HIV-1, however their role in HIV-1 
infection is not completely understood. Siglec -1, -3, -5, 7, and -9 have been shown to bind 
HIV-1 (Zou et al., 2011), but only Siglec-1-HIV interactions have been studied in greater detail 
(Izquierdo-Useros et al., 2012; Pino et al., 2015; Puryear et al., 2013; Rempel et al., 2008; van 
der Kuyl et al., 2007). Binding of HIV-1 to Siglec-1 on macrophages enhances infection  
(Rempel et al., 2008), while binding on DCs also enhances transfer to T cells (Izquierdo-
Useros et al., 2012; Puryear et al., 2013). Siglec-1 expression is typically seen on 
macrophages and monocytes, however HIV-1 infection upregulated Siglec-1 expression on 
circulating CD14+ cells (van der Kuyl et al., 2007) and induces expression on other blood and 
tissue myeloid cells, where it also enhances infection (Pino et al., 2015). Therefore, it is of 
interest to determine which other Siglecs may be expressed on cells in close proximity to HIV-
1 exposure, and whether they, like Siglec-1, enhance HIV-1 infection, thereby posing potential 
targets to inhibit or prevent HIV transmission.  
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1.4. Sexual Transmission of HIV 
 At the end of 2014, approximately 37 million people were living with HIV/AIDS 
worldwide, 2 million of which were newly infected (UNAIDS, 2015). Although there are 
treatments available, they are not curative, and as of 2015 are taken by less than half of those 
infected (UNAIDS, 2015). Furthermore, efforts to develop an effective microbicde have so far 
failed (Hladik and Doncel, 2010; Morris and Lacey, 2010; Nunes et al., 2014), therefore 
understanding the route of infection and the cells involved is key to preventing new infections. 
The majority of new infections occur via sexual transmission, which involve HIV crossing skin 
and mucosal barriers in the genital and anorectal tracts (hereafter refered to collectively as 
the anogenital tract) of both sexes (Royce et al., 1997; Shattock and Moore, 2003). Although 
there is some knowledge on HIV transmission across these surfaces (Le Tortorec and Dejucq-
Rainsford, 2010; Reis Machado et al., 2014), a lot remains unknown, especially in regards to 
the anorectal tract. This represents a critical gap in our knowledge, as transmission rates 
through receptive anal intercourse are 100 times higher than through vaginal intercourse 
(Powers et al., 2008). A better understanding of the similarities and differences between the 
various tissues and immune subsets of the anogenital tracts, and how these influence HIV 
transmission, could hold the key to new and improved prevention strategies, including new 
microbicides to inhibit infection. 
 
1.4.1. Route of HIV transmission across mucosal surfaces 
 The various tissues that make up the male and female anogenital tracts differ in 
anatomy, physiology and immunobiology, and each represent a unique barrier and opportunity 
for HIV transmitted by sexual intercourse. The upper female genital tract (endocervix) and 
anorectal tract (upper anal canal and rectum) represent type I mucosal surfaces (Iwasaki, 
2007), which consist of a single layer of columnar epithelium. The type 1 mucosa abruptly 
changes to type II mucosa at the squamocolumnar junction in the cervix (Fiore, 1967; Pudney 
et al., 2005; Robboy et al., 2008), and pectinate line in the anal canal (Marieb and Hoehn, 
2007a; Prasad, 2007; Sabiston and Townsend, 2012). The lower sites of the female genital 
tract (ectocervix, vagina and parts of the labia minora) and anal canal represent type II 
mucosal surfaces, as does the inner foreskin. Unlike type I mucosae, type II mucosae consist 
of keratinocytes that are arranged to form a multilayered epithelium, and as such represents 
a more significant barrier. The mucosal surfaces are invariably protected by mucous, which is 
of neutral pH in the anorectum (McNeil et al., 1987) but acidic in the female genital tract (Lai 
et al., 2009b), and provides an added barrier for HIV transmission.  
The outermost fringes of the anogenital tracts (labia, outer foreskin, glans penis and 
anus) are covered with keratinised, stratified squamous epithelium (skin) (Marieb and Hoehn, 
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2007c), which represents a significant physical barrier for HIV. However, a significant 
proportion of new HIV infections occur in the presence of inflammation, ulceration, 
microabrasions or other infections (Masson et al., 2015; Qin et al., 2012; Qin et al., 2011; 
Smith et al., 2010; Wald and Link, 2002), which can lead to a breach in the skin and mucosal 
surfaces of the anogenital tracts, thereby allowing HIV to gain access to the tissue below. As 
discussed in section 1.2, the skin and type I and type II mucosal surfaces contain immune 
cells, many of which reside in the dermis/lamina propria and are key HIV targets, such as 
CD4+ T cells, DC and macrophages.  The role DCs play in the transmission of HIV will be 
discussed further in section 1.4.2 below. 
 
1.4.1.1. Transmission across the female genital tract 
 Vaginal intercourse has been considered the leading transmission route for HIV 
infection worldwide, therefore there has been a lot of interest into the susceptibility of the 
female genital tract to HIV infection. As mentioned above, the endocervix is lined with type I 
mucosa, which represents a relatively weak barrier to HIV infection compared to the type II 
mucosal epithelium of the ectovervix and vagina, and skin covering the labia. The vagina, 
endo- and ectocervix contain HIV target cells in the underlying lamina propria, but the vagina 
and ectocerivix also contain HIV target cells within the stratified squamous epithelium (Duluc 
et al., 2013; Shen et al., 2014). The endo- and ectocervix meet abruptly at the 
squamocolumnar junction, which is a single layer epithelium and contains a high density of 
HIV target cells in the underlying lamina propria (Pudney et al., 2005), therefore may be 
particularly vulnerable to HIV infection.  
HIV has been shown to penetrate and infect ex vivo human vaginal and cervical 
explants (Hladik et al., 2007; Maher et al., 2005), however the mechanism of HIV transmission 
in vivo remains unknown (Keele and Estes, 2011; Reis Machado et al., 2014). In vivo, the 
cervix and vagina are protected by mucous, which is acidic and has been shown to impede 
the mobility of HIV virions (Lai et al., 2009b), and therefore inhibit infection. During 
menstruation the cervical mucous changes in viscosity (Robboy et al., 2008; Sabiston and 
Townsend, 2012), and the type II mucosal epithelium varies in thickness (Ildgruben et al., 
2003; Patton et al., 2000), therefore susceptibility to HIV infection may also vary during the 
menstrual cycle. Susceptibility to HIV has also been linked to bacterial vaginosis (Cohen et 
al., 2012; Myer et al., 2005), C. albicans infection (Vachot et al., 2008), inflammation (Masson 
et al., 2015) and other sexually transmitted infections, such as herpes simplex virus type 2 
(HSV-2) (Wald and Link, 2002). 
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1.4.1.2. Transmission across the male genital tract 
 Transmission of HIV across the male genital tract is poorly understood (Ganor 
and Bomsel, 2011), but represents a significant site of HIV transmission for both vaginal and 
anal intercourse. The exposed sites of the male genital tract are covered with keratinised, 
stratified squamous epithelium, while the glans urethra (fossa navicularis) is lined with type II 
mucosa (Ganor and Bomsel, 2011; Ganor et al., 2013). Therefore, there may be significant 
differences in the susceptibility to HIV infection across the different sites, of which the foreskin 
is the most extensively studied. Several clinical trials revealed circumcision can reduce 
female-to-male transmission by 60% (Auvert et al., 2005; Gray et al., 2007; MacLaren et al., 
2015), thereby highlighting the foreskin as a particularly susceptible site for HIV infection. 
The foreskin is divided into the permanently exposed outer foreskin and the inner 
foreksin, which is only exposed during sexual intercourse (Dinh et al., 2015; Dinh et al., 2010). 
Some studies have reported no difference in the level of keratinisation between inner and 
outer foreskin (Dinh et al., 2012; Dinh et al., 2010), while others have shown significantly lower 
levels in the inner foreskin (Ganor and Bomsel, 2011; Lemos et al., 2014; McCoombe and 
Short, 2006; Patterson et al., 2002), thereby bearing closer resemblance to type II mucosa. 
Furthermore, lower keratinisation levels in the inner foreskin have been coupled with increased 
susceptibility to HIV transmission (Dinh et al., 2015), with transfer across the epithelium 
observed in as little as 1 hour post exposure ex vivo (Ganor et al., 2010). This may also be 
due to the increased number of HIV target cells observed in the inner foreskin, including CD4+ 
T cells, macrophages and Langerhans cells (Donoval et al., 2006; Ganor et al., 2010; Lemos 
et al., 2014; Liu et al., 2014; McCoombe and Short, 2006; Patterson et al., 2002), which were 
also observed closer to the surface in comparison to the outer foreskin (Liu et al., 2014; 
McCoombe and Short, 2006). Therefore, the differences in the epithelium and HIV target cells 
may account for differences in HIV susceptibility. 
As with the foreskin, penile (glans and shaft) (Dinh et al., 2015) and urethal (Ganor et 
al., 2013) explant studies have revealed each site is permissive to HIV infection ex vivo. 
Furthermore, HIV target cells such as CD4+ T cells, DCs and macrophages have been 
identified in both of these sites, however, apart from Langerhans cells in the epidermis, the 
majority of target cells reside in the dermis/lamina propria (Dinh et al., 2015; Fischetti et al., 
2009; McCoombe and Short, 2006). As with the female genital tract, bacterial infection, 
inflammation and ulceration increase the risk of infection (Mehta et al., 2012), and may be 
attributed to increased exposure of HIV targets in the dermis/lamina propria. 
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1.4.1.3. Transmission across the anorectal tract 
 There is a greater incidence of HIV transmission observed in both men and women 
who practise receptive anal intercourse (McGregor et al., 2015; Powers et al., 2008), therefore 
highlighting the anorectal tract as a significant site for HIV infection. In Australia this represents 
the most common route of infection (McGregor et al., 2015). Despite its importance, very little 
is known about this route of transmission, which represents a significant gap in our knowledge. 
Similar to the female genital tract, the anorectal tract is lined with skin, type I and type II 
mucosa, and as with the squamocolumnar junction in the cervix (Pudney et al., 2005), the 
transitional zone of the anal canal may represent a site of increased vulnerability to HIV 
infection. The anorectal tract also has a far larger surface area compared to the vagina and 
cervix, and unlike the female genital tract, the anorectal tract is lined predominanlty with fragile 
type I mucosa (Iwasaki, 2007). Although there may be some protection from mucous, unlike 
cervical mucous it is of neutral pH (Jannin et al., 2014; McNeil et al., 1987), which may 
contribute to the increased susceptibility. Furthermore, potential abrasions that occur with 
receptive anal intercourse and anorectal localisation of other STIs that induce inflammation 
are likely to contribute to the greater incidence of HIV in people who practise receptive anal 
intercourse (Van Kemseke, 2009). 
 
1.4.2. Role of dendritic cells in the transmission of HIV 
 As discussed in section 1.3., DCs express a wide range of pathogen binding receptors, 
many of which bind HIV and elicit receptor-specific responses. Binding can result in virus 
uptake, degradation, presentation on MHC-II, productive infection, and transfer to CD4+ T cells 
(Cunningham et al., 2013a; Harman et al., 2013b; Rinaldo, 2013). DC mediated transfer of 
HIV to T cells, also referred to as trans infection, results in much greater virus replication than 
direct cis infection of T cells (Rinaldo, 2013). Therefore, DC-T cell interactions in anogenital 
mucosae play a crucial role in sexual transmission of HIV. 
 
1.4.2.1. Transfer of HIV from dendritic cells to T cells 
 As professional antigen presenting cells, DCs play a key role in transfer of HIV to T 
cells, such that DC-mediated transfer results in greater virus replication in T cells compared 
to T cells that are directly infected (Ayehunie et al., 1995; Rinaldo, 2013). Most HIV enters 
DCs via CLR mediated uptake, with only a minority (<5%) entering via CD4/CCR5-mediated 
neutral fusion (Turville et al., 2004). DC-mediated transfer to T cells has been shown in in 
vitro-derived MDDCs (Turville et al., 2008; Turville et al., 2004) and ex vivo Langerhans cells 
(Nasr et al., 2014) to occur in two phases, which correspond to the two routes of entry, and is 
mirrored by two bursts in DC gene expression (Harman et al., 2009). Within the first hours of 
Chapter 1: Literature Review  Rachel Botting 
55 
 
HIV capture, if a DC comes in close contact with CD4+ T cells it is able to transfer the virus 
across a virological synapse (Martin et al., 2010). However, virions that have entered via PRR-
mediated uptake are eventually degraded, resulting in a reduction in transfer. When de novo 
virus is produced, as a result of entry via CD4/CCR5 neutral fusion, transfer is observed again, 
which subsequently increases with time (Nasr et al., 2014; Turville et al., 2004). 
Thus, the first phase of transfer occurs as a result of PRR-mediated upate of HIV and 
is transferred to T cells independently of viral replication. HIV can be captured by multiple 
CLRs (see Table 1.3.), however after capture it remains unclear how DCs transport this virus 
to T cells; whether it’s through binding to the surface (Cavrois et al., 2007), surface accessible 
compartments (Yu et al., 2008), or internalised compartments (Kwon et al., 2002). It was 
originally thought that HIV entered the endolysosomal pathway, as DCs are able to present 
HIV antigen via MHC-II, which is dependent on endolysosomal processing (Fonteneau et al., 
2003; Larsson et al., 2002; Moris et al., 2006). This was further supported by evidence of HIV 
uptake by clatherin-mediated endocytosis (Garcia et al., 2005), however attempts at 
visualising HIV within endolysosomal compartments have so far failed (Garcia et al., 2005; 
Turville et al., 2008; Turville et al., 2004). Instead, HIV virions have been observed to be taken 
up into pH neutral, tetraspanin (CD81+)-rich caves (Garcia et al., 2005) that are continuous 
with the plasma membrane (Yu et al., 2008). This is most noticeable on mature DCs (Garcia 
et al., 2005), whereas a large proportion of HIV is not co-localised with CD81+ on immature 
DCs (Yu et al., 2008), which still leaves the question of how the HIV is taken up and transferred 
to T cells. 
The second phase of transfer involves CD4/CCR5-mediated neutral fusion of HIV with 
the plasma membrane in a similar manner to cis infection of T cells. HIV taken up by this route 
undergoes productive replication, resulting in de novo synthesised virions (Burleigh et al., 
2006; Nobile et al., 2005; Turville et al., 2004). Only a small proportion of virus productively 
infects DCs, with at least a 20-fold reduction in infectivity compared to T cells (Turville et al., 
2004), but this still represents a significant route of transfer, and may contribute to a pool of 
latently infected cells. Therefore, strategies to prevent transmission of HIV need to target both 
routes of entry in order to be effective. 
 
1.4.2.2. Anogenital dendritic cells and their role in sexual transmission of HIV 
 DCs reside in all tissues of the anogenital tract, and are therefore likely to play a crucial 
role in sexual transmission of HIV. Most commonly studied are Langerhans cells, which are 
present in skin and type II mucosal surfaces of the vagina, ectocervix, labia minora, lower anal 
canal, foreskin and glans (Rinaldo, 2013). Far less is known about the role of DCs in the 
underlying dermis/lamina propria, especially those in the anorectal tract. 
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Langerhans cells in the vagina, ectocervix and foreskin are considered to be among 
the first cells to capture HIV (Harman et al., 2013b; Keele and Estes, 2011; Rinaldo, 2013), 
and as such, Langerhans cells have been extensively studied for their role in HIV infection. 
Most studies have been conducted on Langerhans cells in skin, in which in vivo infection of 
Langerhans cells has been observed by RNA (Cimarelli et al., 1994; Dezutter-Dambuyant, 
1995; Giannetti et al., 1993; Henry et al., 1994) and protein (Compton et al., 1996), as well as 
multiple ex vivo Langerhans cell cultures (Ayehunie et al., 1995; Berger et al., 1992; 
Kawamura et al., 2003; Kawamura et al., 2008; Nasr et al., 2014; Peressin et al., 2011; Pope 
et al., 1994). Furthermore, an investigation by Compton et al. on skin biopsies over 11 years 
from HIV-infected individuals, revealed that 1/3 to 1/2 of skin Langerhans cells were infected 
with HIV (Compton et al., 1996). Therefore, Langerhans cells in the anogenital mucosa could 
represent a significant resevoir of HIV, that could be transmitted upon activation of Langerhans 
cells by other sexually transmitted infections. 
Upon uptake of HIV, ex vivo Langerhans cells have been shown to efficiently transfer the 
virus to CD4+ T cells in both phases (Nasr et al., 2014). Similarly, Langerhans cells in the inner 
foreskin have also been shown to transfer HIV to T cells within hours of exposure, but second 
phase transfer has yet to be demonstrated (Ganor et al., 2010). This may be attributed to HIV 
binding to langerin, which has been shown to be important in both phases of transfer (Nasr et 
al., 2014). Furthermore, Langerhans cells in vaginal, cervical and foreskin express CD4 and 
CCR5 (Hirbod et al., 2010; Hirbod et al., 2011; Hirbod et al., 2009), therefore may also be 
productively infected and involved in second phase transfer to CD4+ T cells.  
 DCs in the anogenital tract are also exposed to unique environmental factors that can 
influence susceptibility to HIV. For example, genital mucosal epithelial cells produce factors 
that activate DCs (Fontenot et al., 2009), thereby increasing HIV trans infection. Semen also 
contains factors that enhance DC uptake of HIV (Ceballos et al., 2009) and enhance infection 
of macrophages (Münch et al., 2007) in vitro, however the role of these semen-derived factors 
in vivo is contentious, and may differ depending on type I and type II mucosa (Allen et al., 
2015). Furthermore, semen has a high carbohydate content that may competetively bind CLRs 
(Sabatté et al., 2007) and actually inhibit trans infection. 
 Inflammation (Bebell et al., 2008; Gumbi et al., 2008; Roberts et al., 2012) and other 
infections, bacterial (Cohen et al., 2012; Myer et al., 2005), fungal (Qin et al., 2012; Qin et al., 
2011; Vachot et al., 2008), and viral (Smith et al., 2010; Wald and Link, 2002), have also been 
linked to inceased HIV susceptibility. This may be due to increased production of 
proinflammatory cytokines, which mature Langerhans cells and subsequently enhance trans 
infection (de Jong et al., 2008; Granelli-Piperno et al., 1998; John et al., 2007; John et al., 
2009; McDonald et al., 2003; Ogawa et al., 2009; Vachot et al., 2008). Trans infection may 
also be enhanced by fungal infections which, as well as maturing DCs, have been shown to 
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increase DC-T cell clustering and CD4+ T cell activation (Qin et al., 2012; Qin et al., 2011; 
Vachot et al., 2008). While in the case of HSV-2, infection may also be increased due to 
upregulation of CCR5 on DCs (Marsden et al., 2015). Furthermore, HSV-2 infection decreases 
langerin expression on Langerhans cells, thereby inhibiting langerin-dependent degradation 
of HIV (de Jong et al., 2010b), and also increases numbers of DC-SIGN+ cells in the dermis 
(Zhu et al., 2009). Therefore, the influence of secondary infections of DCs needs to be taken 
into account when determining the relative susceptibility of anogential DC subsets to HIV 
infection.  
 Unlike Langerhans cells, dermal and lamina propria DCs have received very little 
attention in regards to sexual transmission of HIV (Harman et al., 2013b; Rinaldo, 2013). This 
represents a significant gap in our knowledge due to the equivalent access of lamia propria 
DCs to HIV in type I mucosa and in the context of abrasians in stratified squamous epithelium. 
CD14+ DCs and macrophages have been shown to be susceptible to HIV infection 
(Koppensteiner et al., 2012; Kwan et al., 2005), and due to expression of DC-SIGN (McGovern 
et al., 2014b; Soilleux et al., 2002) may be involved in trans infection. DC-SIGN+ cells have 
also been observed in foreskin (Kim et al., 2015; Soilleux and Coleman, 2004), vagina and 
cervix (Jameson et al., 2002; Rivera-Morales et al., 2012), and may enhance HIV transmission 
in these sites. Furthermore, DC-SIGN+ cells in the colon have been observed to extend 
dendrites into the lumen to capture HIV (Cavarelli et al., 2013), and in the rectal mucosa bind 
and transfer virus (Gurney et al., 2005). DC-SIGN+ cells may therefore may play a key role in 
HIV transmission via anal intercourse. It is crucial to identify whether other DC subsets reside 
in the dermis and lamina propria of the anogenital tracts, and whether their CLR expression 
profiles render them susceptible to HIV infection.  
 
1.4.2.3. Blocking HIV infection with microbicides 
 The relative importance of DCs in sexual transmission of HIV has resulted in the search 
for microbicides to block their infection. Strategies have centred around blocking factors 
required for replication, such as reverese transcriptase and protease inhibitors (Njai et al., 
2005; Stefanidou et al., 2012), as well as entry receptors (Rinaldo, 2013). CD4 and CCR5 
blockers have been shown to be effective in blocking cis infection (Frank and Robbiani, 2011; 
Kawamura et al., 2004), but molecules to block trans infection are more complicated due to 
the numerous CLRs involved. Most of the molecules in development target DC-SIGN (Berzi 
et al., 2012; Du et al., 2012; Nabatov et al., 2008; Sattin et al., 2010), and recently we were 
able to inhibit both phases of HIV transfer by ex vivo LCs using soluble langerin (Nasr et al., 
2014), which provides evidence that blocking key CLRs may hold the key to effective 
microbicides. However, these fail to account for mucosal DCs that are negative for langerin 
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and DC-SIGN, and the numerous other CLRs that bind HIV. Therefore, determining the CLR 
expression profile of anogenital DCs could highlight potential targets to inhibit HIV infection 
and aid microbicide development. 
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1.5. Hypotheses and Aims 
DC subsets differ in frequency, phenotype and function, dependent on their location, 
and little is known about the different subsets found within the anogenital tracts, especially the 
anorectal tract. The surface expression profile of DCs could not only help distinguish known 
and novel subsets, but also help identify susceptibility and specificity to pathogens. DCs in the 
anogenital tract are one of the first immune subsets to encounter HIV during sexual 
transmission, and are not only permisible to infection but also play a key role in transfer of the 
virus to T cells and pathogenesis. Identifying DC subsets and the CLRs they express that are 
known to be involved with HIV infection and transmission could aid the development of new 
microbicides.  
The hypothesis of this research was that mononuclear phagocytes interact with HIV in 
a subset-specific manner, and that this would be influenced by the unique pathogen 
recognition receptor profiles on each subset. Furthermore, it was hypothesised that mucosal 
surfaces would contain a composition of mononuclear phagocytes unique to each mucosal 
type and anatomical site. As such, this study had the following aims: 
 
1. Compare the effect of different isolation techniques on the frequency and activation 
status of all known DC subsets in human skin, and search for any previously 
undescribed DC subsets. 
 
2. Compare the CLR expression profile on all human DC and macrophage subsets 
to determine any subset-specific markers and how expression changes with 
isolation technique. 
 
3. Identify which DC subsets are present in the full range of human anogenital tissues, 
their relative frequencies and how that corresponds to the anatomical location. 
 
4. Investigate the role various DC subsets play in the transfer of HIV to T cells. 
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2.1. General Solutions 
All plasticware used was purchased from Falcon (Becton Dickson; San Jose, CA, USA) and 
Greiner Bio-one (Kremsmünster, Austria) unless otherwise stated. 
 
All chemicals and reagents used were purchased from Sigma Aldrich (Milwaukee, WI, USA) 
unless otherwise stated. 
 
All washes were performed by centrifugation at 480xg for 5 minutes at room temperature, 
unless otherwise stated. 
 
Filter sterilisation was performed using 0.22µm filters (Merck Millipore; Germany). 
 
2.1.1. 5M Sodium hydroxide (NaOH) 
5M Sodium hydroxide (NaOH) was prepared by dissolving 100g of NaOH pellets in 
500mL milliQ water. Autoclaved or filtered to sterilise and stored at room temperature. 
 
2.1.2. 500mM EDTA stock solution, pH8 
Ethylenediaminetetraacetic acid (EDTA; 500mM) was prepared by was dissolving 73g 
EDTA in 250mL milliQ water and the pH adjusted to 8 using NaOH pellets. The solution was 
made up to a final volume of 500mL with milliQ water and autoclaved to sterilise. Stored at 
4°C. 
 
2.1.3.  Human AB serum 
Human AB serum was purchased heat inactivated, or heat inactivated for 30 minutes 
at 56°C.  Heat-inactivated human AB serum was stored at -20°C and filter-sterilised before 
use. 
 
2.1.4. Foetal bovine serum 
Foetal bovine serum (FBS; Serena, Bunbury, WA, Australia) was filtered prior to use 
and stored at 4°C. 
 
2.1.5. Tissue culture medium 
Dulbecco’s Modified Eagle Medium (DMEM) high in glucose (4.5g/L) and containing 
L-glutamine (4mM; Lonza, Basel, Switzerland), was supplemented with 10% (v/v) FBS 
(DMEM10). Roswell Park Memorial Institute (RPMI)-1640 containing L-glutamine (2.1mM; 
Lonza) was supplemented with 10% (v/v) FBS (RF10) or 10% (v/v) human AB serum (RH10). 
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2.1.6. 1X Phosphate-buffered Saline (PBS) 
One PBS tablet (Amresco) was dissolved in 100mL milliQ water. Stored at room 
temperature before use. RNase-free DNase-free PBS (Lonza) was used for sterile work. 
 
 
2.2. Flow Cytometry 
2.2.1. Solutions 
2.2.1.1. Fluorescence-activated cell sorting (FACS) buffer  
FACS buffer was prepared by supplementing 1X PBS with 1% (v/v) FBS, 2mM EDTA 
(pH8) and 0.1% (w/v) sodium azide (NaN3).  Stored at 4°C. 
 
2.2.1.2. Permeability buffer 
Permeability buffer was prepared by supplementing 1X PBS with 1% (v/v) FBS, 2mM 
EDTA (pH8), 1% (w/v) NaN3 and 0.1% (w/v) saponin.  Stored at 4°C. 
 
2.2.2. Live/Dead staining 
Cells were washed twice with PBS and resuspended to a final volume of 1 x 106 
cells/100µL. Live/Dead near infrared (NIR; Invitrogen) was added to the cells at 0.02µL/100µL 
and incubated at 4°C for 30 minutes in the dark. Cells were washed twice with FACS buffer 
and subsequent antibody staining performed (as per section 2.2.3.) 
 
2.2.3.  Surface staining 
Cells were washed twice with FACS buffer and resuspended to a final staining volume 
of 100µL (≤2 x 106 cells/100µL). When multiple brilliant violet (BV)-conjugated antibodies were 
used, cells were resuspended in 50µL FACS buffer per test and antibodies prepared in 50µL 
Brilliant Stain Buffer (BD) per test, to give a final staining volume of 100µL. Antibodies were 
added to resuspended cells (see Table 2.1.) and incubated for 30 minutes at 4°C in the dark. 
Cells were washed twice with FACS buffer prior to running on the cytometer. 
 
2.2.4. Intracellular staining 
Cells were washed twice with 1X PBS, counted and resuspended at ≤2 x 106 cells in 200µL. 
Cells were then permeabilised with 200uL Cytofix/CytoPerm™ (BD; US) for 15 minutes at 
room temperature in the dark. Cells were washed twice with permeability buffer prior to 
staining in a final volume of 100uL permeability buffer for 30 minutes at 4°C.  Antibodies were 
added at the concentrations mentioned in Table 2.1. Unbound antibody was removed by 
washing twice with permeability wash prior to running on the cytometer. 
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Table 2.1. Flow Cytometry Antibodies 
Antibody Company Host Clone Volume* 
Population markers     
CD1a BV510 BD Mouse HI149 1µL 
CD1a PE BD Mouse HI149 2µL 
CD1c PE.Vio770 Miltenyi Mouse AD5-8E7 3µL 
CD1c PE Miltenyi Mouse AD5-8E7 3µL 
CD3 AF700 BD Mouse UCHT1 2.5µL 
CD4 APC BD Mouse RPA-T4 4µL 
CD4 BUV496 BD Mouse SK3 2.5µL 
CD71 FITC BD Mouse M-A712 2µL 
CD11c APC BD Mouse B-Ly6 3µL 
CD14 BUV737 BD Mouse M5E2 2µL 
CD14 BV421 BD Mouse M5E2 2µL 
CD14 PE BD Mouse M5E2 2µL 
CD16 BV650 BD Mouse 3G8 2.5µL 
CD19 BV605 BD Mouse SJ25C1 5µL 
CD45 PE.Cy7 BD Mouse HI30 1µL 
CD45 BV786 BD Mouse HI30 1µL 
CD45 BUV395 BD Mouse HI30 1µL 
CD123 PE.CF594 BD Mouse 7G3 2.5µL 
CD141 BV711 BD Mouse 1A4 2µL 
CD141 APC Miltenyi Mouse AD5-14H12 3µL 
HLA-DR BUV395 BD Mouse G46-6 0.5µL 
HLA-DR PerCP Miltenyi Mouse AC122 2µL 
Langerin PE Beckman Coulter Mouse DCGM4 1µL 
Langerin Vioblue Miltenyi Mouse MB22-9F5 1.5µL 
Live/Dead NIR Invitrogen - - 0.02µL 
Surface Expression     
CCR5 PE BD Mouse 2D7 5µL 
CXCR4 PE BD Mouse 12G5 4µL 
CD80 PE BD Mouse L307.4 2µL 
CD83 PE BD Mouse HB15e 2µL 
CD86 APC BD Mouse 2331 (FUN-1) 2µL 
CD91 ef660 Biolegend Mouse A2MR-a2 1µL 
CLEC4A PE R&D Mouse 216110 4µL 
CLEC4D PE R&D Mouse 413512 2µL 
CLEC4E APC# Abcam Mouse AT16E3 0.25µL 
CLEC4L (DC-SIGN) APC BD Mouse DCN46 5µL 
CLEC4M (L-SIGN) PE R&D Mouse 120604 2µL 
CLEC5A APC R&D Mouse 283834 5µL 
CLEC5B APC BD Mouse DX12 2µL 
CLEC5C APC R&D Rat 239127 2µL 
CLEC6A PE R&D Mouse 545943 2µL 
CLEC7A PE Miltenyi REA1 REA515 2µL 
CLEC8A PE R&D Mouse 331212 5µL 
CLEC9A PE Miltenyi Mouse 8F9 5µL 
CLEC10A PE R&D Mouse 744812 2µL 
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Table 2.1. Flow Cytometry Antibodies (continued) 
Antibody Company Host Clone Volume* 
Surface Expression     
CLEC12A AF647 BD Mouse 50C1 2µL 
CLEC13B (DEC-205) PE Biolegend Mouse HD30 1µL 
CLEC13D (MR) APC BD Mouse 19.2 2µL 
CLEC13D (MR) PE Beckman Coulter Mouse 3.29B1.10 2µL 
CLEC14 APC R&D Mouse 743940 2µL 
Siglec-1 PE Biolegend Mouse 7-239 1µL 
Siglec-3 APC BD Mouse WM-53 2µL 
Siglec-5 APC Miltenyi Mouse 1A5 2µL 
Siglec-6 APC R&D Mouse 767329 5µL 
Siglec-9 APC R&D Mouse 191240 2µL 
Siglec-16 APC R&D Mouse 706022 5µL 
Intracellular Antibody     
HIV P24 PE Beckman Coulter Mouse KC57 2µL 
Controls     
IgG1 APC BD Mouse MOPC-21  
IgG1 PE BD Mouse MOPC-21  
IgG2a PE BD Mouse G155-178  
IgG2b APC BD Mouse 27-35  
IgG1 BUV496 BD Mouse X40  
IgG2a AF647 BD Mouse G155-178  
IgG2a APC R&D Mouse 20102  
IgG1 APC R&D Mouse 11711  
IgG2b PE R&D Mouse 133303  
IgG2b APC R&D Mouse 133303  
IgG1 PE R&D Mouse 11711  
IgG2a APC R&D Rat 54447  
IgG2a PE Miltenyi Mouse S43.10  
IgG1 APC Miltenyi Mouse IS5-21F5  
IgG1 PE Miltenyi REA REA293  
IgG1 PE Beckman Coulter Mouse 679.1Mc7  
IgG1 ef660 eBioscience Mouse P3.6.2.8.1  
IgG1 PE Biolegend Mouse MOPC-21  
 
* Amount of antibody per ≤2.5 x 106 cells in 100µL 
# Primary antibody (Abcam) conjugated to APC (Invitrogen) prior to use. 
1 Recombinant human antigen  
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2.2.5. Flow cytometry and statistical analysis 
Flow cytometry data was acquired on the FACSCanto™ II (BD; US) and LSRFortessa 
(BD) using FACSDiva software (version 6.2; BD). Further analysis was performed using 
FlowJo Version 10.0.8 (Tree Star Inc.; Ashland, OR, USA). Geometric mean fluorescence 
intensity (gMFI) was used as the measure of expression. An arbitrary limit of significant 
expression for a given marker was determined to be a gMFI >100 above that of the isotype. 
All statistical analyses were performed using GraphPad Prism (version 6). Due to the 
variable nature of data sets obtained from human donors, non-parametric tests were used to 
determine whether there was any statistical significance across the data sets. Mann-Whitney 
tests were used for comparison of variables on a single subset, for example comparing 
expression of a single marker on a migrated subset versus the collagenase liberated 
equivalent subset. Kruskal-Wallis tests were used to compare multiple subsets or tissues, and 
a Dunn’s multiple comparison post hoc test applied to determine specifically which subsets or 
tissues differed from the others. 
 
2.2.6. Antibody titrations 
Antibodies were prepared in 50µL FACS buffer and added to 1 x 106 cells in 50µL 
FACS buffer to give a final staining volume of 100µL. The recommended concentration was 
used as the starting amount, which was serially diluted 1: 2 or 1: 5 in FACS buffer up to 5 
dilutions. The positive and negative populations were gated and their respective gMFIs plotted 
as a ratio of positive:negative. The optimal antibody concentration has the greatest separation 
between the positive population and background staining. 
 
 
2.3. Isolation of Cells from Human Blood 
2.3.1. Solutions 
2.3.1.1. Magnetic-activated cell sorting (MACS) buffer  
MACS buffer was prepared by supplementing sterile 1X PBS (Lonza; Walkerville, MD, 
USA: sterile tissue culture grade) with 1% (v/v) heat-inactivated human AB serum (Invitrogen; 
filtered) and sterile 2mM EDTA (pH8). Stored at 4°C. 
 
2.3.1.2. Preparation of GM-CSF and IL-4 working stocks 
Recombinant GM-CSF (Miltenyi Biotech) was resuspended to a final concentration of 
1000IU/mL in sterile PBS supplemented with 0.1% (v/v) human serum albumin.  Recombinant 
IL-4 (Miltenyi Biotech; Gladbach, Germany) was resuspended to a final concentration of 
1000IU/mL in PBS supplemented with 0.1% (v/v) human serum albumin. 
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2.3.1.3. Maturation cocktail 
Master stocks of IL-1β (8 µg/mL; R&D Minneapolis, MN, USA), IL-6 (800 000 U/mL; 
R&D), TNF-α (8 µg/mL; R&D) and Prostaglandin E2 (800 µg/mL; PGE2; Sigma) were 
prepared by reconstituting in PBS + 0.1% (v/v) human serum albumin (HSA; Sigma). The 
working stock was prepared by mixing equal volumes of each master stock, and stored at -
80°C. The working stock was used at 5µL/mL to give a final concentration of 10ng/mL IL-1β, 
1000U/mL IL-6, 10ng/mL TNF-α, and 1µg/mL PGE2 in culture medium. 
 
2.3.2. Isolation of peripheral blood mononuclear cells (PBMCs) 
Whole blood sourced from the Red Cross (Sydney, Australia) was diluted 3:1 with 
sterile PBS. Diluted blood was transferred to 50mL falcon tubes (40mL per tube) and underlain 
with 10mL Ficoll-Plaque (GE healthcare; Sweden) using a cannula (Unomedical; Sydney, 
NSW Australia). Tubes were centrifuged at 500xg for 20 minutes at room temperature with no 
brake. The Ficoll-serum interface containing PBMCs was collected using a transfer pipette 
(Copan Innovation; Brescia, Italy), pooled and washed 3 times with PBS prior to counting. 
 
2.3.3. Generation of monocyte-derived dendritic cells/macrophages 
2.3.3.1. Isolation of CD14+ monocytes 
CD14+ monocytes were isolated from PBMCs by magnetic bead separation using 
CD14 magnetic beads (Miltenyi Biotech) as per manufacturer’s instructions. Briefly, PBMCs 
were washed once with ice-cold MACS buffer and resuspended at 1 x 107 cells/10µL MACS 
buffer. Cells were incubated with 3µL CD14-conjugated magnetic beads per 1 x 107 PBMCs 
(Miltenyi Biotech) for 30 minutes on ice. Cells were washed and resuspended in 5mL MACS 
buffer prior to loading onto a pre-washed LS column (Miltenyi Biotech) mounted in a 
VarioMACS magnet (Miltenyi Biotech). Cells were allowed to flow through and the loaded 
column was washed twice with MACS buffer before eluting the bead-bound cells. Cells were 
then counted and differentiated into monocyte-derived macrophages (MDMs; see section 
2.3.4.2.) or immature monocyte-derived dendritic cells (iMDDCs; section 2.3.4.3). 
 
2.3.3.2. Generation of monocyte-derived macrophages (MDMs) 
CD14+ monocytes, isolated as per section 2.3.4.1., were plated at 0.5x106 cells/mL in 
RPMI-1640 in 12 well plates (1 x 106/well). The plates were centrifuged at 110xg and the cells 
allowed to adhere for 90 mins at 37°C with 5% CO2 before replacing the media with RH10 and 
allowing to differentiate for 5-7 days. Differentiation was confirmed by surface expression of 
CD71 by flow cytometry. 
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2.3.3.3. Generation of immature monocyte-derived DCs (iMDDCs) 
CD14+ monocytes, isolated as per section 2.3.4.1., were resuspended at 0.5x106 
cells/mL in RF10 supplemented with 500IU/mL GM-CSF and 300IU/mL IL-4. Cells were 
transferred to vented T150 flasks and allowed to differentiate for 5 days. Flow cytometry was 
used to confirm differentiation by the following surface expression profile: CD83-, CD14-, DC-
SIGN+, CD1a+, MR+. 
 
2.3.3.4. Maturation of MDDCs 
Differentiated iMDDCs were resuspended at 0.5 x 106 cells/mL in fresh RF10 
supplemented with cytokines (section 2.3.4.3.) and 5µL/mL maturation mix (section 2.3.1.3.). 
Cells were allowed to mature at 37°C, 5% CO2 for 48 hours. Surface expression of maturation 
markers CD80, CD83 and CD86 was determined by flow cytometry. 
 
 
2.4. Isolation of Cells from Human Tissue 
Surgical equipment used for skin processing was purchased from Zimmer (Warsaw, Indiana, 
USA).  
 
Solutions used during dermal and mucosal tissue cell isolation were supplemented with 
DNase (50U/mL) unless otherwise stated. 
 
2.4.1. Reagents 
2.4.1.1. Deoxyribonuclease (DNase) 
Sterile DNAse I (Grade II; Roche) was dissolved in PBS to a final concentration of 
1000U/µL. Stored at -20°C. 
 
2.4.1.2. Dispase 
Dispase II (Roche; Basal, Switzerland) was dissolved in RPMI to a final activity of 
1U/mL, and supplemented with Gentamicin (50µg/mL; Gibco). The media was filter sterilised 
with a 0.22µM filter before addition to the skin. 
 
2.4.1.3. Collagenase 
Type IV (Worthington; Lakewood, NJ, USA) or Blend F (Sigma) collagenase was 
dissolved in pre-warmed RPMI to a final concentration of 3mg/mL, and filter sterilised 
(0.22µm). For digestion of dermis and mucosal surfaces, the solution was supplemented with 
DNase to a final concentration of 100U/mL. 
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2.4.2. Preparation of skin sheets for cell isolation 
Human abdomens that would otherwise have been discarded were obtained from 
abdominoplasties in concordance with the Western Sydney Local Health District human 
research ethics committee ((4192) AU RED HREC /15 WMEAD/11), and processed within 3 
hours of collection (see Chapter 3 Figure 3.1.). Discarded tissue was stretched using forceps, 
and a 0.5mm layer shaved off the surface using a skin graft knife (Zimmer). The skin sheets 
were then passed through a skin graft mesher using a 3:1 blade (Zimmer). 
 
2.4.3. Separation of epidermis and dermis 
Netted skin sheets were evenly distributed to fill ≤25% of a 50mL conical tube.  Dispase 
was added at 3X volume of skin and incubated at 4°C overnight or 37° for 90-120 minutes. 
Skin sheets were dunked in 1X PBS to dilute dispase prior to peeling. Epidermis was peeled 
from the dermis using sterile forceps and both washed once in PBS. 
 
2.4.4. Enzymatic isolation of epidermal cells 
Epidermis free from dispase was evenly distributed to fill ≤10% volume of a 50mL 
conical tube. Epidermis was incubated in 3X volume collagenase at 37°C for 90 minutes with 
agitation. The mixture was passed through a loose mesh followed by a 100µm filter and 
washed twice with PBS. The pellet was resuspended in 10mL RPMI, transferred to a 15mL 
conical tube, underlaid with 5mL Ficoll (GE Healthcare) and centrifuged at room temperature 
for 20 minutes at 600xg with no breaks. The Ficoll-RPMI interface was collected and washed 
twice with PBS before counting. Cells were then stained for flow cytometric analysis or cell 
sorting. 
 
2.4.5. Enzymatic isolation of dermal cells 
Dermis was cut into 2cm2 sections, which were evenly distributed to fill ≤5-10% of 
50mL conical tubes. Dermis was incubated in 3X volume collagenase at 37°C for 90-120 
minutes with gentle agitation. The mixture was passed through a loose mesh followed by a 
100µm filter and washed twice with PBS. Cells were then enriched for CD45+ cells, as per 
section 2.4.7. prior to flow cytometric analysis or cell sorting. 
 
2.4.6. Culture for migration of epidermal and dermal cells 
After washing in PBS, epidermis and dermis were distributed across separate 10cm 
tissue culture dishes.  RH10 supplemented with DNase (50U/mL), Gentamicin (25µg/mL) and 
GM-CSF (500IU/mL) was filtered (0.22µm) and 25mL added to each dish. Cells were allowed 
to spontaneously migrate (‘crawlout’) for 24h-48h at 37°C, 5% CO2. Cells were collected by 
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passing the media through a loose mesh and 100µm filter (Griener), and washing twice in PBS 
prior to counting.  Cells were then stained for flow cytometric analysis (Section 2.2.3.) or cell 
sorting (Section 2.4.8.). 
 
2.4.7. CD45+ cell enrichment 
Cells isolated from dermis were enriched for CD45 positive cells with CD45 magnetic 
beads (Miltenyi Biotech) as per manufacturer’s instructions. Briefly, cells were washed once 
in MACS buffer and counted. Cells were resuspended in 8µL MACS buffer per 1 x 106 cells 
prior to addition of CD45-conjugated magnetic beads at 2µL per 1 x 106 cells. The mixture was 
incubated at 4°C for 20 minutes and washed twice in PBS + DNase (50U/mL) before loading 
onto an LS column (Miltenyi Biotech) through a pre-separation filter (70µm; Miltenyi Biotech). 
The column was washed once with PBS + DNase prior to eluting the CD45+ cells in the same 
wash buffer. Cells were counted prior to staining for flow cytometry or cell sorting. 
 
2.4.8. Sorting cells from human tissue 
Isolated dermal or epidermal cells were resuspended at ≤1x106cells/mL PBS.  
Live/Dead NIR was added at 0.02µL/100µL and cells stained for 30 minutes at 4°C. Cells were 
washed twice with MACS buffer and stained at ≤2x106cells/100µL for 30 minutes on ice. Cells 
were washed twice in RPMI and resuspended at 1x106cells/100µL for sorting.  Sterile 
collection tubes were prepared by adding 500µL human AB serum. All sorting was performed 
by trained technicians on the FACSAria (BD). 
 
 
2.5. Immunofluorescence imaging of human skin 
All incubations were carried out in a humidified chamber, and washes were performed by 
placing the slide in a container filled with the washing solution for at least 2 minutes. 
 
2.5.1. Reagents 
2.5.1.1. Blocking buffer 
 Blocking buffer was made fresh by supplementing 1X PBS with 1% (w/v) bovine serum 
albumin, 10% (v/v/) human serum and 0.01% (w/v) saponin.  
 
2.5.1.2. Antibody staining buffer 
 Antibody staining buffer was made fresh by supplementing 1X PBS with 0.5% (w/v) 
bovine serum albumin, 10% (v/v/) human serum and 0.01% (w/v) saponin.  
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2.5.2. Tissue cryo-embedding and sectioning 
 Samples with an area of 5mm2 and 3mm deep were cut from human abdominal skin, 
and each placed epidermal side down in a cryomold (ProSciTech; Australia) with O.C.T 
Compound (ProSciTech; Australia). Embedded tissue was frozen in liquid nitrogen and stored 
at -80°C until sectioned. Frozen tissue blocks were sectioned to 7µm on a HM-505E MICROM 
Cryostat set at -20°C, and stuck to Superfrost™ Ultra Plus Adhesion Slides (Thermo Scientific; 
MA, US) by thawing. 
 
2.5.3. Immunofluorescence staining 
Sections were encircled that a DAKO pen (DAKO; Denmark) and fixed for 20 minutes with 2% 
paraformaldehyde (Electron Microscopy Sciences; PA, US) at room temperature in the dark 
before washing three times. Sections were then blocked and permeabilised for 30 minutes at 
room temperature with 100µL blocking buffer (see section 2.5.1.1). Sections were washed 
once in PBS before the addition of primary antibodies (see Table 2.2.). Following incubation 
for 45 minutes at 37°C, sections were washed once with 0.2% (v/v) TWEEN-20 and three 
times with PBS. Secondary antibodies were added (see Table 2.2.) and incubated for 30 
minutes at 37°C. Secondary antibodies were washed as per the primary antibodies followed 
by a wash in water. Nuclear counterstaining and mounting was carried out using Slowfade® 
Gold antifade with DAPI (Molecular Probles (OR, US). 
 
Table 2.2. Immunofluorescent Microscopy Antibodies  
Antibody Host Company Clone Dilution* 
Primary     
CD1a Mouse BD HI149 1:50 
Langerin Goat R&D Polyclonal 1:50 
Secondary     
Goat AF546 Donkey Molecular Probes Polyclonal 1:400 
Mouse AF488 Donkey Molecular Probes Polyclonal 1:400 
* Prepared in 100µL antibody staining buffer (see section 2.5.1.2.) 
 
2.5.4. Acquisition of images 
 Slides were visualised using a 40X 1.5.16 NA oil immersion lens with an inverted 
Olympus IX-70 microscope and images collected with a Photometrics CoolSnap HQ2 camera 
(Olympus; Japan). Images were acquired as a serial Z-stack (0.5µm; 10-16 optical sections), 
deconvolved and visualised as a max intensity projection using DeltaVision SoftWoRx 
software (version 6.1.3). Images were further analysed in Fiji image analysis software 
(Madison version).  
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2.6. Culture of ex vivo and in vitro cells 
2.6.1. Cell Culture 
 All cells were propagated in a bio-safety cabinet class II (BSCII) and maintained in a 
humidified incubator with 5% CO2 at 37°C (Thermo Scientific, Waltham, MA, USA). 
 
2.6.2. JLTR.R5 cells 
JLTR.R5 cells (NIH AIDS Research and Reference Reagent Program, contributed by 
Dr. Olaf Kutsch) are an indicator cell line derived from Jurkat T cells that express low levels of 
CCR5 and have been transfected to express GFP under control of the HIV-1 promotor 
(Ochsenbauer-Jamor et al., 2006). JLTR.R5 cells were cultured in RF10 and passaged every 
3-4 days when cells reached a density of 1-2 x 106 cells/mL. 
 
2.6.3. Ex vivo skin cells 
 Cells isolated from skin were resuspended in RH10 supplemented with GM-CSF 
(500IU/mL) and Gentamicin (25µg/mL) at a density of 1 x 106 cells/mL. Cells were cultured in 
48-well (200µL) or 96-well (100µL) flat-bottom plates at 37°C, 5% CO2. 
 
 
2.7. Transfer Assay 
All experiments involving HIV were conducted in a PC3 facility. 
 
HIV-1BaL, which is a commonly used lab strain of the virus, was used for all infections. It was 
grown to a high titre by the host lab to enable more efficient infection of DCs and macrophages. 
 
2.7.1. Infection of mononuclear phagocytes with HIV 
 Mononuclear phagocytes sorted from skin or in vitro-derived iMDDCs were counted, 
spun down at 400xg for 5 minutes and resuspended in 200µL RH10. High titre HIV-1BaL was 
added to the cells at an MOI of 3 and incubated at 37°C, 5% CO2 for 2 hours. The cells were 
washed 3 times by adding 2-5mL RPMI, spinning at 400xg for 5 minutes and discarding the 
supernatant. Cells were resuspended at 1 x 105 cells per 100µL RH10 supplemented with GM-
CSF (500IU/mL) and Gentamicin (25µg/mL), and seeded in 48-well (200µL/well) or 96-well 
(100µL) plates. 
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2.7.2. Co-culture of DCs and macrophages with T cells 
 JLTR.R5 cells were added to the infected cells at a ratio of 4:1 in 1:1 volume of RF10 
every 1-2 hours for 6 hours and then daily for 4-5 days. Media was replaced every 2 days after 
JLTR.R5 addition. 
 
2.7.3. Determination of the percent of HIV transfer from DCs and macrophages to T 
cells 
 JLTR.R5 cells were collected after 4-5 days of culture with DCs and macrophages. 
Cells were washed twice in PBS and fixed with 200µL 1% (v/v) PFA for 15 minutes at room 
temperature. Fixed cells were washed once with PBS and run on the FACSCanto™ II to 
determine the percent of GFP-positive cells. HIV-infected JLTR.R5 cells express GFP under 
the LTR promoter, therefore the percent of GFP-positive cells is equivalent to the percent of 
HIV-infected cells. The percent of infected cells was plotted over time to map the kinetics of 
transfer. 
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3.1. Introduction 
Dendritic cells (DCs) and macrophages play a fundamental role in pathogen detection 
and priming an immune response (Haniffa et al., 2015a; Natsuaki et al., 2014; Schlitzer et al., 
2015). In skin, these cells represent one of the first lines of contact between incoming 
pathogens and the immune system (Nestle et al., 2009). However, DCs and macrophages are 
firmly embedded in tissue, which makes them difficult to isolate and often results in low cell 
yields. Furthermore, human tissue is not easy to obtain. Therefore, model DC systems are 
used for most studies involving human DCs, which typically involve the culture of blood-
derived monocytes with various cytokines. The most common model is monocyte-derived 
DCs, which are derived from CD14+ monocytes cultured with IL-4 and GM-CSF (Romani et 
al., 1994; Sallusto and Lanzavecchia, 1994), and we have shown that genotypically these are 
most closely related to CD14+ dermal cells (Harman et al., 2013a). LC-like cells can also be 
generated from either CD14+ monocytes cultured with IL-4, GM-CSF and TGFβ (Geissmann 
et al., 1998), or CD34+ bone marrow or blood precursors cultured with GM-CSF and TNFα 
(Caux et al., 1992). However, these model cell types are not the same as the skin DC subsets 
found at the portals of pathogen entry, and importantly they differ in the array of pathogen 
binding receptors they express (Harman et al., 2013a), which is investigated in detail in 
Chapter 5. Therefore, it is important to confirm observations made using model systems with 
ex vivo tissue DCs. This is especially relevant when investigating viruses such as HIV-1 and 
HSV, that infect via the skin and mucosa, and where specific subsets have been shown to 
play a direct and critical role in their transmission (Harman et al., 2013b; Kim et al., 2015; 
Marsden et al., 2015; Nasr et al., 2014). 
Phenotypic and functional investigation of tissue DC and macrophage subsets requires 
liberation of the cells from tissue with the lowest possible impact on the cells. In order to isolate 
cells that are most likely to resemble those residing in skin prior to extraction, enzymatic 
digestion is commonly used. However, there is little consistency with regards to how the skin 
is processed, the enzyme used, or the duration and temperature of the digestion incubation. 
Furthermore, mononuclear phagocytes found in inflamed tissue can display significantly 
different surface expression profiles compared to steady state, which can lead to 
misinterpretation of specific DC subsets (Durand and Segura, 2015). These factors influence 
not only the cell yield, but also the viability, activation status and phenotype of the cells 
liberated. This is notably observed in the study of CD141+ DCs, in which three separate 
publications by different labs that each used a different method of isolation yielded differing 
phenotypes (Artyomov et al., 2015; Chu et al., 2012; Haniffa et al., 2012). Inconsistent use of 
enzymes also resulted in controversy in the literature with regards to the ability for LCs to be 
infected with HIV. Specifically, the use of trypsin to isolate LCs resulted in cleavage of CD4 
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from the surface which rendered the cells resistant to infection (de Witte et al., 2007; Lynch et 
al., 2003), while permissive infection was achieved if liberated with collagenase (Nasr et al., 
2014). These differences therefore have significant implications in further investigations, and 
as such, this chapter focuses on identifying the ideal conditions for enzymatic digestion of 
skin, as well as the optimal cocktail of antibodies to distinguish the various DC and 
macrophage subsets liberated. 
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3.2. Results 
3.2.1. Isolation of cells from human skin 
In order to ensure maximal cell yield from human skin, it is important that the tissue is 
processed consistently in a precise and timely manner to minimise cell death due to hypoxia. 
Therefore, healthy human skin was obtained from abdominoplasty operations and processed 
within 3 hours of removal. The process of obtaining epidermal and dermal skin sheets had 
been optimised previously by the host lab (Harman et al., 2013a; Harman et al., 2006; Nasr et 
al., 2014), and is summarised in Figure 3.1. Skin grafts (sheets of skin incorporating the 
epidermis and a thin section (>100µm) of upper dermis) were removed from the surface using 
a skin graft knife, and passed through a skin graft mesher in order to create the largest surface 
area for enzymatic digestion and cell migration (Figure 3.1.). The meshed skin grafts were 
incubated overnight in dispase at 4°C, which is ideal for minimal cell activation, after which the 
epidermis was peeled from the dermis and each processed separately. Cells were then either 
liberated by enzymatic digestion, or the tissue sheets were cultured for 48 hours to allow DCs 
to migrate out.  
 
3.2.2. Titration of antibodies used to discriminate skin mononuclear phagocyte subsets 
by flow cytometry 
Following isolation from the tissue, multicolour flow cytometry was used to differentiate 
the multiple macrophage and DC subsets. Due to the difficulty in identifying the different 
subsets in tissue because of the promiscuous expression of surface markers, a large pool of 
antibodies specific for the most commonly used population-identifying markers were titrated 
(Figure 3.2.). Furthermore, in order to develop multiple panels, a few antibodies conjugated 
to a number of different fluorophores were tested. The antibodies were titrated on cells isolated 
from skin by enzymatic digestion and after migration, or on peripheral blood mononuclear 
cells. The highest concentration of antibody was determined according to the manufacturer’s 
instructions and then serially diluted. Cells were stained for 30 minutes on ice or at 4°C to 
ensure minimal surface receptor internalisation and ideal antibody specificity, and then 
analysed by flow cytometry. The positive and negative populations were gated (Figure 3.2.A) 
to correlate antibody dilution with the best separation of stained populations from unstained 
background. The geometric mean fluorescence intensity (gMFI) was determined for each, and 
the ratio of the positive population gMFI to the negative population gMFI was plotted for each 
dilution (Figure 3.2.B). The higher the gMFI ratio, the greater the separation in fluorescence 
of the positive and negative populations. The optimal antibody concentration was chosen 
based on the lowest amount that showed clear visual separation (plots) and a high signal to 
noise ratio (+/- gMFI; i.e. in close proximity to the plateau).
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Figure 3.1. Isolation of cells from human skin 
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Figure 3.1. Isolation of cells from human skin. Discarded human skin obtained from 
abdominoplasty operations was processed within 3 hours of removal. Skin was stretched and 
0.2-1mm sheets of skin (skin grafts) removed using a skin graft knife. Skin grafts were put 
through a skin graft mesher and then digested with dispase overnight at 4°C. The epidermis 
was peeled from the dermis and each processed separately.  Cells were either isolated by 
digestion with collagenase at 37°C (enzymatic digestion), or allowed to migrate from the tissue 
over 48h at 37°C (‘crawlout’). 
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Figure 3.2. Titration of mononuclear phagocyte population-identifying antibodies.  
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Figure 3.2. Titration of mononuclear phagocyte population-identifying antibodies. 
Antibodies used for macrophage and dendritic cell staining were titrated on PBMCs and cells 
isolated from skin. Live/Dead Near Infrared (NIR), HLA-DR BUV395, CD45 BV786, CD14 
BUV737 and CD1c PE.Vio770 were titrated on PBMCs. Langerin Vioblue and CD141 BV711 
were titrated on cells that migrated from epidermis and dermis, respectively. Remaining 
antibodies were titrated on cells isolated from collagenase-digested dermis. The volumes of 
antibody displayed are those used to stain ≤2.5 x 106 cells in a final volume of 100µL. Positive 
(full line) and negative (dotted line) populations were gated on whole cells (HLA-DR, CD45 
and Live/Dead) or live, HLA-DR+CD45+ cells (A). The ratio of geometric MFIs (positive 
population / negative population; +/-) for each antibody volume are plotted (B). The selected 
optimal antibody volume is marked with *. 
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See Table 3.1. for a summary of the optimal concentrations for each antibody tested. 
 
3.2.3. Discrimination of macrophage and DC subsets based on size and granularity 
For optimal flow cytometric analysis, it was important to exclude as much cell debris, 
and as many cell doublets and irrelevant cell types as possible that contribute noise to the 
data. This allowed more accurate gating of the cell type of interest. Live cells were marked by 
their exclusion of the viability dye Live/Dead, and single cells were gated on a FSC-A vs FSC-
H plot. DCs and macrophages make up the vast majority of HLA-DR+CD45+ cells, which 
allowed them to be largely discriminated from most other populations in skin, including T cells, 
keratinocytes, and NK cells. The live, single, HLA-DR+CD45+ cells were gated on first, and 
could roughly be discriminated by size (forward scatter; FSC) and granularity (side scatter; 
SSC) when backgated (Figure 3.3.). By applying a gate based on the position of the live, 
single, HLA-DR+CD45+ cells in FSC/SSC prior to subsequent gating, the number of HLA-DR-
CD45- cells in the live, single population from epidermis and dermis was reduced by 
approximately 25% and 50% respectively. Therefore, this process was utilised in subsequent 
analyses to enrich the populations of interest. 
 
3.2.4. Maximising the yield of viable HLA-DR+CD45+ cells from skin  
 Access to human skin specimens is limited, and therefore it is crucial to maximise the 
yield of viable cells to best utilise each specimen supplied. In order to isolate cells that maintain 
their in vivo phenotype, enzymes such as collagenase and trypsin are commonly used to 
digest the skin. Collagenase is often a blend of enzymes; therefore, it not only differs between 
companies but also batches. As such, two blends of collagenase that are commonly used to 
digest skin were tested: Blend F (Sigma) and Type IV (Worthington). To determine whether 
trypsin or collagenase was the ideal enzyme of use, weight-matched epidermis and dermis 
was spiked with counting beads and digested at 37°C for 120 minutes, and cells collected 
every 10 to 30 minutes. The viability and yield of the HLA-DR+CD45+ cells were determined 
by flow cytometry, and plotted for epidermis and dermis over the period of digestion (Figure 
3.4.).  
Variability was observed between the types of enzyme, and between the batches of 
collagenase. Trypsin liberated markedly fewer cells from both epidermis and dermis, and 
these cells were approximately 10% less viable than those liberated with collagenase. 
Furthermore, trypsin has been reported to cleave some epitopes, including CD4, from the 
surface of immune cells (Lynch et al., 2003; Nasr et al., 2014). As such, trypsin was omitted 
from the remainder of the optimisations. The yield of live, single, HLA-DR+CD45+ cells from 
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Table 3.1. Optimised antibody concentrations against population markers 
 
Antibody Company Cells# 
Optimal  
volume * 
CD1a BV510 BD Dermis (E) 1µL 
CD1c PE.Vio770 Miltenyi PBMCs 3µL 
CD14 BUV737 BD PBMCs 2µL 
CD14 BV421 BD Dermis (E) 2µL 
CD45 BUV395 BD Dermis (E) 1µL 
CD45 BUV768 BD PBMCs 1µL 
CD45 PE.Cy7 BD Dermis (E) 1µL 
CD141 BV711 BD Dermis (C) 2µL 
HLA-DR PerCP Miltenyi Dermis (E) 2µL 
HLA-DR BUV395 BD PBMCs 0.5µL 
Langerin Vioblue Miltenyi Epidermis (C) 1.5µL 
Live/Dead NIR Invitrogen PBMCs 0.02µL 
 
* Optimal volume of antibody for staining ≤2 x 106 cells in 100µL buffer 
# Cells used for antibody optimisation. E, enzymatic digested; C, ‘crawlout’ cells; PBMCs, 
peripheral blood mononuclear cells 
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Figure 3.3. Optimisation of the gating strategy for HLA-DR+CD45+ cells from human skin. 
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Figure 3.3. Optimisation of the gating strategy for HLA-DR+CD45+ cells from human skin. Cells isolated from collagenase digested 
epidermis (A) and dermis (B) were stained with Live/Dead Near Infrared (NIR), HLA-DR BUV395 and CD45 PE.Cy7. Cells were gated for live, 
single, HLA-DR+CD45+ cells (red), and back gated to determine their position in FSC-A versus SSC. This new FSC-A/SSC gate was applied to 
determine the enrichment of the HLA-DR+CD45+ population. 
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Figure 3.4. Identification of the optimal enzyme for the isolation of HLA-DR+CD45+ cells 
from skin. Epidermis (A) and dermis (B) were spiked with true count beads and digested with 
trypsin (black) or collagenase (Worthington Type IV (blue) or Sigma Blend F (red)) at 37°C. 
Cells harvested at 10 to 30 minute intervals over 120 minutes were stained with Live/Dead 
NIR, HLA-DR PerCP and CD45 PE.Cy7, and analysed by flow cytometry for cell yield (left) 
and viability (right). n = 1.  
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epidermis increased with time for both collagenase batches until 120 minutes, by which the 
time the number of cells liberated with Blend F collagenase had plateaued. Type IV 
collagenase liberated 2-5 times the number of cells from epidermis compared to Blend F 
Collagenase at each time point, and the cells maintained a higher viability over the duration of 
digestion (85% compared to as low as 67%). The converse was true however for the dermis. 
The yield of live, single, HLA-DR+CD45+ from dermis increased over time for both collagenase 
batches, but was 7-8 times higher for Blend F than Type IV up to 90 minutes. There was a 
drop in cell yield with Blend F after incubation for 120 minutes, but this may have been due to 
increased cell clumping. There was no difference in the viability of HLA-DR+CD45+ cells 
liberated from dermis, which remained greater than 90% viable at all time points for both 
collagenase blends. 
 
3.2.5. Identification of macrophage and DC subsets from human skin by multicolour 
flow cytometry 
Unlike blood DCs, identifying markers on macrophage and DC subsets in tissue 
overlap substantially; therefore, a complex gating strategy was developed to distinguish the 
subsets by flow cytometry. After gating on the HLA-DR+CD45+ population, LCs in the 
epidermis were defined by CD1a expression (Figure 3.5.). Unlike epidermis, dermis contains 
multiple DC and macrophage subsets, and as such definition of the subsets is crucial to 
prevent misidentification. At the commencement of this research, CD141+ DCs were the most 
recently identified skin DC subset, and were described to be CD141+CD14-CD11clow 
population (Haniffa et al., 2012). This was confirmed, and it was observed that the 
CD141+CD14- cells were equivalent to the CD141+CD11clow population (Figure 3.6). For this 
thesis CD141+ DCs were defined as the CD141+CD14- population in order to minimise the 
number of antibodies required to define populations.  
Dermal macrophage and DC subsets were gated in a sequential strategy in order to prevent 
cross-contamination from any of the other subsets (Figure 3.7.A). Within the HLA-DR+CD45+ 
population, macrophages were defined as the autofluorescent CD14+ population. Within the 
non-autofluorescent population, CD141+ DCs were defined as the CD141+CD14- population. 
Within the CD141- population, CD1a+ DCs and CD14+ DCs, were defined as the CD1a+CD14-
/low and CD14+CD1a- populations respectively. Each subset was overlayed on CD45 versus 
HLA-DR in order to determine its relative position in the HLA-DR+CD45+ population (Figure 
3.7.B). Macrophages, CD1a+ DCs and CD14+ DCs were located in relatively the same 
position, while CD141+ DCs sat lower in the HLA-DR gate. Therefore, it is important that the 
HLA-DR+CD45+ gate is extended to include the CD141+ DCs. 
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Figure 3.5. Identification of epidermal LCs isolated from collagenase digested skin. 
Cells isolated from epidermis were stained with Live/Dead NIR, HLA-DR BUV395, CD45 
PE.Cy7, and CD1a BV510. LCs (teal) were defined as the CD1a+ cells within the live, single, 
HLA-DR+CD45+ population. 
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Figure 3.6. CD141+ DC gating strategy. Cells isolated from collagenase digested dermis 
were stained with live/dead NIR, HLA-DR BUV395, CD45 BV786, CD14 BUV737, CD141 
BV711 and CD11c APC. Within the live, single, HLA-DR+CD45+autofluorescence- population, 
CD141+CD14- cells (left; purple) and CD141+CD11c- cells (right; pink) (A) were gated and 
their relative percentage of HLA-DR+CD45+ displayed. Both populations were overlayed on 
CD141 vs CD14 (left) and CD11c (right) (B).  
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Figure 3.7. Identification of dermal macrophage and DC subsets isolated from collagenase digested human skin by flow cytometry. 
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Figure 3.7. Identification of dermal macrophage and DC subsets isolated from 
collagenase digested human skin by flow cytometry. Cells isolated from dermis were 
stained with Live/Dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, 
and CD141 BV711. Autofluorescence was detected in the FITC and/or BV605 channels. DC 
and macrophages subsets were identified within the live, single, HLA-DR+CD45+ population. 
Dermal DC and macrophage populations were identified using a successive gating strategy 
(A). Macrophages (green) were defined as CD14+ autofluorescent cells. Within the 
autofluorescence negative gate, CD141+ DCs (purple) were defined as the CD141+CD14- 
cells. Within the CD141- gate, CD1a+ DCs (blue) were defined as the CD1a+CD14low cells, 
and CD14+ DCs (orange) were defined as the CD14+CD1a- cells. Each population was back 
gated to determine its position in HLA-DR vs CD45 (B). 
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3.2.6. Investigating the effect of different collagenase blends on the yield of specific 
macrophage and DC subsets from human skin. 
Due to the variety of DC and macrophage subsets in skin, it was important to determine 
whether the viability or yield of any single subset was affected differently by either of the 
collagenase blends. The above gating strategies were employed to investigate the effect of 
collagenase on each macrophage and DC subset liberated by digestion of epidermis and 
dermis (Figure 3.8.). For both collagenase blends, there was a similar trend and number of 
viable LCs liberated (Figure 3.8.A and B, right) compared to those observed for the total 
epidermal HLA-DR+CD45+ cells (Figure 3.4.). Type IV collagenase liberated more LCs with 
increasing incubation time, which began to plateau at 120 minutes with a 10 times greater 
yield than Blend F collagenase (Figure 3.8.B and C). Contrastingly, the LC yield remained 
relatively constant for the duration of digestion with Blend F (Figure 3.8.A, left). 
Regardless of collagenase, CD1a+ DCs were the most abundant dermal subset 
isolated, CD141+ DCs were the least abundant, and there were similar numbers of CD14+ 
DCs and macrophages isolated. Each subset liberated by Type IV collagenase followed a 
similar trend in yield, where there was a steep increase in the number of cells isolated after 
more than 90 minutes of digestion, which was slightly lower for the CD141+ DCs (Figure 
3.8.B, left). In contrast, the yield of macrophages, CD1a+ DCs and CD14+ DCs peaked at 90 
minutes of digestion with Blend F (Figure 3.8.A, left). Unlike the other subsets, the number of 
CD141+ DCs liberated by Blend F collagenase was not dependent on length of digestion.  
To determine the collagenase that liberated the optimal number of dermal macrophage 
and DC subsets, the maximum yield for individual subsets liberated using each collagenase 
was compared. This was at 90 minutes for Blend F and 120 minutes for Type IV (Figure 
3.8.D). The maximum number of macrophages and CD14+ DCs isolated was independent of 
collagenase blend, unlike CD1a+ DCs and CD141+ DCs which differed between blends. Blend 
F collagenase liberated twice the number of CD1a+ DCs than Type IV collagenase, while Type 
IV collagenase liberated over twice the number of CD141+ DCs than Blend F collagenase. 
Furthermore, CD141+ DCs liberated by Blend F collagenase had slightly lower viability than 
those liberated by Type IV collagenase (Figure 3.8.). Greater than 95% of macrophages, 
CD1a+ DCs and CD14+ DCs that were isolated were viable, which was not dependent on the 
collagenase used.  
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Figure 3.8. Identification of the optimal collagenase digestion conditions for isolation 
of macrophages and DC subsets from human skin.  
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Figure 3.8. Identification of the optimal collagenase digestion conditions for isolation 
of macrophages and DC subsets from human skin. Weight-matched epidermal and dermal 
sheets were digested with 3mg/mL Sigma Blend F collagenase (A) or Worthington Type IV 
collagenase (B) at 37ºC, and cells collected at 30 minute intervals up to 120 minutes. Collected 
cells were spiked with true count beads and stained with Live/Dead NIR, HLA-DR PerCP, 
CD45 PE-Cy7, CD1a BV510 CD14 BV421, and CD141 BV711 for flow cytometry. The cell 
yield (left) and percent viliability (right) were determined for LCs (teal), macropahges (green) 
and CD14+ (orange), CD1a+ (blue) and CD141+ (purple) DCs (Figure 3.8.A gating 
strategy). The total LC yield was compared between Sigma Blend F (red) and Worthington 
Type IV (blue) after 120 minutes digestion (C). For each dermal population, the cell yield after 
90 minutes of digestion with Sigma Blend F collangenase (red) was compared to the cell yield 
after 120 minutes of digestion with Worthington Type IV collagenase (blue) (D). 
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3.2.7. Investigating the effect of different collagenase blends on the surface expression 
of population markers on skin macrophage and DC subsets. 
Definition of each subset is reliant on the expression of a combination of markers 
expressed on its surface, and as such it was important to determine whether any were cleaved 
by either blend of collagenase. Cells were isolated from epidermis and dermis by digestion 
with Blend F collagenase for 90 minutes and compared to those isolated by digestion with 
Type IV collagenase for 120 minutes. The isolated cells were stained with commonly used 
population markers (HLA-DR, CD45, CD1a, CD1c, CD14, CD141 and langerin) and analysed 
by flow cytometry. Macrophage and DC subsets were gated according to the strategies 
outlined above (Figure 3.5 and Figure 3.7), and the geometric mean fluorescence (gMFI) for 
each population marker determined for individual subsets (summarised in Table 3.2). For each 
population marker, a single subset of cells was chosen that expressed a high level of that 
marker for the comparison. Expression of HLA-DR, CD45, CD1a, CD11c, CD14 and CD141 
on subsets isolated using Blend F collagenase did not differ significantly from subsets isolated 
using Type IV collagenase. However, CD1c and langerin expression on CD1a+ DC and LCs, 
respectively, was 75% lower when isolated with Blend F collagenase than Type IV 
collagenase. Therefore, langerin and CD1c may be less reliable markers to define subsets 
isolated using Blend F collagenase. 
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Table 3.2. Collagenase cleavage of population-determining surface expression 
 
Marker Subset 
tested 
Blend F 
(gMFI) 
Type IV 
(gMFI) 
Expression 
Difference 
(Log10FC) 
Statistics 
# 
Best 
Enzyme 
Mean SD Mean SD 
HLA-DR LC 6094 2128 4975 2947 0 ns NA 
CD45 LC 7544 4211 12974 7724 1 ns NA 
CD1a LC 41052 11087 38823 10006 0 ns NA 
CD1c CD1a 2193 108 8771 5543 2 ** Type IV 
CD11c CD1a 2118 41 3094 218 1 ns NA 
CD14 CD14 2254 796 3262 2291 1 ns NA 
CD141 CD141 3534 2213 2403 1239 1 ns NA 
Langerin LC 4753 2915 20262 18157 2 * Type IV 
 
FC = fold-change; gMFI = geometric mean fluorescence intensity; SD = standard deviation;  
#Mann-Whitney test; ns = not significant, * p ≤ 0.05, ** p ≤ 0.01, n = 15. 
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3.3. Discussion  
Inconsistent methods of mononuclear phagocyte isolation from skin has lead to 
conflicting phenotypes reported in the literature (Haniffa et al., 2015b). This study therefore 
began by optimising the ideal conditions for isolation of all known human DC and macrophage 
subsets from human skin, and their classification by surface expression markers using flow 
cytometry. Enzymatic digestion, as opposed to the spontaneous migration or ‘crawl-out’ 
method, is the best way of isolating DCs in the immature state that they are in when they 
encounter incoming pathogens, and was therefore used as the primary isolation technique 
throughout this thesis. The use of a skin graft knife and skin graft mesher to produce thin nets 
of skin allows for minimal amounts of enzyme to be added and shorter incubation times, which 
reduces the influence either may have on the health or phenotype of the cells.   
It remains unknown as to whether there is single marker that is exclusively expressed 
by each macrophage or DC subset in human tissue; therefore, a combination of markers is 
needed to define each subset. Antibodies targeting each marker were optimised to ensure 
populations could be clearly distinguished, and tested for susceptibility to enzymatic cleavage. 
Cleavage of markers by dispase was not tested as dispase was needed to separate the 
epidermis from the dermis; however, the concentration was titrated down to have a minimal 
effect, and all populations markers were detected. The population markers used to classify 
macrophages and DCs were not affected by collagenase; however, langerin and CD1c were 
susceptible to cleavage by Blend F collagenase. As with cleavage of CD4 by trypsin (Lynch 
et al., 2003; Nasr et al., 2014), cleavage of these markers could have significant implications 
not only on the identification of these cells but also on future functional studies. Therefore, 
Type IV collagenase would need to be used for any functional or phenotypic studies that may 
rely on either of those markers, and further highlights the importance of the enzyme selected 
for tissue digestion. 
The yield and viability of cells obtained from epidermis and dermis was dependent on 
the type of enzyme (e.g. trypsin or collagenase), blend of enzyme and length of digestion. 
Digestion of epidermis with Type IV collagenase for 120 minutes liberated the maximum yield 
of viable LCs, and were therefore the conditions used for subsequent investigations on LCs. 
While digestion of dermis with Blend F collagenase for 90 minutes liberated the maximum 
yield of viable HLA-DR+CD45+ cells when compared with Type IV collagenase digestion for 
120 minutes, CD1a+ DCs were the only enriched population. Type IV collagenase digestion 
liberated comparable numbers of CD14+ DCs and macrophages, and more CD141+ DCs after 
120 minutes of digestion than Blend F collagenase after 90 minutes. Therefore, to isolate an 
optimal yield of all populations of interest, dermis was digested with Type IV collagenase for 
120 minutes. 
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Unlike the other cell subsets, the yield of CD141+ DCs remained relatively constant 
regardless of the length of enzymatic digestion. Rapid liberation of the CD141+ DCs may be 
a reflection of their location in proximity to the dermoepidermal junction (DEJ). The majority of 
dermal DCs are located 0-20µm beneath the DEJ (Wang et al., 2014), and these results 
indicate that CD141+ DCs may be the most superiorly located dermal DC subset. Together 
with their enhanced cross-presentation capabilities (Haniffa et al., 2012), CD141+ DCs may 
provide a significant first line of defence against pathogens that invade the barriers posed by 
the epidermis.  
 The enzyme-specific differences observed with cell viability, cell yield and population 
marker cleavage observed with these results highlights the importance of enzyme selection 
for isolation of cells from skin. While Blend F collagenase liberated the most cells from dermis, 
it cleaved important population markers that could significantly influence further studies. Type 
IV collagenase liberated significantly more cells from the epidermis and had lesser influence 
on population marker expression, and is therefore the ideal enzyme for isolation of both dermal 
and epidermal mononuclear phagocyte subsets. This method of isolation was the gold 
standard used for comparison against the ‘crawl-out’ method and for investigation epidermal 
and dermal subsets in subsequent chapters.
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4.1. Introduction 
 Macrophage and DC subsets have specialised functions (Haniffa et al., 2015a), and 
their accurate identification and classification is therefore important. Classification of human 
tissue macrophages and DCs is difficult due to the lack of mutually exclusive expression of 
single markers by specific subsets. Unlike blood DCs, which express either CD1c (BDCA1), 
CD303 (BDCA2) or CD141 (BDCA3) (MacDonald et al., 2002), multiple tissue DC subsets 
express CD1c (Haniffa et al., 2012; McGovern et al., 2014b), and CD141 expression can be 
upregulated on multiple subsets (Chu et al., 2012). Therefore, multiple markers are required 
to correctly identify each subset by flow cytometry and the gating strategy employed is a 
crucial element in preventing subset misidentification. 
 As was mentioned in Chapter 3, healthy epidermis is considered to contain a single 
DC population called an LC, which is characterised by the presence of intracellular Birbeck 
granules and the expression of CD1a, langerin, E-cadherin and EpCAM (Angel et al., 2006; 
Haniffa et al., 2009; Zaba et al., 2007). However, in states of inflammation, inflammatory 
dendritic epidermal cells (IDECs), which are distinct from LCs and dermal DCs, can also be 
observed in the epidermis (Wollenberg et al., 1996; Wollenberg et al., 2002a). Similarly, 
distinct subsets of DCs have been observed in the dermis of inflamed skin that are absent 
from healthy skin (Lowes et al., 2005; Segura et al., 2013b; Zaba et al., 2009), such as Slan+ 
DCs and pDCs in psoriatic lesions (Hänsel et al., 2011; Nestle et al., 2005). Furthermore, in 
response to various stimuli, such as infection or inflammation, DCs undergo a process of 
maturation (Harman et al., 2006; John et al., 2007). As a result of maturation, DCs become 
less endocytic (Platt et al., 2010; Reis e Sousa, 2006) and migrate out of the tissue towards 
the lymph nodes (Hansson et al., 2006; Martín-Fontecha et al., 2009; Randolph et al., 2005), 
which is marked by a downregulation of pathogen binding receptors (e.g. CLRs) (Harman et 
al., 2006; Mercier et al., 2013) and upregulation of chemokine receptors (e.g. CCR7) (Haniffa 
et al., 2012; Hansson et al., 2006), respectively. Mature DCs are very efficient antigen 
presenters, and as such express high levels of MHC-II and cell adhesion molecules (e.g. 
CD54) (Mercier et al., 2013). Unlike other mononuclear phagocytes, such as macrophages, 
DCs are very potent naïve T cell stimulators and do not require a secondary stimulus to do so 
(Bousso, 2008; Ni and O'neill, 1997), as such they upregulate co-stimulatory molecules (e.g. 
CD40, CD80, CD83 and CD86) (Aerts‐Toegaert et al., 2007; Harman et al., 2006). Although 
tissue resident DCs express higher levels of co-stimulatory molecules than blood DCs (Angel 
et al., 2007; Haniffa et al., 2012), here they are referred to as immature because they efficiently 
bind and endocytose pathogens (Cerny et al., 2014), and migrate out of tissue as a result 
(Randolph et al., 2005). 
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 There are two methods of isolating DCs from skin; enzymatic digestion (as previously 
discussed in Chapter 3) and the ‘crawl-out’ method (Haniffa et al., 2015b). The ‘crawl-out’ 
method involves allowing cells to migrate from tissue over 24-72 hours (Lenz et al., 1993; 
Nestle et al., 1993), and is popular as it is less labour intensive and the enzymes used to 
digest tissue are costly. Despite reported similarity in the antigenic profile of enzymatic vs 
migrated DCs, the higher frequency of cells liberated by spontaneous migration suggests that 
the cells may display plasticity (Haniffa et al., 2015b). Furthermore, macrophages have been 
shown not to migrate from tissue (Wang et al., 2014), and therefore the subsets isolated by 
the crawl-out method are not a true representation of the mononuclear phagocyte subsets that 
reside in the tissue. 
It is important to consider that the two methods of isolating DCs from tissue liberates 
cells with distinct phenotypes: enzymatic digestion liberates immature DCs, whereas the 
crawl-out method isolates migrated, and therefore mature DCs. This is particularly an issue in 
studying the interactions of these cells with pathogens as mature cells downregulate pathogen 
binding receptors, which will be discussed in further detail in Chapter 5. 
The aim of this chapter was to use a full range of commonly used DC and macrophage 
population markers to classify known mononuclear phagocyte subsets, and to determine 
whether there were any previously undescribed subsets. Furthermore, the methods of 
isolation from tissue were compared to determine their influence on the identification, 
frequency and phenotype of subsets liberated. 
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4.2. Results 
4.2.1. Identification of two novel epidermal DC-like subsets in healthy human skin 
 In healthy human skin, the epidermis is generally believed to contain a single DC 
subset, the LC (Romani et al., 2003). Previously, the host lab identified LCs in the epidermis 
as the CD45+CD1a+ population (Harman et al., 2013a; Nasr et al., 2014), which was employed 
for optimisations in Chapter 3. In order to further characterise LCs, the surface phenotype was 
analysed in detail on cells liberated from epidermis by collagenase digestion. Cells were gated 
by size and granularity, as outlined in Figure 3.3., and dead cells and doublets excluded. 
Within the live, single cell gate, two distinct populations were observed that both expressed 
HLA-DR and CD45, but could be distinguished by their relative expression of each marker – 
HLA-DR+CD45+ and HLA-DR++CD45++ (Figure 4.1.A). The HLA-DR++CD45++ population was 
typically the larger population, and could be further subdivided into two populations based on 
the level of CD1a and langerin expression. One population was CD1a++langerin+ and 
constitute LCs, while the other population was langerin negative and expressed less CD1a, 
henceforth referred to as a CD1a+Langerin- DC. The HLA-DR+CD45+ population contained a 
single CD1a+ population that also expression langerin, henceforth referred to as a 
CD1a+Langerin+ DC. When backgated to determine their position relative to HLA-DR and 
CD45 (Figure 4.1.B), each population was located in a distinct location. Furthermore, when 
overlaid on HLA-DR versus CD1a, the above defined subsets appear as three distinct 
populations (Figure 4.1.C), which was consistent across 13 donors. Langerin+ and langerin- 
CD1a-expressing epidermal populations were also observed in situ (Figure 4.1.D). As 
expected, LCs were the most frequent subset observed in epidermis, while CD1a+Langerin- 
DCs were the least frequent subset (Figure 4.2.A). 
 To determine whether the separated subsets were significantly different based on 
surface expression of population markers, the gMFI of each marker was compared across 
multiple experiments (Figure. 4.2.B). The CD1a+Langerin+ subset was similar to LCs in 
expression of langerin, CD1c and CD11c, but they had lower levels of HLA-DR, CD45 and 
CD1a. In contrast, the CD1a+Langerin- population expressed higher levels of CD1c, CD11c 
and HLA-DR (only HLA-DR reached statistical significance) than the other two subsets, but 
they lacked langerin expression. Their CD1a expression was also not as high as LCs. 
Furthermore, none of the subsets were autofluorescent, nor did they express CD141 or CD14 
(Figure 4.2.C). Thus we have identified two new potential epidermal DC subsets, in addition 
to LCs, and each population was investigated as a separate DC subset for the remainder of 
this thesis. 
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4.2.2. Identification of a novel subset of langerin+ dermal dendritic cell 
 Unlike the epidermis, which had previously been reported to contain a single DC 
subset, the dermis contains multiple subsets of macrophages and DCs. Multiple markers are 
required to distinguish these subsets, and overlapping expression of the markers means the 
gating strategy used to define the subsets is also crucial. Therefore, cells isolated from human 
dermis by enzymatic digestion were stained with the most commonly used population markers 
in order to characterise the macrophage and DC subsets. Following the gating strategy 
outlined in Figure 3.7.A to define the subsets, it was observed that the CD1a+ population could 
be further split according to langerin expression (Figure 4.3.A), which when backgated, 
occupied the same location in HLA-DR versus CD45 (Figure 4.3.B). The langerin- and 
langerin+ populations were gated separately in order to determine whether they possessed 
any other phenotypic differences beyond langerin expression, and are hereafter referred to as 
CD1a+ DCs and langerin+ dermal DCs (DDCs) respectively. 
 
4.2.3. Epidermal and dermal DCs expressing langerin and/or CD1a appear to be 
distinct subsets 
At the commencement of this research, langerin expression was considered to be 
restricted to a single subset, LCs, which reside in the epidermis. However, the observation of 
a langerin- DC subset in the epidermis and a langerin+ DC subset in the dermis contradicts 
this. Therefore, it was important to compare the CD1a and langerin expressing subsets in the 
epidermis to those in the dermis in order to determine whether they represent distinct subsets. 
To do this, the expression of HLA-DR, CD1a, CD1c, CD11c and langerin on the epidermal 
subsets was compared to the dermal subsets (Figure 4.4.).  
Langerin expression did not differ significantly between epidermal and dermal DCs, 
but both dermal subsets expressed significantly more HLA-DR and CD11c than the langerin+ 
epidermal subsets. Contrastingly, the langerin- epidermal DCs expressed similar levels of 
HLA-DR and higher levels of CD11c than the dermal subsets. LCs were distinguished from all 
subsets by their very high expression of CD1a. As such, these findings warranted further 
investigation of each population as a distinct DC subset. 
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Figure 4.1. Identification of epidermal DC subsets isolated by enzyme digestion. Cells 
isolated from epidermis by collagenase digestion were stained with Live/Dead NIR, HLA-DR 
BUV395, CD45 PE.Cy7, CD1a BV510, and langerin Vioblue. Epidermal populations were 
gated based on CD1a and langerin expression within HLA-DR+CD45+ and HLA-DR++CD45++ 
populations (A). CD1a+Lang+ DCs (grey) were gated within the HLA-DRlowCD45low 
population. Within the HLA-DR+CD45+ population were CD1a++Langerin+ Langerhans cells 
(LCs; teal), and CD1a+Langerin- DCs (navy). Each population was back gated to determine 
its position based on HLA-DR and CD45 (B), and CD1a and HLA-DR (C). A representative 
human abdominal skin section stained for CD1a (green), langerin (red) and DAPI (blue) is 
shown (D). CD1a+Langerin+ LCs are identified by the teal arrow, and CD1a+Langerin- 
epidermal DCs are identified by the yellow arrow. The basement membrane is outlined with a 
dotted line. Scale bar = 50µm.  
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Figure 4.2. Characterisation and frequency of known and novel epidermal DC 
populations. 
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Figure 4.2. Characterisation and frequency of known and novel epidermal DC 
populations.
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Figure 4.2. Characterisation and frequency of known and novel epidermal DC populations. Epidermal populations isolated by collagenase 
digestion were stained for 30 minutes with Live/Dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, CD1c PE-Vio770, CD11c APC, CD14 
BUV737, CD141 BV711 and langerin Vioblue, and run on the BDFortessa flow cytometer. The percent each population comprises of the 
CD45+HLA-DR+ population is expressed as mean +/- standard deviation where each dot represents a separate donor (A). The geometric mean 
fluorescence intensity (gMFI) for HLA-DR, CD45, CD1a, langerin, CD1c, and CD11c for Langerhans cells (LCs; teal), CD1a+Langerin- DCs 
(navy), and CD1a+Langerin+ cells (grey) are expressed as mean +/- 95% confidence interval where each dot represents a separate donor (B)., 
and representative histogram of all population markers are displayed (C). A gMFI of 100 was set as the limit of detection (dotted line). Statistics 
were generated using the Mann-Whitney test. * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001. n ≥ 3. 
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Figure 4.3. Identification of a novel CD1a+langerin+ dermal dendritic cell. Cells isolated from dermis were stained with Live/Dead NIR, 
HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 BV711 and langerin vioblue. Within the live, single,  
HLA-DR+CD45+autofluorescence(AF)-CD141-CD14-CD1a+ population, CD1a+ DCs (blue) and Langerin+CD1a+ dermal DCs (DDCs) (dark 
blue) were defined as the langerin- and langerin+ cells, respectively (A). Both CD1a+ populations were back gated to determine their relative 
position in HLA-DR versus CD45 (B). 
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Figure 4.4. Comparison of epidermal and dermal CD1a+ and langerin+ DC populations.
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Figure 4.4. Comparison of epidermal and dermal CD1a+ and langerin+ DC populations. 
Epidermal and dermal cells were isolated by collagenase digestion, stained with Live/Dead 
NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 BV711, CD1c 
PE.Vio770, CD11c APC and langerin Vioblue, and run on the BDFortessa. The geometric 
mean fluorescence intensity (gMFI) for HLA-DR, langerin, CD1a, CD1c and CD11c for 
epidermal Langerhans cells (LCs; teal), CD1a+Langerin- DCs (navy), and CD1a+Langerin+ 
cells (grey), and dermal CD1a+ DCs (blue) and CD1a+Langerin+ DCs (dark blue) are 
expressed as mean +/- 95% confidence interval and each dot represents a separate donor. 
A gMFI of 100 was set as the limit of detection (dotted line). Statistics were generated using 
the Mann-Whitney test. * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001. n ≥ 3.
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4.2.4. CD14+ non-autofluorescent cells represent two distinct populations  
 The dermis contains a mixed CD14-expressing population that can be further split 
based on autofluorescence; autofluorescent macrophages and recently re-defined non-
autofluorescent monocyte-derived macrophages (MDMs) (McGovern et al., 2014b). Recently 
it was proposed that the latter population was actually a mixture of CD1c-/low MDMs and CD1c+ 
CD14+ DCs (Durand and Segura, 2015). To investigate this, the gating strategy in Figure 
3.7.A was amended to look at CD1c on the non-autofluorescent CD14+ population (Figure 
4.5.A). These two populations occupied a similar position in HLA-DR vs CD45 (Figure 4.5.B), 
and consistent with the proposal, were consistently observed. Henceforth, the CD1c-/low 
population is referred to as MDMs, and the CD1c+ population referred to as CD14+ DCs. 
 
4.2.5. DC and macrophage subsets are present in different frequencies and have 
distinct population marker expression profiles 
As the dermis contains multiple mononuclear phagocyte subsets that overlap in their 
expression of population markers (Haniffa et al., 2015a), the expression of commonly used 
population markers was compared across all subsets. First, the relative frequency of each 
subset, isolated by collagenase digestion, was determined as a percent of the live, single HLA-
DR+CD45+ population (Figure 4.6.A). CD1a+ DCs were present at the highest frequency 
(37%), followed by macrophages and MDMs at 10% and 6% respectively. Langerin+ DDCs 
and CD141+ DCs were present at the lowest frequency, which was significantly lower than 
MDMs and macrophages. A representative pie chart of the contributions of each subset to the 
HLA-DR+CD45+ population is shown in Figure 4.6.B. 
 Next, the expression of commonly used population markers was compared across the 
subsets. HLA-DR, CD1c and CD11c are reported to be expressed on multiple subsets, as 
such, the gMFI for each was determined for all subsets (Figure 4.6.C). The gMFI for langerin 
was also examined to determine whether langerin expression was limited to a single subset. 
CD141+ DCs expressed significantly less HLA-DR than all other subsets, and together with 
macrophages expressed the lowest levels of CD11c. CD1c expression was significantly lower 
on MDMs and macrophages, and langerin expression was limited to the Langerin+ DDCs. A 
representative histogram of all population markers on each subset is shown in Figure 4.6.D. 
Intermediate expression of CD141 and langerin, which were otherwise exclusively expressed 
on CD141+ DCs and Langerin+ DDCs, was observed on macrophages. However, the 
expression was similar to other subsets if controlled with an isotype (data not shown), and 
therefore likely to be contributed by the autofluorescence of macrophages. Therefore, the 
gating strategy in Figure 4.5.A is optimal for investigation of mononuclear subsets isolated 
from dermis by collagenase digestion. 
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                          Figure 4.5. Observation of monocyte-derived macrophages and CD14+ DCs in dermis. 
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Figure 4.5. Observation of monocyte-derived macrophages and CD14+ DCs in dermis. 
Cells isolated by collagenase digestion of dermis were stained with Live/Dead NIR, HLA-DR 
BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 BV711, langerin Vioblue, and 
CD1c PE.Vio770. Autofluorescence was detected under FITC and BV605. DC and 
macrophages subsets were identified within the live, single, HLA-DR+CD45+ population and 
identified using a successive gating strategy (A). Macrophages (green) were defined as 
CD14+Autofluorescent+ cells. Within the autofluorescent negative gate, CD141+ DCs (purple) 
were defined as the CD141+CD14- cells. Within the CD1a+ population, CD1a+ DCs (blue) and 
CD1a+Langerin+ dermal DCs (dark blue) were defined as langerin- and langerin+ cells, 
respectively. Within the CD14+ population, CD14+ DCs (orange) and monocyte-derived 
macrophages (MDMs; red) were defined as CD1c+ and CD1c- cells, respectively. MDMs and 
CD14+ DCs were back gated to determine their relative position in HLA-DR versus CD45 (B).  
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Figure 4.6. Characterisation and frequency of dermal macrophage and DC subsets.  
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Figure 4.6. Characterisation and frequency of dermal macrophage and DC subsets. 
Cells isolated from collagenase digested dermis were stained with Live/Dead NIR, HLA-DR 
BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 BV711, langerin Vioblue, CD1c 
PE.Vio770 and CD11c APC, and run on a BDFortessa. The percent of the CD45+HLA-DR+ 
population that each subset contributes was plotted with mean +/- standard deviation (A) and 
as a representative pie chart, including the undefined population (grey) of HLA-DR+CD45+ 
cells that do not express the above listed markers (B). The geometric mean fluorescence 
intensity for HLA-DR, langerin, CD1c, and CD11c on CD141+ DCs (purple), CD14+ DCs 
(orange), monocyte-derived macrophages (MDMs; red), CD1a+ DCs (blue), langerin+ 
dermal DCs (dark blue), and macrophages (green) were plotted with the mean +/- 95% 
confidence interval (C). Representative histograms of surface expression of population 
markers are displayed (D). A gMFI of 100 was set as the limit of expression (dotted line). 
Statistics were generated using the Kruskal-Wallis test and Dunn’s multiple comparison post 
hoc test. * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001; n ≥ 3. 
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4.2.6. Skin mononuclear phagocytes remain immature after isolation by collagenase 
digestion 
 The maturation state of a DC has significant implications on its surface expression 
profile and function (e.g. upregulation of co-stimulatory molecules on mature DCs, which aids 
efficient antigen presentation, but decreased antigen uptake capacity) (Harman et al., 2006; 
Jin et al., 2004). The process of isolating cells from skin by enzymatic digestion could be 
sufficient to stimulate DC maturation. Therefore, surface expression of co-stimulatory markers 
CD80, CD83 and CD86 was investigated on cells isolated from skin by collagenase digestion 
and compared to in vitro-derived MDMs and immature monocyte-derived DCs (MDDCs) 
(Figure 4.7.) to determine their maturation status. CD80 and CD83 were negative or 
expressed as low levels on all skin and in vitro subsets. CD86 was expressed constitutively at 
low levels on all skin and in vivo subsets, excluding CD1a+Langerin+ epidermal DCs which 
were negative. In summary, expression of each maturation marker by the skin subsets was 
as low, or lower than immature in vitro MDDCs, suggesting that all subsets isolated from skin 
by collagenase digestion have an immature phenotype. 
 
4.2.7. Skin mononuclear phagocytes begin to mature rapidly after isolation 
 While it was observed that DCs were immature immediately after isolation by 
collagenase digestion, it was next determined how quickly the cells matured in culture, to 
provide a window for performing phenotyping and functional assays on immature cells. To do 
this, CD80, CD83 and CD86 expression was investigated on dermal cells immediately after 
isolation by collagenase digestion and after culture in RPMI at 37°C over 6 hours. CD1a+ DCs, 
CD14+ cells (mixed population of MDMs and CD14+ DCs) and macrophages were the only 
subsets present at a high enough frequency to follow over the time course, and were examined 
every 1-2 hours (Figure 4.8.). CD80 expression was upregulated slightly on macrophages 
after 4 hours of culture, and on CD1a+ DCs and CD14+ cells after 6 hours. CD83 began to be 
upregulated after 1 hour, while CD86 expression fluctuated. Despite the lack of statistical 
significant maturation due to variability between donors, cells were used immediately after 
digestion in future experiments due to evidence of maturation by 1 hour post isolation. 
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Figure 4.7. Surface expression of maturation markers on in vitro-derived and 
collagenase isolated skin DC and macrophage subsets. Cells isolated from collagenase 
digested epidermis and dermis were stained with Live/Dead NIR, HLA-DR BUV395, CD45 
BV786, CD1a BV510, CD14 BUV737, CD141 BV711, langerin Vioblue, CD1c PE.Vio770, and 
surface expression receptors on APC and PE. Epidermal LCs (teal), CD1a+Langerin+ DCs 
(navy) and CD1a+Langerin+ cells (grey) were defined according to the gating strategy in 
Figure 4.1.A. Dermal CD141+ DCs (purple), CD1a+ DCs (blue), CD1a+Langerin+ DCs 
(Lang; dark blue) CD14+ DCs (orange), monocyte-derived macrophages (MDMs; red), and 
macrophages (green) were defined according to the gating strategy in Figure 4.5.A. In vitro 
blood MDMs (pink) and monocyte-derived DCs (MDDCs; dark red) were stained with 
Live/Dead NIR and surface expression receptors on APC and PE. Cells were run on a 
BDFortessa flow cytometer and the geometric mean fluorescence intensity (gMFI) for each 
surface expression minus isotype plotted with the mean +/- 95% confidence interval. A gMFI 
of 100 was set as the limit of detection (dotted line). Statistics were generated using the 
Kruskal-Wallis test and Dunn’s multiple comparison post hoc test. * p<0.05; ** p<0.01; *** 
p<0.001; **** p<0.0001. 
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Figure 4.8. Maturation kinetics of cells isolated by collagenase digestion. Cells isolated 
from collagenase digested dermis were cultured in RPMI at 37°C for 6 hours. Cells were 
collected immediately after digestion and every 1-2 hours to examine expression of CD80, 
CD83 and CD86. Cells were stained with Live/Dead NIR, HLA-DR BUV395, CD45 BV786, 
CD1a BV510, CD14 BUV737, CD141 BV711, langerin Vioblue, CD1c PE.Vio770, and surface 
expression receptors on APC and PE. Dermal CD1a+ DCs (blue), CD14+ cells (MDMs and 
CD14+ DC mixed population; brown), and macrophages (green) were defined according to 
the gating strategy in Figure 3.7. Cells were run on a BDFortessa flow cytometer and the 
geometric mean fluorescence intensity (gMFI) for each surface expression minus isotype 
plotted with the mean +/- SD. A gMFI of 100 was set as the limit of detection (dotted line). 
Statistical comparisons were made using repeated measure ANOVA; n = 4. 
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4.2.8. Epidermal DCs are more mature after migration than enzymatic digestion 
 LCs from skin are commonly reported to be isolated by either enzymatic digestion or 
after spontaneous migration (Haniffa et al., 2015b). As such, it was important to determine 
whether both methods of isolation are valid by investigating which epidermal subsets could be 
isolated and whether they expressed similar levels of population markers. All three populations 
were observed when using the same gating strategy employed for collagenase digested cells 
(Figure 4.9.A), and were situated in distinct positions in HLA-DR vs CD45 (Figure 4.9.B) and 
HLA-DR vs CD1a (Figure 4.9.C). Using the crawl-out method, LCs made up a larger fraction, 
and CD1a+Langerin+ DCs a smaller fraction of the live, single HLA-DR+CD45+ population 
compared to digested epidermis (Figure 4.10.A). A low level of langerin expression was 
observed on the migrated equivalent of CD1a+Langerin- DCs (Figure 4.10.B), which 
remained distinguishable from LCs and CD1a+Langerin+ DCs. Langerin expression was 
significantly lower on migrated LCs and CD1a+langerin+ DCs than their collagenase-isolated 
counterparts (Figure 4.10.B). The converse was seen for HLA-DR expression, which was 
higher on migrated LCs and CD1a+Langerin- DCs than their digested counterparts, consistent 
with maturation of the migrated cells. Expression of other population markers did not change 
with isolation method, but CD80, CD83 and CD86 expression was significantly higher on each 
subset isolated by crawl-out method compared to collagenase digestion, indicating the cells 
were of a mature phenotype (Figure 4.11.). 
 
4.2.9. Dermal cells upregulate CD141 expression during spontaneous migration 
 As shown in Figure 4.6.D, CD141 is exclusively expression on CD141+ DCs that have 
been isolated by collagenase digestion; however, CD141 expression has been reported on 
multiple skin DC subsets (Haniffa et al., 2012), which has led to the misidentification of 
CD141+ DCs (Chu et al., 2012). Therefore, it was of interested to determine whether wider 
expression was a result of isolation method. It was observed that when cells were isolated by 
the crawl-out method rather than collagenase digestion, almost all of the CD14+ cells 
expressed CD141 (Figure 4.12.A and B). Also, in contrast to the collagenase isolated 
populations (Figure 4.12.B), there was no distinct CD141+CD14- or CD141+CD11clow subset 
in the crawl-out cells (Figure 4.12.A). A far greater proportion of CD141+CD1a+ cells (Figure 
4.12.A, right) was observed in the crawl-out cells than when cells were isolated by collagenase 
digestion (Figure 4.12.B, right). This suggested that CD1a+ DCs also upregulate CD141 as 
a result of maturation during migration, and thus collagenase isolated CD1a+ DCs were sorted 
to determine CD141 expression after 24 hours of culture. No CD141 was observed on the 
surface of CD1a+ DCs directly after isolation (Figure 4.12.C, left), but a gradient of expression 
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was observed on the cells after 24 hours of culture in RPMI (Figure 4.12.C, right). Therefore, 
CD141+ DCs could not be distinguished from CD1a+ DCs after migration from skin. 
 
4.2.10. Dermal DC subsets are more mature after spontaneous migration than 
enzymatic digestion 
 Using a similar approach applied to the epidermis, mononuclear phagocytes were 
isolated from the dermis by collagenase digestion and compared to those that spontaneously 
migrated from skin. Due to the upregulation of CD141 on migrated cells, the gating strategy 
used to classify migrated subsets was amended to limit misidentification of subsets (Figure 
4.13.A). As expected, very few autofluorescent macrophages were observed in the migrated 
fraction, and they were therefore omitted from future investigation of migrated skin 
populations. The CD14+ fraction contained a single CD1c+ population, which were defined as 
CD14+ DCs. As shown in Figure 4.12., CD141+ DCs could not be distinguished from CD1a+ 
DCs; therefore, CD1a+ DCs were defined as the CD1a+CD141- population. Langerin+ DDCs 
were rarely observed, and therefore, as with macrophages, were omitted from future 
experiments. Therefore, CD14+ DCs and CD1a+ DCs were the only mononuclear phagocytes 
that could be confidently identified in cells that spontaneously migrate from skin. 
 The surface expression of population markers HLA-DR, CD1c, CD11c and langerin 
was compared on CD1a+ DCs and CD14+ DCs isolated by collagenase digestion and after 
48 hour migration (Figure 4.14.). Crawl-out CD14+ DCs expressed significantly lower levels 
of HLA-DR than their collagenase isolated counterparts, which was reflected in their position 
in HLA-DR vs CD45 (Figure 4.13.B). The method of isolation did not influence the expression 
on any of the other populations markers on either subset. 
 The influence of each isolation method on maturation status was determined by 
surface expression of CD80, CD83 and CD86 on CD1a+ DCs and CD14+ DCs (Figure 4.15.). 
Crawl-out CD1a+ DCs expressed significantly more CD80, CD83 and CD86 than their 
collagenase-isolated counterpart. Similarly, crawl-out CD14+ DCs expressed significantly 
more CD80 and CD86 than their digested counterpart, but the opposite was seen for CD83 
expression. Overall, the crawl-out populations were significantly mature in comparison to the 
dermal subsets isolated by collagenase digestion. 
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Figure 4.9. Identification of DC populations that migrate from epidermis. Cells isolated 
after 48 hours of spontaneous migration from epidermal sheets were stained with Live/Dead 
NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510 and langerin Vioblue. Live, single cells 
were gated based on HLA-DR and CD45 expression. CD1a+Langerin+ DCs (grey) were 
identified within the HLA-DR+CD45+ populations. Within the HLA-DR++CD45++ population, 
Langerhans cells (LCs; teal) were identified as the CD1a++langerin+ population, and the 
CD1a+langerin- population defined as a CD1a+lang+ DC (navy) (A). Each population was 
back gated to determine its position in relation to HLA-DR and CD45 (B), and HLA-DR and 
CD1a (C).  
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Figure 4.10. Comparison of epidermal DCs isolated by collagenase digestion or the 
crawl-out method.  
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Figure 4.10. Comparison of epidermal DCs isolated by collagenase digestion or the 
crawl-out method. 
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Figure 4.10. Comparison of epidermal DCs isolated by collagenase digestion or the 
crawl-out method. Epidermal populations that were isolated by collagenase digestion (closed 
dots) or after 48 hour migration (“C”; open dots) were stained with Live/Dead NIR, HLA-DR 
BUV395, CD45 BV796, CD1a BV510, langerin Vioblue, CD1c PE.Vio770 and CD11c APC, 
and run on a BDFortessa flow cytometer. The percent each population comprises of the 
CD45+HLA-DR+ population is expressed as mean +/- standard deviation (A). The geometric 
mean fluorescence intensity (gMFI) for HLA-DR, CD45, CD1a, langerin, CD1c, and CD11c for 
Langerhans cells (LCs; teal), CD1a+Langerin- DCs (navy), and CD1a+Langerin+ cells (grey) 
are expressed as mean +/- 95% confidence interval (B). A gMFI of 100 was set as the limit of 
expression (dotted line). Statistics were generated using the Mann-Whitney test. * p<0.05; ** 
p<0.01; *** p<0.001; **** p<0.0001. n ≥ 3.  
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Figure 4.11. Comparison of maturation marker expression on epidermal DCs isolated 
by collagenase digestion or the crawl-out method. Epidermal populations that were 
isolated by collagenase digestion (closed dots) or after 48 hour migration (“C”; open dots) 
were stained with Live/Dead NIR, HLA-DR BUV395, CD45 BV796, CD1a BV510, langerin 
Vioblue, CD1c PE.Vio770, CD11c APC, and other surface expression receptors on PE and 
APC. Epidermal Langerhans cells (LCs; teal), CD1a+Langerin+ DCs (navy) and 
CD1a+Langerin+ cells (grey) were defined according to the gating strategy in Figure 4.1.A 
and Figure 4.10.A. Cells were run on a BDFortessa flow cytometer and the geometric mean 
fluorescence intensity (gMFI) for each surface expression minus isotype plotted with the mean 
+/- 95% confidence interval. A gMFI of 100 was set as the limit of expression (dotted line). 
Statistics were generated using Mann-Whitney test. * p<0.05; ** p<0.01; *** p<0.001; **** 
p<0.0001. 
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Figure 4.12. CD141 is upregulated on migrated dermal DCs.  Cells collected after 48 hour 
migration from human dermis were stained with Live/dead NIR, HLA-DR BUV395, CD45 
BV786, CD14 BUV737, CD141 BV711, CD1a BV510 and CD11c APC. CD141+CD14- cells 
(purple) were gated within the live, single HLA-DR+CD45+autofluorescence(AF)- population 
(left) from crawlout cells (A) or after collagenase digestion (B), and overlaid on CD11c vs 
CD141 (middle) and CD1a vs CD141 (right). CD1a+ DCs were sorted from collagenase 
digested dermis according to Figure 4.5., and expression of CD141 determined at time of 
isolation and after 24 hours of culture at 37ºC in RH10 (C). 
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Figure 4.13. Identification of DC populations that migrate from human dermis. 
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Figure 4.13. Identification of DC populations that migrate from human dermis. Cells 
isolated after 48 hour migration from dermal skin sheets were stained with Live/Dead NIR, 
HLA-DR BUV395, CD45 BV786, CD1a BV510, CD11c APC, CD14 BUV737, CD141 BV711, 
CD1c PE.Vio770 and langerin Vioblue. CD1a+ DCs and CD14+ DCs were identified within 
the live, single, HLA-DR+CD45+autofluorescence-CD141 population (A). CD14+ DCs 
(orange) were defined as the CD14+CD1c+ population. CD1a+ DC (blue) were defined as the 
CD14-CD141-CD1a+langerin- population. CD14+ and CD1a+ DCs were back gated to 
determined their position within the HLA-DR+CD45+ population (B).  
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Figure 4.14. Comparison of population markers expressed on CD1a+ and CD14+ DCs 
isolated by collagenase digestion or the crawl-out method. Cells isolated from dermis by 
collagenase digestion (closed dots) or after 48 hour migration (open dots) were stained with 
Live/Dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 
BV711, langerin Vioblue, CD1c PE.Vio770 and CD11c APC, and run on a BDFortessa flow 
cytometer. The geometric mean fluorescence intensity (gMFI) for HLA-DR, langerin, CD1c 
and CD11c was plotted for CD14+ DCs (orange) and CD1a+ DCs (blue), with the mean +/- 
95% confidence interval. A gMFI of 100 was set as the limit of detection (dotted line). Statistics 
were generated using the Mann-Whitney test. * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001.   
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Figure 4.15. Comparison of maturation marker expression on CD1a+ and CD14+ DCs 
isolated by collagenase digestion or the crawl-out method. Cells isolated from dermis by 
collagenase digestion (closed dots) or after 48 hour migration (open dots) were stained with 
Live/Dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 
BV711, langerin Vioblue, CD1c PE.Vio770, and other surface expression receptors on PE and 
APC. Dermal CD1a+ DCs (blue) and CD14+ DCs (orange) were defined according to the 
gating strategy in Figure 4.14.A. Cells were run on a BDFortessa flow cytometer and the 
geometric mean fluorescence intensity (gMFI) for each surface expression minus isotype 
plotted with the mean +/- 95% confidence interval. A gMFI of 100 was set as the limit of 
expression (dotted line). Statistics were generated using the Mann-Whitney test. * p<0.05; ** 
p<0.01; *** p<0.001; **** p<0.0001. 
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4.3. Discussion 
There is little consistency in the literature in regard to the method of isolation or the 
markers used to define specific subsets of mononuclear phagocytes that reside in human skin. 
As a result, subsets have been misidentified or grouped together as a single population (Chu 
et al., 2012; Durand and Segura, 2015). This is a key problem as DCs and macrophages 
display a diverse range of functions, which differ between subsets (Durand and Segura, 2015; 
Haniffa et al., 2015a; Haniffa et al., 2015b). Furthermore, DCs mature in response to certain 
stimuli, which results in a change in their phenotype and function (Jin et al., 2004; Mildner and 
Jung, 2014), and further diversifies the mononuclear phagocyte system. Thus, in order to best 
assign functional or phenotypic traits to a given subset, correct identification and classification 
of populations is crucial. Therefore, it was the aim of this chapter to compare the frequency, 
population marker expression and maturation status of all known skin macrophage and DC 
subsets isolated by collagenase digestion and the ‘crawl-out’ method. 
A number of different population markers are used interchangeably to identify 
macrophage and DC subsets in human skin (Bigley et al., 2015; Haniffa et al., 2015b; Haniffa 
et al., 2012; McGovern et al., 2014b; Zaba et al., 2007). In order to determine whether the 
epidermal and dermal gating strategies employed in Chapter 3 (Figure 3.5.  and 3.7.) were 
optimal for the identification and classification of each subset, cells isolated from collagenase 
digested skin were stained with a panel of commonly used population markers and the relative 
expression compared.  
The epidermis of healthy skin is generally considered to contain a single DC subset, 
called an LC, which is commonly identified by langerin and high expression of CD1a (Romani 
et al., 2010). However, when an extensive panel of population markers was used to investigate 
LCs further, three clusters of cells were observed (Figure 4.1.), two of which could be 
visualised in situ. Initially the subsets could be distinguished by their relative expression of 
HLA-DR and CD45, and then further subdivided by their relative expression of CD1a and 
langerin into CD1a++langerin+ LCs, CD1a+Langerin+ DCs and CD1a+Langerin- DCs. HLA-
DR, CD45, CD1a, langerin, CD1c and CD11c expression differed significantly across the three 
populations (Figure 4.2.B), which also clustered separately on CD1a vs HLA-DR. Neither 
subset was autofluorescent or expressed CD14 (Figure 4.2.C), and therefore were not likely 
to be macrophages or infiltrating monocytes.  
LCs were approximately 3-4 times more abundant than either of the other two 
populations (Figure 4.2.A). Limited number of cells can be isolated from epidermis, which 
together with the relatively low frequency of the two undescribed subsets may have 
contributed to the delay in identification, as occurred with CD141+ DCs in skin. The second 
langerin+ population is likely to have been overlooked due to the common expression of CD1a 
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and langerin with LCs. Despite this, the relative expression of multiple markers differs 
significantly between the two subsets, specifically CD1a, HLA-DR and CD45 (Figure 4.2.B). 
In mice, LCs have been shown to be derived from foetal liver and yolk sac-derived 
macrophages (Hoeffel et al., 2012); therefore, it is possible that similar to mice, the two 
langerin+ epidermal subsets are a reflection of different lineages. Much still remains unknown 
in relation to the lineage and development of human tissue DC subsets (Durand and Segura, 
2015; Ginhoux and Jung, 2014; Haniffa et al., 2013; Merad et al., 2013), and therefore it is 
also possible that the CD1a+Langerin+ DCs may be a precursor to the terminally differentiated 
LC. It will be of interest to sort the CD1a+Langerin+ DCs and culture them in various conditions 
to determine whether they differentiate into a population indistinguishable from LCs. 
Immunofluorescence microscopy is unable to distinguish between subtle differences in 
fluorescence intensity; therefore, other markers may be required to confirm their presence in 
situ. Genomic comparison may also reveal differences, similarities and/or evidence of lineage 
relationship between the two subsets. 
CD1a+Langerin- DCs may have been overlooked due to the assumption that they were 
contaminating CD1a+ DCs from the dermis. However, the epidermis is processed 
independently from dermis after peeling, and therefore it is unlikely that dermal cells 
contaminate the epidermal fraction after peeling. It is also unlikely that the cells are remnants 
of inefficiently separated epidermis and dermis, because no evidence of other dermal DC 
subsets (CD14+ DCs and CD141+ DCs) was observed. Furthermore, CD1a+langerin- cells 
were visualised alongside CD1a+langerin- cells in the epidermis in situ (Figure 4.1.D). The 
presence of CD1a+langerin- cells in the epidermis in situ does not conclusively confirm 
CD1a+Langerin- epidermal DCs are distinct from CD1a+ DCs, because DCs are able to 
migrate into and out of tissue. As such, CD1a+Langerin- DCs may represent a CD1a+ dermal 
DC that has migrated into the epidermis. However, if that were the case, it may be via a 
mechanism separate from spontaneous migration, as there was no difference in maturation 
markers (CD80, CD83 and CD86) observed compared to expression on CD1a+ DCs in dermis 
(Figure 4.7.). CD1a+Langerin- DCs express significantly more CD11c than CD1a+ dermal 
DCs (Figure 4.2.B), and it therefore appears to be a distinct subset. Differential surface 
expression of more markers could further support their distinction, and will be covered in detail 
in Chapter 5.  
The CD1a+Langerin- DCs observed may also be Inflammatory Dendritic Epidermal 
Cells (IDECs), which have previously been reported to be absent from healthy skin 
(Wollenberg et al., 1996; Wollenberg et al., 2002a). Consistent with IDECs, CD1a+Langerin- 
DCs did not express langerin and expressed relatively high levels of CD11c (Figure 4.2.B) 
(Wollenberg et al., 1996). CD206 (MR) and CD209 (DC-SIGN) are also expressed on IDECs 
(Wollenberg et al., 2002a), and will be investigated in Chapter 5 along with other pathogen 
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recognition receptors. All of the abdominal specimens obtained for this study were from 
clinically healthy donors; however, future experiments to look at signs of inflammation by 
QPCR and/or histology may reveal low levels of asymptomatic inflammation. If present, the 
level of inflammatory markers may correlate with the frequency of CD1a+Langeirn- DCs 
observed. However, CD1a+Langerin- DCs were observed in all donors (n = 13), therefore it is 
unlikely their presence is inflammation-dependent. Hypoxia can result in accumulation of 
reducing agents (Chen and Shi, 2008), which in vitro can be used to generate model IDECs 
(Novak et al., 2002). Therefore, it will be important to determine whether the presence of 
CD1a+Langerin- DCs in the epidermis are induced during the isolation procedure. 
CD1a+Langerin- DCs were observed in both collagenase digested and migrated cells; 
therefore, overnight incubation in dispase, which is common to both isolation methods, would 
need to be tested for its influence on the frequency of CD1a+Langerin- DCs observed. More 
phenotypic, functional and genomic comparisons would be needed to confirm whether 
CD1a+Langerin- DCs and IDECs were identical subsets; however, the host lab does not 
currently have access to skin from psoriatic and atopic dermatitis lesions needed for the 
comparison with IDECs. 
The dermis is known to contain multiple DC subsets and resident macrophages, which 
were also compared for their expression of commonly used population markers. Within the 
non-autofluorescent, CD141-CD14- cells, the CD1a+ population was observed to contain a 
minor population of langerin+ cells. Apart from langerin, they are identical to CD1a+ DCs in 
population marker and maturation marker expression. While this data was being collected, 
Bigley et al. independently identified and classified this subset of Langerin+ DDCs, which are 
distinct from CD1a+ DCs and LCs (Bigley et al., 2015). The results shown here support their 
findings, with significant difference in expression of CD1a, HLA-DR and CD11c compared to 
LCs. Furthermore, the Langerin+ DDCs also differ significantly from the CD1a+Langerin+ DC 
subset in the epidermis, with higher expression of HLA-DR, CD11c and CD1c. 
Within the dermis, the non-autofluorescent CD14+ population has also recently been 
described to comprise two separate subsets based on CD1c expression (Durand and Segura, 
2015; McGovern et al., 2014b): monocyte-derived macrophages (MDMs) and CD14+ DCs. 
CD1c expression on the CD14+ population was therefore investigated, and the two populations 
were consistently observed. As such, the CD1c- (MDM) and CD1c+ (CD14+ DC) populations 
were treated as two separate subsets for comparison. However, apart from CD1c expression 
no other differences were observed in the expression of population of maturation markers. 
Functional assays, specifically to look at efficiency of T cell stimulation and cytokine 
production, and genomic comparison (e.g. RNAseq) of the known and novel subsets is 
required to confirm the relation between the subsets and/or whether they represent distinct 
subsets. Due to the limited availability of skin and the number of epidermal cells that can be 
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isolated, the time required to complete the experiments extends beyond the capacity of this 
PhD candidature. Extended characterisation of the surface expression profile on each subset 
could support the similarities and/or differences observed in population marker expression, 
and is covered in more detail in Chapter 5.    
 As mentioned previously, immature and mature DCs display distinct phenotypic and 
functional characteristics. In comparison to immature in vitro-derived MDDCs, there was little 
evidence of any maturation on subsets isolated by collagenase digestion (Figure 4.7.). This 
suggests that DCs isolated by collagenase digestion are immature and are therefore most 
likely to represent those present in situ. However, there was evidence of maturation on 
macrophages, non-autofluorescent CD14+ cells and CD1a+ DCs within 1 hour of culture in 
RPMI (Figure 4.8.). The fact that evidence of maturation could be observed in some donors 
so quickly after isolation implies that factors within the skin maintain the DCs in an immature 
state, and this warrants further investigation. This was further supported by the variability in 
maturation markers observed in the cells investigated immediately following isolation (Figure 
4.7.), which reflects the susceptibility of skin mononuclear phagocytes to maturation upon 
isolation. Therefore, it is important to isolate and utilise the cells in a timely manner for any 
studies that are trying to investigate effects that may occur at the site in vivo. 
 Large discrepancies were seen in the subsets isolated by collagenase digestion 
compared to the ‘crawl-out’ method. All 3 epidermal subsets could be observed regardless of 
isolation method; however, the relative frequency of LCs and CD1a+Langerin+ subsets 
differed (Figure 4.10.) and all 3 subsets isolated using the ‘crawl-out’ method expressed 
significantly higher levels of maturation markers (Figure 4.11.). Langerin expression was 
significantly decreased on the langerin+ subsets and began to be expressed on the 
CD1a+Langerin- DCs after migration, however expression was very low compared to the two 
other langerin+ subsets (Figure 4.10.). Furthermore, this langerinlow population still expressed 
significantly higher levels of HLA-DR and lower levels of CD1a than CD1a+Langerin+ DCs 
and LC, respectively. Therefore, despite the low langerin expression observed, it still likely 
represents a discrete epidermal subset. 
It was a lot more difficult to define dermal DC subsets isolated by the ‘crawl-out’ method 
compared to collagenase digestion due to changes in population marker expression. As 
expected, very few autofluorescent macrophages were observed (Figure 4.13.A), because 
they generally do not migrate from tissue (Haniffa et al., 2009; McGovern et al., 2014b; Wang 
et al., 2014). Only CD1c+ cells were observed in the non-autofluorescent CD14+ population of 
migrated cells (Figure 4.13.A), which would suggest that CD14+ DCs migrated while the 
MDMs remained in tissue, like autofluorescent macrophages. In future experiments, the 
remaining tissue could be digested with collagenase to determine whether macrophages and 
MDMs were still present in the tissue. MDMs isolated by collagenase digestion could be sorted 
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and cultured in order to determine whether they can upregulate CD1c expression, and 
therefore included in the CD14+ DC population. Single cell sequencing of the ‘crawl-out’ 
CD14+CD1c+ could also show a heterogeneous population that may be split to show similarity 
to CD14+ DCs or MDMs.  
 CD141 expression was upregulated on multiple migrated DC subsets (Figure 4.12.), 
which meant CD141+ DCs could not be identified using this method of cell isolation. In cells 
isolated by collagenase digestion, CD141+ DCs appear as a distinct CD141+CD14- or 
CD141+CD11c- population. In cells isolated by the ‘crawl-out’ method, the former was not a 
distinct population, and the latter could not be observed. The majority of CD141+CD14- cells 
in the migrated fraction were likely to be CD1a+ DCs, as they expressed CD11c and CD1a+ 
DCs were shown to upregulate CD141 expression within 24 hours. Despite this, ‘crawl-out’ 
CD1a+ DCs were defined within the CD141- population because CD141+ DCs could not be 
excluded from the CD141+ fraction. CD141+ DCs may be identifiable by XCR1 expression, 
but this could not be confirmed as the antibodies tested were ineffective for flow cytometry. 
Similar to MDMs, Langerin+ DDCs were not observed using the ‘crawl-out’ method. 
This may mean they do not migrate from tissue, and could be confirmed in future experiments 
by digesting the tissue after collection of cells from the ‘crawl-out’ method and identifying the 
subsets that remained in the skin. If the Langerin+ DDCs did migrate out of tissue, they may 
not have survived, or they may be included in the CD1a+ DC population if langerin expression 
was significantly downregulated similar to epidermal subsets. Downregulation of langerin 
expression on cultured skin subsets contrasts what is observed for cultured blood CD1c 
myeloid DCs (Milne et al., 2015). This may have been due to different culture durations, in 
which case the presence of ‘crawl-out’ Langerin+ DDCs could be re-assessed in future in skin 
that has been cultured for less than 24 hours. 
Due to changes in population marker expression, CD14+ DCs and CD1a+ DCs are 
the only mononuclear subsets that could confidently be defined when using the ‘crawl-out’ 
method. When compared to their collagenase-isolated counterparts, there was no difference 
in population marker expression, except for a down-regulation of HLA-DR on CD14+ DCs 
(Figure 4.14.). Spontaneously migrated CD14+ DCs also expressed lower levels of CD83 
than their collagenase digested counterparts (Figure 4.15.), which along with lower HLA-DR 
expression is curious as it contradicts commonly observed maturation-related changes in 
expression of both markers. Despite this, CD80 and CD86 expression was significantly higher 
on these cells, consistent with maturation. Similar to epidermal ‘crawl-outs’, the dermal CD1a+ 
‘crawl-out’ DCs were significantly more mature in comparison to the subsets isolated by 
collagenase digestion. As such, cells isolated by the ‘crawl-out’ method are mature and 
therefore not a suitable model for mononuclear phagocyte subsets that are present in healthy 
skin. 
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 The use of multiple population markers allows more confident identification and 
classification of mononuclear phagocyte subsets in human skin, and may allow the 
identification of novel subsets. Due to the observation of differences in relative rather than 
absolute expression of multiple population markers, two previously undescribed DC subsets 
were identified in the epidermis, and 5 populations (3 DC and 2 macrophage subsets) were 
confirmed in the dermis. While subsets isolated by collagenase were observed to be immature, 
they began to spontaneously mature within 1 hour of culture. Therefore, collagenase digestion 
and assays on isolated cells need to occur promptly in order to maintain an immature 
phenotype. Not only were the dermal mononuclear phagocyte subsets more difficult to define 
by the ‘crawl-out’ method, but epidermal and dermal ‘crawl-outs’ were also mature. The cells 
isolated by the ‘crawl-out’ method are therefore more likely to resemble cells in or en route to 
the lymph nodes after receiving a signal, while the cells isolated by collagenase digestion more 
closely resemble cells that reside in skin. Therefore, papers that use the ‘crawl-out’ method 
for isolation need to be taken with caution, because the cells are in a very different state 
compared to collagenase isolated cells. 
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5.1. Introduction 
Mononuclear phagocytes play a crucial role in immunity, which is dependent on the 
recognition of self and non-self via an array of receptors on their surface, such as C-type lectin 
receptors (CLRs) and sialic acid-binding IgG-like lectins (Siglecs) (Pillai et al., 2012; Sancho 
and Sousa, 2012). CLRs and Siglecs recognise carbohydrates, proteins and lipids from 
pathogens and damaged cells, which subsequently triggers endocytosis, phagocytosis, 
microbicidal activity and an array of other immune and homeostatic functions (Macauley et al., 
2014; Sancho and Sousa, 2012; Zelensky and Gready, 2005). Some CLRs interact with a 
wide range of pathogens, for example MR and DC-SIGN bind viruses (HIV, HCV, SARS, 
measles) (de Witte et al., 2006; Fanibunda et al., 2011; Lai et al., 2006; Miller et al., 2008; Op 
den Brouw et al., 2009), bacteria (Geijtenbeek et al., 2003; Gringhuis et al., 2009a; Kang et 
al., 2005) and fungi (Cambi et al., 2003; Cambi et al., 2008). Other CLRs are more limited in 
their specificity, for example dectins bind fungi (McGreal et al., 2006; Palma et al., 2006), and 
CLEC5A is an entry receptor for dengue virus (Chen et al., 2008; Tung et al., 2014).  
Mononuclear phagocyte subsets express unique repertoires of surface molecules, 
which have direct effects on the pathogens they interact with. Furthermore, specific CLRs 
differ in the efficiency by which they target antigens for processing and presentation by MHC-
II to elicit either an immune response or tolerance (Caminschi et al., 2009; Mahnke et al., 
2000; Mintern et al., 2013; Moffat et al., 2013). This has been the focus of novel DC-based 
vaccine strategies, which target delivery of antigens to specific CLRs (Caminschi et al., 2009; 
Tacken et al., 2005). As such, a more thorough understanding of the repertoire of CLRs 
expressed by specific DC subsets has important implications for vaccine development. 
Furthermore, it is also crucial in understanding which subsets are likely to play the most 
prominent role in pathogenesis of infectious diseases. 
DCs are most likely to encounter pathogens in a relatively inactivated state, and as 
such it is important to investigate the surface expression profile on immature DCs. 
Furthermore, DCs are known to down regulate several CLRs as a result of maturation (Mercier 
et al., 2013). Determining which CLRs persist is important for vaccine design because 
vaccines may encounter DCs undergoing maturation, such as in patients with underlying 
inflammation or infection. As shown in Chapter 4, enzymatic digestion and the crawl-out 
method isolate DCs in an immature or mature state, respectively; however, both methods have 
their limitations. The enzymes used for tissue digestion have the potential to cleave surface 
molecules, while not all mononuclear phagocyte subsets can be isolated and/or identified 
using the crawl-out method. For these and other reasons, model systems where the DCs are 
differentiated from either CD14- or CD34-expressing peripheral blood mononuclear cells have 
often been used (Caux et al., 1992; Romani et al., 1994; Sallusto and Lanzavecchia, 1994).  
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However, these are not the same as the mononuclear phagocytes encountered at the portals 
of vaccine or pathogen entry (Harman et al., 2013a). 
 HIV is one such pathogen that has been shown to bind to multiple surface molecules 
on DCs and macrophages; for example CLRs, such as langerin (de Jong et al., 2010a; de 
Witte et al., 2007), MR (Fanibunda et al., 2011; Lai et al., 2009a; Trujillo et al., 2007), DC-
SIGN (Geijtenbeek and van Kooyk, 2003; Gringhuis et al., 2009a; Gringhuis et al., 2010) and 
DEC-205 (Hatsukari et al., 2007), as well as its entry receptor CD4 and co-receptor CCR5 
(Borggren and Jansson, 2015). Importantly, the fate of the virus is dependent on the surface 
molecules to which it binds (summarised in Chapter 1 section 1.3.), which can result in two 
distinct mechanisms of virus uptake. The majority of virions enter via CLR-binding (Turville et 
al., 2004), after which the trafficking of the virus remains unclear. Upon CLR-mediated uptake, 
HIV can enter tetraspanin-rich, caves (Garcia et al., 2005), be rapidly endocytosed, processed 
by the endolysosomal pathway and presented on MHC-II (Fonteneau et al., 2003; Larsson et 
al., 2002; Moris et al., 2006), and/or transferred to T cells (Moris et al., 2006; Nasr et al., 2014; 
Turville et al., 2008; Turville et al., 2004). A minority of the virus (<5%) enters DCs by binding 
to CD4/CCR5, which mediates fusion of the virus envelope with the plasma membrane of the 
host cell, and productive viral replication (Turville et al., 2008; Turville et al., 2004). HIV transfer 
from DCs to T cells occurs in two phases, which correspond to the route of entry (Harman et 
al., 2009; Nasr et al., 2014; Turville et al., 2008; Turville et al., 2004). The first phase of transfer 
occurs as a result of CLR-mediated uptake of virus that is transferred to T cells independently 
of viral replication (Harman et al., 2009). The second phase of transfer occurs after de novo 
synthesised virions are produced (Turville et al., 2008; Turville et al., 2004), which results from 
virus that entered by CD4/CCR5-mediated neutral fusion. Novel strategies to prevent 
transmission of HIV have included blocking virus binding to CLRs, such as DC-SIGN (Berzi et 
al., 2012; Nabatov et al., 2008) and langerin (Nasr et al., 2014), thereby preventing transfer to 
T cells. Therefore, the CLR-profile on DCs and macrophages may have significant implications 
in transmission of HIV and reveal key targets for microbicides. 
 The aim of this chapter was to determine the surface pathogen recognition receptor 
profile on all known immature and mature skin mononuclear phagocytes, and to compare it to 
model MDMs and MDDCs. Specifically, CLRs known to bind HIV (see Chapter 1 Table 1.3.) 
were investigated together with the ability for skin mononuclear subsets to transfer HIV to T 
cells. 
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5.2. Results 
5.2.1. Collagenase cleaves surface molecules in a batch-specific manner 
 In order to determine which pathogen recognition receptors were expressed on 
immature skin mononuclear phagocytes, it was important to first determine whether any were 
susceptible to cleavage by collagenase. Blend F and Type IV collagenase were used to isolate 
cells from skin, and the expression of a wide range of pathogen recognition receptors 
compared between the two blends (Table 5.1.). For each receptor, a cell subset that 
expressed high levels of that surface molecule was used to compare expression after 
digestion with each collagenase blend. As well as langerin and CD1c (Table 3.1.), CD4 was 
also susceptible to cleavage by Blend F collagenase, therefore Type IV collagenase was used 
to investigate CD4 expression on mononuclear phagocytes. Compared to cells isolated with 
Blend F collagenase, CCR5, CD91, CLEC4D, CLEC4L/DC-SIGN, CLEC4M/L-SIGN, CLEC8A 
and CLEC10A were almost completely absent from cells isolated with Type IV collagenase, 
and significantly lower levels of CLEC4A, CLEC12A, CLEC13D/MR, and Siglec-1 were 
observed. Therefore, Blend F collagenase was used to further investigate the expression of 
all molecules cleaved by Type IV collagenase. The expression of all other makers was not 
collagenase blend dependent, therefore blends were used interchangeably for future 
experiments. 
 
5.2.2. HIV entry receptor expression differs between skin mononuclear phagocyte 
subsets and in vitro MDMs/MDDCs 
 HIV infection requires viral binding and entry via CD4 and CCR5 (R5 HIV) or CXCR4 
(X4 HIV) (Borggren and Jansson, 2015). Most studies on the role of mononuclear phagocytes 
in HIV infection use in vitro-derived cells (Ahmed et al., 2015; Harman et al., 2006; Izquierdo-
Useros et al., 2012; Mercier et al., 2013; Turville et al., 2003; Turville et al., 2008; Turville et 
al., 2002) due to the difficulty of isolating cells from tissue. In order to determine which human 
tissue mononuclear phagocytes may be permissive to HIV infection, surface expression of 
CD4, CCR5 and CXCR4 was investigated on all known skin subsets (see gating strategy 
Figure 5.1., as presented in Chapter 4), and compared to monocyte-derived DCs (MDDCs) 
and macrophages (MDMs). In the epidermis, CCR5 could only be detected on 
CD1a+Langerin- DCs, which was similar to the level of expression observed on dermal 
subsets and in vitro-derived cells (Figure 5.2.). In the dermis, CD141+ DCs and 
autofluorescent macrophages were negative for CCR5 expression, and MDMs expressed 
lower levels than the other dermal subsets, although not statistically significant. CD4 was 
expressed on all skin and in vitro subsets, excluding CD1a+Langerin+ epidermal DCs. 
Conversely, there was little to no CXCR4 expression on any subset. 
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Table 5.1. Collagenase cleavage of pathogen recognition receptors 
 
Marker Subset 
tested 
Blend F 
(gMFI) 
Type IV 
(gMFI) 
Expression 
Difference 
(Log10FC) 
Statistics 
# 
Best 
Enzyme 
Mean SD Mean SD 
CCR5 CD1a 454 323 39 53 4 ** Blend F 
CD4 CD1a 322 225 843 457 1 ns Type IV 
CD80 CD1a 57 0 56 31 0 - NA 
CD83 CD1a 36 0 522 350 4 - Type IV 
CD86 CD1a 180 0 406 305 1 - Type IV 
CD91 CD14 212 43 1 0 8 - Blend F 
CXCR4 CD14 3 7 156 150 6 ns Type IV 
CLEC4A/ 
DCIR 
CD1a 13770 4813 631 142 4 ** Blend F 
CLEC4D CD14 575 271 136 123 2 ** Blend F 
CLEC4E/ 
Mincle 
CD14 7021 3008 4890 1840 1 - Blend F 
CLEC4L/ 
DC-SIGN 
Mac 1264 450 152 205 3 ** Blend F 
CLEC4M/ 
L-SIGN 
CD14 2077 1621 165 135 4 ** Blend F 
CLEC5A CD1a 18772 7665 16767 4976 0 ns NA 
CLEC5B CD1a 66 67 112 102 1 ns NA 
CLEC5C CD1a 16 1 39 44 1 - NA 
CLEC6A/ 
Dectin-2 
CD1a 12 11 34 47 2 ns NA 
CLEC8A CD14 263 199 90 118 2 ns Blend F 
CLEC9A CD141 186 66 188 116 0 ns NA 
CLEC10A CD14 561 334 44 43 4 * Blend F 
CLEC12A CD14 5042 869 1439 1211 2 * Blend F 
CLEC13B/ 
DEC-205 
CD1a 518 321 428 276 0 ns NA 
CLEC13D/ 
MR 
CD14 6571 712 2219 582 3 ** Blend F 
CLEC14A CD1a 92 105 99 118 0 ns NA 
Siglec-1/ 
CD169 
CD14 1168 578 316 306 2 * Blend F 
Siglec-3/ 
CD33 
CD1a 12616 12452 5644 4117 1 ns Blend F 
Siglec-5/ 
CD170 
CD1a 668 126 298 350 1 ns Blend F 
Siglec-6 LC 5 0 17 0 2 - NA 
Siglec-9 CD1a 3757 2304 4827 3767 0 - NA 
Siglec-16 CD1a 181 175 144 99 0 ns NA 
 
FC = fold-change; gMFI = geometric mean fluorescence intensity; SD = standard deviation;  
#Mann-Whitney test; ns = not significant; - = not enough data points for statistics; * p ≤ 0.05;  
** p ≤ 0.01 
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Figure 5.1. Macrophage and DC subsets in human epidermis and dermis.
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Figure 5.1. Macrophage and DC subsets in human epidermis and dermis. As presented 
earlier in Chapter 4, cells isolated by collagenase digestion of epidermis (A) and dermis (B) 
were stained with Live/Dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 
BUV737, CD141 BV711, langerin Vioblue, and CD1c PE.Vio770. Autofluorescence was 
detected under FITC and BV605. Epidermal populations were gated based on CD1a and 
langerin expression within HLA-DRlowCD45low and HLA-DR+CD45+ populations (A). 
CD1a+Lang+ DCs (grey) were gated within the HLA-DRlowCD45low population. Within the 
HLA-DR+CD45+ population were CD1a++Langerin+ Langerhans cells (LCs; teal), and 
CD1a+Langerin- DCs (navy). Dermal DC and macrophages subsets were identified within 
the live, single, HLA-DR+CD45+ population and identified using a successive gating strategy 
(B). Macrophages (green) were defined as CD14+Autofluorescent+ cells. Within the 
autofluorescent negative gate, CD141+ DCs (purple) were defined as the CD141+CD14- 
cells. Within the CD1a+ population, CD1a+ DCs (blue) and CD1a+Langerin+ dermal DCs 
(dark blue) were defined as langerin- and langerin+ cells, respectively. Within the CD14+ 
population, CD14+ DCs (orange) and monocyte-derived macrophages (MDMs; red) were 
defined as CD1c+ and CD1c- cells, respectively. 
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Figure 5.2. Surface expression of HIV entry receptors on epidermal and dermal macrophage and DC subsets isolated from 
collagenase digested human skin, and in vitro MDMs and MDDCs.
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Figure 5.2. Surface expression of HIV entry receptors on epidermal and dermal 
macrophage and DC subsets isolated from collagenase digested human skin, and in 
vitro MDMs and MDDCs. Cells isolated from collagenase digested epidermis and dermis 
were stained with Live/Dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 
BUV737, CD141 BV711, langerin Vioblue, CD1c PE.Vio770, and surface expression 
receptors on APC and PE. Epidermal Langerhans cells (LCs; teal), CD1a+Langerin+ DCs 
(navy) and CD1a+Langerin+ cells (grey) were defined according to the gating strategy in 
Figure 5.1.A. Dermal CD141+ DCs (purple), CD1a+ DCs (blue), CD1a+Langerin+ DCs 
(Lang; dark blue) CD14+ DCs (orange), monocyte-derived macrophages (MDMs; red), and 
macrophages (green) were defined according to the gating strategy in Figure 5.1.B. In vitro 
blood MDMs (pink) and monocyte-derived DCs (MDDCs; dark red) were stained with 
Live/Dead NIR and surface expression receptors on APC and PE. Cells were run on a 
BDFortessa flow cytometer and the geometric mean fluorescence intensity (gMFI) for each 
surface expression minus isotype plotted with the mean +/- 95% confidence interval. A gMFI 
of 100 was set as the limit of detection (dotted line). Statistics were generated using the 
Kruskal-Wallis test and Dunn’s multiple comparison post hoc test. * p<0.05; ** p<0.01; *** 
p<0.001; **** p<0.0001.
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These results suggest that CD1a+Langerin- epidermal DCs and all dermal DCs, excluding 
CD141+ DCs have the potential for permissive HIV infection.  
See Table 5.2. for a comparison of expression of HIV entry receptors and other 
pathogen binding receptors across the subsets. 
 
5.2.3. CLEC4 and CLEC13 family receptor expression differs between skin 
mononuclear phagocyte subsets and in vitro MDMs/MDDCs 
 CLEC4 and CLEC13 are two families of CLRs that contain multiple members involved 
in pathogen binding (detailed in Chapter 1 section 1.3.1). Surface expression of those known 
to interact with pathogens (see Table 1.3.), in particular HIV, was investigated on skin 
mononuclear phagocyte subsets and in vitro-derived cells (Figure 5.3., Figure 5.4. and Table 
5.2.). HIV-binding receptors CLEC4A/DCIR, CLEC4M/L-SIGN, CLEC13B/DEC-205 and 
CLEC13D/MR were expressed on CD1a+Langerin- epidermal DCs and all dermal subsets, 
excluding CD141+ DCs. Of these, only CLEC4A/DCIR and CLEC13B/DEC-205 were 
expressed on LCs and CD1a+Langerin+ epidermal DCs, while in-vitro-derived cells only 
lacked CLEC4M/L-SIGN. The so-named Dendritic Cell-specific ICAM-3-grabbing non-integrin 
(DC-SIGN/CLEC4L) was only expressed on macrophages and CD14+ DCs in skin, and was 
highly expressed on in vitro-derived cells. CLEC4E was expressed on all cells, while CLEC4D 
was only expressed on LCs and dermal subsets. 
 
5.2.4. Differential expression of other pathogen recognition receptors on skin 
mononuclear phagocytes and in vitro MDMs/MDDCs 
 Aside from CLEC4 and CLEC13 CLRs, there are many other CLRs and surface 
molecules that are involved in pathogen binding or immune recognition. A number of these 
molecules known to be expressed on mononuclear phagocytes and/or involved in immune 
recognition were investigated on skin mononuclear phagocytes and in vitro subsets (Figure 
5.5. and Table 5.2.). In tissue, CD91 and CLEC8A expression was highest on dermal 
macrophages (MDMs and autofluorescent), and CD91 was also expressed on in vitro-derived 
cells. CLEC9A was exclusively expressed by CD141+ DCs, and CLEC6A was only expressed 
on CD1a+Langerin+ epidermal DCs, albeit at very low levels. CLEC5A was expressed on all 
subsets, but was highest on epidermal and dermal DCs, excluding CD141+ DC. Similarly, 
CLEC10A and CLEC12A were widely expressed on dermal subsets and CD1a+Langerin- 
epidermal DCs, but only CLEC12A was expressed on in vitro-derived subsets. There was little 
to no expression of CLEC5B, CLEC5C or CLEC14A on any cell type. 
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Figure 5.3. Surface expression of CLEC4 receptors on epidermal and dermal macrophage and DC subsets isolated from collagenase 
digested human skin, and in vitro MDMs and MDDCs.
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Figure 5.3. Surface expression of CLEC4 receptors on epidermal and dermal 
macrophage and DC subsets isolated from collagenase digested human skin, and in 
vitro MDMs and MDDCs. Cells isolated from collagenase digested epidermis and dermis 
were stained with Live/Dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 
BUV737, CD141 BV711, langerin Vioblue, CD1c PE.Vio770, and surface expression 
receptors on APC and PE. Epidermal Langerhans cells (LCs; teal), CD1a+Langerin+ DCs 
(navy) and CD1a+Langerin+ cells (grey) were defined according to the gating strategy in 
Figure 5.1.A. Dermal CD141+ DCs (purple), CD1a+ DCs (blue), CD1a+Langerin+ DCs 
(Lang; dark blue) CD14+ DCs (orange), monocyte-derived macrophages (MDMs; red), and 
macrophages (green) were defined according to the gating strategy in Figure 5.1.B. In vitro 
blood MDMs (pink) and monocyte-derived DCs (MDDCs; dark red) were stained with 
Live/Dead NIR and surface expression receptors on APC and PE. Cells were run on a 
BDFortessa flow cytometer and the geometric mean fluorescence intensity (gMFI) for each 
surface expression minus isotype plotted with the mean +/- 95% confidence interval. A gMFI 
of 100 was set as the limit of detection (dotted line). Statistics were generated using the 
Kruskal-Wallis test and Dunn’s multiple comparison post hoc test. * p<0.05; ** p<0.01; *** 
p<0.001; **** p<0.0001. 
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Figure 5.4. Surface expression of CLEC13 receptors on epidermal and dermal macrophage and DC subsets isolated from collagenase 
digested human skin, and in vitro MDMs and MDDCs.
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Figure 5.4. Surface expression of CLEC13 receptors on epidermal and dermal 
macrophage and DC subsets isolated from collagenase digested human skin, and in 
vitro MDMs and MDDCs. Cells isolated from collagenase digested epidermis and dermis 
were stained with Live/Dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 
BUV737, CD141 BV711, langerin Vioblue, CD1c PE.Vio770, and surface expression 
receptors on APC and PE. Epidermal Langerhans cells (LCs; teal), CD1a+Langerin+ DCs 
(navy) and CD1a+Langerin+ cells (grey) were defined according to the gating strategy in 
Figure 5.1.A. Dermal CD141+ DCs (purple), CD1a+ DCs (blue), CD1a+Langerin+ DCs 
(Lang; dark blue) CD14+ DCs (orange), monocyte-derived macrophages (MDMs; red), and 
macrophages (green) were defined according to the gating strategy in Figure 5.1.B. In vitro 
blood MDMs (pink) and monocyte-derived DCs (MDDCs; dark red) were stained with 
Live/Dead NIR and surface expression receptors on APC and PE. Cells were run on a 
BDFortessa flow cytometer and the geometric mean fluorescence intensity (gMFI) for each 
surface expression minus isotype plotted with the mean +/- 95% confidence interval. A gMFI 
of 100 was set as the limit of detection (dotted line). Statistics were generated using the 
Kruskal-Wallis test and Dunn’s multiple comparison post hoc test. * p<0.05; ** p<0.01; *** 
p<0.001; **** p<0.0001.
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Figure 5.5. Surface expression of other pathogen recognition receptors on epidermal and dermal macrophage and DC subsets 
isolated from collagenase digested human skin, and in vitro MDMs and MDDCs. 
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isolated from collagenase digested human skin, and in vitro MDMs and MDDCs.
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Figure 5.5. Surface expression of other pathogen recognition receptors on epidermal and dermal macrophage and DC subsets 
isolated from collagenase digested human skin, and in vitro MDMs and MDDCs.
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Figure 5.5. Surface expression of other pathogen recognition receptors on epidermal 
and dermal macrophage and DC subsets isolated from collagenase digested human 
skin, and in vitro MDMs and MDDCs. Cells isolated from collagenase digested epidermis 
and dermis were stained with Live/Dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, 
CD14 BUV737, CD141 BV711, langerin Vioblue, CD1c PE.Vio770, and surface expression 
receptors on APC and PE. Epidermal Langerhans cells (LCs; teal), CD1a+Langerin+ DCs 
(navy) and CD1a+Langerin+ cells (grey) were defined according to the gating strategy in 
Figure 5.1.A. Dermal CD141+ DCs (purple), CD1a+ DCs (blue), CD1a+Langerin+ DCs 
(Lang; dark blue) CD14+ DCs (orange), monocyte-derived macrophages (MDMs; red), and 
macrophages (green) were defined according to the gating strategy in Figure 5.1.B. In vitro 
blood MDMs (pink) and monocyte-derived DCs (MDDCs; dark red) were stained with 
Live/Dead NIR and surface expression receptors on APC and PE. Cells were run on a 
BDFortessa flow cytometer and the geometric mean fluorescence intensity (gMFI) for each 
surface expression minus isotype plotted with the mean +/- 95% confidence interval. A gMFI 
of 100 was set as the limit of detection (dotted line). Statistics were generated using the 
Kruskal-Wallis test and Dunn’s multiple comparison post hoc test. * p<0.05; ** p<0.01; *** 
p<0.001; **** p<0.0001.
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5.2.5. Siglec expression differs between skin mononuclear phagocyte subsets and in 
vitro MDMs/MDDCs 
 Similar to CLRs, Siglecs play a role in immune recognition (Crocker et al., 2007; 
Macauley et al., 2014; Pillai et al., 2012; Zou et al., 2011), and those known to be expressed 
on mononuclear phagocytes and/or involved in pathogen binding were investigated on skin 
mononuclear phagocyte and in vitro subsets (Figure 5.6. and Table 5.2.). Siglec-1 was 
expressed on all dermal subsets and in vitro MDMs, but was absent from epidermal subsets 
and in vitro MDDCs. Siglec-1 expression was highest on autofluorescent macrophages, but 
this was not significantly higher than other positive subsets. Siglec-3 and Siglec-9 were 
expressed on all subsets, but both were notably lower on CD1a+Langerin+ epidermal DCs. 
Conversely, Siglec-6 was not expressed on any subset. Siglec-16 ranged from no to low 
expression on dermal and in vitro-derived subsets, but was almost always absent from 
epidermal subsets. Similarly, Siglec-5 was only expressed in the dermis and on in vitro-derived 
cells; however, low expression was occasionally detected on CD1a+Langerin- epidermal DCs. 
 
5.2.6. Mature skin mononuclear phagocytes express a pathogen recognition receptor 
profile distinct from their immature counterparts 
 Immature DCs are phenotypically and functionally distinct from mature DCs. In order 
to determine how the surface expression profile varied with maturation status, surface 
expression of pathogen recognition receptors on collagenase digested skin (immature) was 
compared to cells isolated after spontaneous migration (mature) from epidermis (Figure 5.7.) 
and dermis (Figure 5.8.). HIV entry receptors CD4 and CCR5 were significantly 
downregulated on CD1a+ DCs, while CXCR4 was upregulated. CCR5 was also 
downregulated on CD14+ DCs and CD1a+Langerin- epidermal DCs, as well as HIV binding 
receptors CLEC4A/DCIR and CLEC4M/L-SIGN, which were also downregulated on CD1a+ 
DCs. CLEC4D was downregulated on CD1a+Langerin- epidermal DCs and CD1a+ DCs, while 
CLEC4E, CLEC5C and CLEC6A were only downregulated on CD1a+ DCs, LCs, and 
CD1a+Langerin- epidermal DCs, respectively. CLEC13D/MR was significantly down 
regulated on all subsets, excluding LCs and CD1a+Langerin+ epidermal DCs, while CLEC10A 
and CLEC12A were only downregulated on dermal DCs. Conversely, CLEC13B/DEC-205 
was upregulated on all subsets, excluding CD14+ DCs. CLEC5A expression was upregulated 
on mature CD14+ DCs, but downregulated on mature MDDCs. Siglec-1 and CLEC9A were 
upregulated on LCs and CD1a+Langerin- epidermal DCs, while Siglec-1 was downregulated 
on mature CD14+ DCs. CLEC9A was also upregulated on mature MDDCs, as was CLEC14A. 
CD91 and Siglec-16 were upregulated on mature CD14+ DCs, and Siglec-16 was also 
upregulated on CD1a+Langerin- epidermal DCs. 
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Figure 5.6. Surface expression of Siglecs on epidermal and dermal macrophage and DC subsets isolated from collagenase digested 
human skin, and in vitro MDMs and MDDCs.
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Figure 5.6. Surface expression of Siglecs on epidermal and dermal macrophage and DC 
subsets isolated from collagenase digested human skin, and in vitro MDMs and 
MDDCs. Cells isolated from collagenase digested epidermis and dermis were stained with 
Live/Dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 
BV711, langerin Vioblue, CD1c PE.Vio770, and surface expression receptors on APC and PE. 
Epidermal Langerhans cells (LCs; teal), CD1a+Langerin+ DCs (navy) and CD1a+Langerin+ 
cells (grey) were defined according to the gating strategy in Figure 5.1.A. Dermal CD141+ 
DCs (purple), CD1a+ DCs (blue), CD1a+Langerin+ DCs (Lang; dark blue) CD14+ DCs 
(orange), monocyte-derived macrophages (MDMs; red), and macrophages (green) were 
defined according to the gating strategy in Figure 5.1.B. In vitro blood MDMs (pink) and 
monocyte-derived DCs (MDDCs; dark red) were stained with Live/Dead NIR and surface 
expression receptors on APC and PE. Cells were run on a BDFortessa flow cytometer and 
the geometric mean fluorescence intensity (gMFI) for each surface expression minus isotype 
plotted with the mean +/- 95% confidence interval. A gMFI of 100 was set as the limit of 
detection (dotted line). Statistics were generated using the Kruskal-Wallis test and Dunn’s 
multiple comparison post hoc test. * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001.
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Table 5.2. Summary of pathogen recognition receptor expression on collagenase 
isolated epidermal and dermal macrophage and DC subsets, and in vitro MDMs and 
MDDCs. 
 
 
 
 
  
 
 
 
LC
CD1a+
Lang-
CD1a+
Lang+
CD141 CD1a Lang+ CD14 MDM Mac MDM MDDC
CCR5
CD4
CD80
CD83
CD86
CD91
CXCR4
CLEC4A (DCIR)
CLEC4D
CLEC4E (Mincle)
CLEC4L (DC-SIGN)
CLEC4M (L-SIGN)
CLEC5A
CLEC5B
CLEC5C
CLEC6A (Dectin-2)
CLEC8A (LOX-1)
CLEC9A (DNGR-1)
CLEC10A (MGL)
CLEC12A (MICL)
CLEC13B (DEC205)
CLEC13D (MR)
CLEC14A
Siglec-1 (CD169)
Siglec-3 (CD33)
Siglec-5 (CD170)
Siglec-6
Siglec-9
Siglec-16
Marker
Epidermis Dermis In vitro
gMFI 
 < 100 
 100 - 499 
 500 - 999 
 1 000 - 4 999 
 5 000 - 9 999 
 ≥ 10 000 
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Figure 5.7. Comparison of pathogen recognition receptor surface expression on 
epidermal DCs isolated by collagenase digestion and after 48 hour migration.
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Figure 5.7. Comparison of pathogen recognition receptor surface expression on 
epidermal DCs isolated by collagenase digestion and after 48 hour migration. Epidermal 
populations that were isolated by collagenase digestion (closed dots) and after 48 hour 
migration (open dots) were stained with Live/Dead NIR, HLA-DR BUV395, CD45 BV796, 
CD1a BV510, langerin Vioblue, CD1c PE.Vio770, CD11c APC, and other surface expression 
receptors on PE and APC. Epidermal Langerhans cells (LCs; teal), CD1a+Langerin+ DCs 
(navy) and CD1a+Langerin+ cells (grey) were defined according to the gating strategy in 
Figure 5.1.A. Cells were run on a BDFortessa flow cytometer and the geometric mean 
fluorescence intensity (gMFI) for each surface expression minus isotype plotted with the mean 
+/- 95% confidence interval. A gMFI of 100 was set as the limit of detection (dotted line). 
Statistics were generated using Mann-Whitney test. * p<0.05; ** p<0.01; *** p<0.001; **** 
p<0.0001. 
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Figure 5.8. Comparison of pathogen recognition receptor surface expression on dermal 
DC subsets isolated by collagenase digestion and after 48 hour migration, and on in 
vitro MDDCs. 
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Figure 5.8. Comparison of pathogen recognition receptor surface expression on dermal 
DC subsets isolated by collagenase digestion and after 48 hour migration, and on in 
vitro MDDCs. Cells isolated from dermis by collagenase digestion (closed dots) and after 48 
hour migration (open dots) were stained with Live/Dead NIR, HLA-DR BUV395, CD45 BV786, 
CD1a BV510, CD14 BUV737, CD141 BV711, langerin Vioblue, CD1c PE.Vio770, and other 
surface expression receptors on PE and APC. Dermal CD1a+ DCs (blue) and CD14+ DCs 
(orange) were defined according to the gating strategy in Figure 5.1.B. In vitro day 5 
monocyte-derived MDDCs (dark red) were stained with Live/Dead NIR and other surface 
expression markers on PE and APC after 5 days of differentiation (immature MDDCs, 
iMDDCs; closed dots) or after a further 48 hour culture with maturation mix (mature MDDCs, 
mDDCs; open dots). Cells were run on a BDFortessa flow cytometer and the geometric mean 
fluorescence intensity (gMFI) for each surface expression minus isotype plotted with the mean 
+/- 95% confidence interval. A gMFI of 100 was set as the limit of detection (dotted line). 
Statistics were generated using the Mann-Whitney test. * p<0.05; ** p<0.01; *** p<0.001; **** 
p<0.0001. 
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Apart from the upregulation of maturation markers CD80, CD83 and CD86 (see Chapter 4 
Figure 4.11.), and CLEC13B/DEC-205, there was no change in the surface expression profile 
on CD1a+Langerin+ epidermal DCs with maturation.  
A summary of the expression changes is shown in Table 5.3., which highlights how 
drastically different the phenotype of immature and mature mononuclear phagocytes is. 
 
5.2.7. Skin mononuclear phagocytes transfer HIV to T cells in a subset-specific 
manner 
 DCs have been shown to transfer HIV to T cells, resulting in greater efficiency of HIV 
replication than if T cells were directly infected with HIV (Ayehunie et al., 1995; Rinaldo, 2013). 
However, many of these studies used model DCs (Harman et al., 2009; Rinaldo, 2013; Turville 
et al., 2004); therefore, it was of interest to determine whether ex vivo mononuclear 
phagocytes were able to transfer HIV to T cells. Macrophages and DCs isolated from 
collagenase digested skin were infected with HIV-1, and a reporter T cell line, JLTR.R5, was 
used to determine how efficiently HIV was transferred to T cells. JLTR.R5 cells encode GFP 
under the HIV-1 promoter, so HIV-infected T cells express GFP (Ochsenbauer-Jamor et al., 
2006) and could be quantified by flow cytometry (Figure 5.9.A), and the number of HIV-
infected cells over time determined. In all experiments, the combined CD1a-expressing 
epidermal DC population and combined CD1a-expressing dermal DC population transferred 
HIV to T cells in two phases (Figure 5.9.B), which did not differ with isolation method (Figure 
5.9.C). However, dermal CD1a+ DCs transferred the virus more efficiently (Figure 5.9.D). In 
initial experiments all of the CD14+ cells were grouped together, but were later separated into 
autofluorescent macrophages and non-autofluorescent CD14+ cells according to the gating 
strategy outlined in Figure 5.1.B.  CD14+ cells (with or without autofluorescent macrophages) 
were only observed to transfer HIV in the first phase whether isolated by collagenase digestion 
(Figure 5.9.B) or after spontaneous migration (Figure 5.9.C). Autofluorescent macrophages 
by themselves were observed to transfer HIV in two phases in one of two experiments (Figure 
5.9.C). Due to the low frequency of CD141+ DCs, these were only investigated twice and with 
a single time point, 2h, at which no first phase transfer was observed (Figure 5.9.C).
Chapter 5: Skin mononuclear phagocyte pathogen recognition Rachel Botting 
                  receptor expression and their ability to transfer HIV 
186 
 
 
Table 5.3. Summary of pathogen recognition receptor expression on migrated skin 
mononuclear phagocyte subsets, and in vitro mature MDDCs, compared to their 
immature counterparts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 no change 
 down regulated 
 up regulated 
In vitro
LC
CD1a+ 
Lang-
CD1a+ 
Lang+
CD1a CD14 MDDC
CCR5
CD4
CD80
CD83
CD86
CD91
CXCR4
CLEC4A (DCIR)
CLEC4D
CLEC4E (Mincle)
CLEC4L (DC-SIGN)
CLEC4M (L-SIGN)
CLEC5A
CLEC5B
CLEC5C
CLEC6A (Dectin-2)
CLEC8A (LOX-1)
CLEC9A (DNGR-1)
CLEC10A (MGL)
CLEC12A (MICL)
CLEC13B (DEC205)
CLEC13D (MR)
CLEC14A
Siglec-1 (CD169)
Siglec-3 (CD33)
Siglec-5 (CD170)
Siglec-6
Siglec-9
Siglec-16
Marker
Epidermis Dermis
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Figure 5.9. Transfer of HIV from DCs and macrophages to T cells.
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Figure 5.9. Transfer of HIV from DCs and macrophages to T cells.
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Figure 5.9. Transfer of HIV from DCs and macrophages to T cells. Macrophage and DC 
subsets isolated from human skin were sorted and treated with HIV-1BaL (MOI = 3) for 2 hours 
at 37°C. The cells were washed 3x with PBS and plated in 96-well round-bottom plates at 3 x 
104 - 1 x 105 cells per well in 200µL RH10 supplemented with 200ng/mL GM-CSF and 25µg/mL 
gentamicin. JLTR cells were added to the ex vivo cells at a ratio of 3:1 at various hours post 
infection (hpi). JLTR cells were collected 4 days post addition and the percentage of HIV-
infected cells (GFP positive) was determined by flow cytometry. Representative flow cytometry 
plots are shown for a transfer assay using CD1a+ dermal DCs plated at 1 x 105 cells/well, 
including the gating strategy and controls (A). The percentage of GFP positive JLTR cells is 
shown in the top right hand corner of each plot. The kinetics of transfer are shown for 
epidermal CD1a+ cells (CD1a+ Epi), and dermal CD14+ cells (AF- = non-autofluorescent), 
CD1a+ DCs, CD141+ DCs, and macrophages across 7 experiments (Ex) isolated by 
collagenase digestion (B and D) or after 48 hours of migration (C). A representative graph 
comparing all 5 subsets is also shown (D). 
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5.3. Discussion 
5.3.1. Overview 
One of the key roles of mononuclear phagocytes is the surveillance of blood and tissue 
for the presence of pathogens. Surface molecules, such as CLRs and Siglecs contain 
recognition sites for carbohydrates, lipids, and proteins, many of which can be found on 
pathogens (Crocker et al., 2007; Pillai et al., 2012; Sancho and Sousa, 2012). Thus, many 
CLRs and Siglecs act as pathogen recognition receptors. The expression of surface molecules 
on mononuclear phagocytes therefore has significant implications for how individual subsets 
interact with pathogens. The first aim of this chapter was to investigate the surface expression 
profile of pathogen recognition receptors on skin mononuclear phagocytes, specifically those 
known to bind HIV (see Chapter 1 Table 1.3.). This was extended to investigate how 
expression changed with maturation, and what role tissue mononuclear phagocytes play in 
HIV transmission through transfer to T cells. 
 
5.3.2. Enzymatic cleavage of surface molecules 
 DCs that survey and encounter pathogens in healthy skin are of an immature 
phenotype, and require isolation by enzymatic digestion to be investigated in their immature 
state as ex vivo cells. However, caution is required when using enzymes as they can cleave 
surface molecules, which not only alters the phenotype but also potentially the function of the 
cells. This is particularly crucial when investigating pathogen recognition receptors, because 
cleavage of markers could result in the loss of interaction between the pathogen and the cell 
of interest. For example, a study that isolated LCs using trypsin, which cleaves CD4, 
concluded that LCs were not susceptible to HIV infection (de Witte et al., 2007); however, the 
opposite was seen when cells were isolated using collagenase and CD4 expression was 
preserved (Nasr et al., 2014).  
With the above in mind, expression of a range of pathogen recognition receptors, 
including HIV entry receptors, were examined on skin mononuclear phagocytes isolated using 
two blends of collagenase in order to determine whether either blend significantly cleaved 
molecules. HIV entry receptors, CD4 and CCR5 were cleaved by Blend F and Type IV 
collagenase, respectively (Table 5.1.). CCR5 was cleaved below the level of detection, while 
CD4 was only partially cleaved; therefore, isolation by Blend F collagenase may preserve HIV 
entry even if at reduced levels. Type IV collagenase partially and fully cleaved multiple 
markers, therefore Blend F collagenase was generally superior for investigation of surface 
expression, despite the fact that Type IV collagenase is reportedly designed for minimal 
receptor cleavage. The use of MDDCs would have allowed comparison of enzyme treated to 
untreated cells, but MDDCs were negative for multiple markers expressed on skin 
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mononuclear phagocytes, such as langerin, CLEC4D, CLEC4M and Siglec-1, therefore ex 
vivo cells were used. Where no expression of a receptor was observed, it could not be 
conclusively determined to be absent from cells as both enzymes may have completely 
cleaved it. Similarly, cleavage by dispase could not be ruled out, but as dispase is required to 
separate the epidermis and dermis, it could not be avoided. This is an especially important 
consideration for CLEC5B and CLEC5C which have been shown by the host lab to be 
expressed at a transcriptional level (Harman et al., 2013a). Transcriptomics could be used to 
confirm the absence of other markers, and microscopy used to confirm whether molecules 
could be detected on the surface of the cell. Future functional assays will require the use of 
enzymes for isolation of cells in an immature state, and as such the functionality of cleaved 
markers cannot currently be invested using ex vivo skin subsets. 
 
5.3.3. Surface expression on immature mononuclear phagocytes 
Pathogen binding receptor expression on all skin mononuclear phagocytes subsets 
was next investigated. Surface expression was shown to differ significantly between the 
epidermis and dermis, and between subsets within these sites, and even more so compared 
to in vitro-derived cells (Table 5.2.). Surface expression was determined by flow cytometry, 
and normalised between experiments through the use of isotype controls. In future, variation 
could be further controlled by using software analyses such as Application Settings, which 
also allows clustering of subsets based on surface expression. The range of CLRs and Siglecs 
investigated were those shown to bind pathogens and/or expressed on mononuclear 
phagocytes. Restricted access to skin, frequency of subsets, and availability of antibodies 
meant that not all CLRs and Siglecs of interest could be investigated, for example surface 
expression of CLEC1B, CLEC4G, CLEC7A/Dectin-1 and Siglec-7 is yet to be determined. 
 
5.3.3.1. Epidermal DC subsets 
 It is not surprising that differences in surface receptor expression were observed 
between epidermal and dermal subsets, as these tissues contain distinct physical and cytokine 
environments (see Chapter 1, section 1.1.1.). The two langerin+ epidermal subsets expressed 
a similar profile of surface molecules to each other, which was distinct from that of the 
CD1a+Langerin- epidermal DCs. They expressed CLEC4E and Siglec-9, but always at lower 
levels than dermal subsets and CD1a+Langerin- epidermal DCs, and they were negative for 
CCR5, CLEC4M/L-SIGN, CLEC13D/MR, CLEC6A, CLEC10A, CLEC12A and Siglec-5. Thus, 
Langerin and CLEC4A/DCIR are the primary CLRs expressed on these cells. Harman et al. 
also showed CLEC4M, CLEC6A and CLEC12A expression by transcriptomics (Harman et al., 
2013a); however, this analysis was carried out using combined CD1a-expressing epidermal 
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cells. Negative to low expression of multiple pathogen recognition receptors on the langerin+ 
cells indicates they may be inferior to dermal DCs at pathogen detection, or more tolerant of 
the numerous microbes they encounter. The CD1a+Langerin- DCs may therefore play a more 
major role in epidermal pathogen detection, though this remains to be investigated. Within the 
langerin+ population, LCs differed from the CD1a+Langerin+ DCs with the expression of CD4 
and CLEC4D, and higher expression of CLEC4A, CLEC5A, and Siglec-3. Lower expression 
of CD4, CLEC4A and CLEC4D is consistent with maturation; however, the lower expression 
of HLA-DR seen on these cells (Figure 4.2.B) is not, and may instead indicate these cells are 
an LC precursor. The surface marker profile on CD1a+Langerin- DCs was markedly similar to 
dermal CD1a+ DCs, except they exclusively expressed CLEC6A and lacked Siglec-1. 
CLEC6A recognises house dust mite allergens, and as such this subset may be involved in 
allergic reactions in skin. CLEC4D was expressed at lower levels on mature CD1a+ DCs, 
which may indicate that CD1a+Langerin- DCs are CD1a+ DCs that have migrated into the 
epidermis from the dermis. However, epidermal CD1a+Langerin- DCs do not mimic dermal 
CD1a+ DCs that have migrated out of skin according to CLEC6A, Siglec-1 and CLEC14A 
expression. Therefore, these may represent a novel DC subset, and transcriptomic profiling is 
the next logical step in order to resolve this question. 
 
5.3.3.2. Dermal CD141+ DCs 
CD141+ DCs were the most notably distinct subset from other dermal DCs in the range 
of surface molecules they expressed. They were the only dermal DCs that did not express 
CCR5, and they expressed lower levels of CLEC13D and all CLEC4 family markers, which 
apart from CLEC4L were expressed at similar levels across all other dermal subsets. Similarly, 
CLEC5A and CLEC10A were lowest on CD141+ DCs compared to other dermal subsets. 
Interestingly, surface expression more closely resembled epidermal langerin+ subsets than 
dermal DCs or macrophages. CD141+ DCs were also distinct with the exclusive expression 
of CLEC9A (albeit at very low levels), which is involved in the recognition of dead cells. This, 
together with the lack of common pathogen recognition receptors, is consistent with the 
literature that implies CD141+ DCs play a more significant role in the detection of dead cells, 
such as those killed by pathogens, and cross-presentation of pathogen-associated antigens 
associated with the dead cells, rather than direct pathogen detection (Jongbloed et al., 2010; 
Zelenay et al., 2012). 
 
5.3.3.3. Dermal CD1a+ DCs 
 CD1a+ DCs are the most abundant mononuclear phagocyte subset in healthy human 
skin, and together with CD14+ DCs express the widest range of surface molecules known to 
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interact with pathogens. Therefore, these are most likely to be the predominant pathogen 
detectors in skin. The surface expression profile of Langerin+ dermal DCs was almost identical 
to that of CD1a+ DCs. This probably indicates they are derived from the same precursor, and 
may be CD1a+ DCs that have been driven to express langerin, as postulated by Mathew Collin 
and his team at Newcastle University (Bigley et al., 2015; Milne et al., 2015). Apart from higher 
CCR5 and CLEC5A expression, both CD1a+ populations express similar levels of surface 
molecules to CD14+ DCs, which for CLEC5A is reflected in their transcriptomes (Harman et 
al., 2013a). The similarity between these subsets further highlights how different CD141+ DCs 
are from the other dermal DCs. 
 
5.3.3.4. Dermal CD14+ DCs and macrophages 
 Non-autofluorescent CD14+ cells have only recently been observed to be a mixed 
population, and as such very little is known on how the subsets differ from each other, and 
from other dermal subsets. As mentioned above, surface expression of CD14+ DCs more 
closely resembles CD1a+ DCs than MDMs and macrophages. CD14+ DCs express higher 
levels of CLEC5A than macrophages (MDMs and autofluorescent), which in the case of MDMs 
is distinct enough to separate the two non-autofluorescent populations, similar to CD1c. Unlike 
autofluorescent macrophages, CD14+ DCs also express CCR5, but lack CD91. Conversely, 
CD14+ DCs, MDMs and macrophages were the only subsets in skin to express CLEC4L/DC-
SIGN. As its name suggests, DC-SIGN (Dendritic Cell-specific ICAM3-grabbing non-integrin) 
has long been considered a DC-specific marker (Geijtenbeek and Gringhuis, 2009), and is still 
used to define DC subsets (Cavarelli et al., 2013; Jameson et al., 2002; Liu et al., 2014); 
however, in skin the expression is more correctly a macrophage marker. 
Dermal macrophages (MDMs and autofluorescent) are distinct from skin DCs, 
specifically in their expression of CD91, and higher expression of CLEC8A. Macrophages 
(MDMs and autofluorescent) also express lower levels of CLEC5A than other dermal subsets, 
similar to CD141+ DCs, which contrasts reports in literature which claim CLEC5A is only 
expressed on macrophages (Chen et al., 2008; Watson et al., 2011). Macrophages differ from 
MDMs with the higher expression of CLEC13D and CLEC4M/L-SIGN. Despite its name and 
reports in literature (Bashirova et al., 2001; Gardner et al., 2003), Liver-specific ICAM3-
grabbing non-integrin (L-SIGN/CLEC4M) was highly expressed on all dermal mononuclear 
phagocytes and CD1a+Langerin- epidermal DCs. Despite their wide range of surface 
receptors, macrophages are less efficient at stimulating naïve T cells and play a more 
prominent role in scavenging and wound healing (Varol et al., 2015).  
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5.3.3.5. In vitro monocyte-derived DCs and macrophages 
  The biggest difference in surface expression was observed between ex vivo and in 
vitro subsets. In vitro-derived MDMs and MDDCs are often used as model cells due to their 
ready availability, and MDDCs have been shown to cluster closely with ex vivo CD14+ cells 
(Harman et al., 2013a). This was reflected with similar expression of CD91 and CLEC5A on 
ex vivo macrophages (MDMs and autofluorescent). In vitro MDMs also express similar levels 
of CLEC4L/DC-SIGN to ex vivo CD14+ cells, while in vitro MDDCs express significantly more. 
Despite these similarities, there were many more marked differences observed between in 
vitro and ex vivo subsets in relation to surface expression. Unlike dermal subsets, the in vitro 
subsets did not express CLEC4D, CLEC4M, CLEC8A, CLEC10A, and expressed lower 
CLEC4E. Conversely, in vitro subsets expressed higher CLEC13B than ex vivo subsets. In 
vitro MDDCs also differed from dermal subsets with the absence of Siglec-1 expression, which 
more closely resembled epidermal DCs. The extensive differences between in vitro and ex 
vivo subsets should therefore caution against the use of in vitro subsets as a model of 
interactions between pathogens and skin mononuclear phagocytes. 
 
5.3.4. Expression of surface molecules on mature cell subsets 
CLRs have been investigated as targets for microbicides and vaccines (Caminschi et 
al., 2009; Tacken et al., 2005), so it was important to determine whether their expression was 
up or downregulated on mature DCs. In healthy skin, DCs are immature; however, in inflamed 
skin the DCs may be exposed to maturation stimuli. Vaccines designed to target DCs to prime 
an efficient immune response rely on DCs migrating to lymph nodes, in which case the DCs 
interacting with T cells may be mature and phenotypically distinct from the targeted subset. 
CLEC13B/DEC-205 has been shown to mediate HIV-1 internalisation (Hatsukari et al., 2007); 
therefore, its upregulation on mature DCs may indicate DCs in inflamed or infected tissue are 
able to more efficiently internalise HIV. Similarly, Siglec-1 has been shown to bind HIV 
(Izquierdo-Useros et al., 2012; Pino et al., 2015; Puryear et al., 2013; Rempel et al., 2008; 
Zou et al., 2011), and was upregulated on mature epidermal DCs, but downregulated on 
mature dermal DCs. As such, in inflamed skin, epidermal subsets may be more permissive to 
HIV infection, while the opposite may be seen with dermal DCs. More commonly observed 
was the downregulation of surface expression with maturation, and therefore decreased 
susceptibility to associated pathogens. As with Siglec-1, decreased expression of CLEC4A 
(Lambert et al., 2011; Lambert et al., 2008), CLEC4M (Snyder et al., 2005) and CLEC13D/MR 
(Fanibunda et al., 2011; Lai et al., 2009a; Nguyen and Hildreth, 2003; Trujillo et al., 2007) may 
be associated with decreased HIV binding. Decreased CLEC4M expression with maturation 
may also result in impaired interactions with HCV (Gardner et al., 2003), SARS (Jeffers et al., 
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2004; Marzi et al., 2004) and filoviruses (Marzi et al., 2004; Marzi et al., 2007), and decreased 
CLEC13D/MR expression may also impair interactions with HBV (Op den Brouw et al., 2009), 
dengue virus (Miller et al., 2008), mycobacteria (Kang et al., 2005), fungi (Cambi et al., 2008; 
Tachado et al., 2007; Zhang et al., 2004) and parasites (Kooij et al., 2015). CLEC4E has been 
shown to bind C. albicans (Bugarcic et al., 2008; Vijayan et al., 2012) and M. tuberculosis 
(Furukawa et al., 2013; Yamasaki et al., 2009), and as such interactions with these may be 
impaired on mature DCs. Unlike the other markers which were downregulated but remained 
detectable, CLEC6A expression decreased below detectable levels on mature cells; therefore, 
recognition of fungi (Saijo et al., 2010; Sato et al., 2006), mycobacteria (Yonekawa et al., 
2014) and house dust mite allergens (Barrett et al., 2009) on mature CD1a+Langerin- DCs 
through this receptor may be ablated. Decreased expression on mature subsets may have 
significant implications on the ability of cells in infected and/or inflamed skin to be able to 
detect and interact with pathogens, and therefore should be a consideration for DC-based 
vaccines administered at inflamed sites. Furthermore, this again highlights how the use of 
crawl-out cells could grossly misrepresent how mononuclear phagocytes interact with 
pathogens in vivo. 
 
5.3.5. HIV entry receptor expression 
Multiple skin mononuclear phagocytes express HIV entry receptors, and as such may 
be permissive to HIV infection. Excluding CD1a+Langerin+ epidermal DCs, all skin 
mononuclear phagocytes expressed CD4. CD4 expression was lower on skin subsets than in 
vitro MDMs and MDDCs, which may be due to enzymatic cleavage and could render them 
less permissive to HIV infection after isolation than the in vitro subsets. Expression of CCR5 
on ex vivo subsets, or lack thereof, indicates that excluding CD141+ DCs, dermal DCs are 
more permissive to infection with R5 HIV than macrophages, and in the epidermis only the 
CD1a+Langerin- DCs may be productively infected. Furthermore, lack of CXCR4 expression 
may render all subsets resistant to infection with X4 HIV. The converse may be true for mature 
DCs, which downregulated CCR5 below the level of detection and upregulated CXCR4. 
Therefore, in healthy skin, cells are more susceptible to infection with the more commonly 
transmitted HIV strain, R5, while in the presence of inflammation or a secondary infection, 
cells may be more susceptible to infection with X4 HIV. 
 
5.3.6. DC-mediated transfer of HIV to CD4+ T cells 
DCs reside throughout the skin in close proximity to the ultimate HIV target cell, CD4+ 
T cells (Clark, 2015; Heath and Carbone, 2013; Wang et al., 2014), which together with their 
superior ability to activate T cells marks them as a cell of interest in the investigation of HIV 
Chapter 5: Skin mononuclear phagocyte pathogen recognition Rachel Botting 
                  receptor expression and their ability to transfer HIV 
196 
 
transmission in tissue. As shown previously by the host lab, both MDDCs (Harman et al., 2009; 
Turville et al., 2004) and epidermal DCs (Nasr et al., 2014) transfer HIV to T cells in two 
phases. In order to compare these results with the ability of dermal mononuclear phagocytes 
in mediating HIV transfer to CD4+ T cells, the same epidermal gating strategy was used (Nasr 
et al., 2014). As such, the epidermal DCs were a mixture of all CD1a-expressing cells, and 
thus the transfer assay results may be confounded by the mixed population. As shown by Nasr 
et al., the mixed epidermal population was able to mediate both phases of transfer. The first 
phase of transfer could be mediated by various HIV-binding CLRs, as such all three 
populations could potentially contribute to the mediation of this first phase of transfer. The 
langerin+ epidermal subsets may be transferring HIV after binding to langerin, supported by 
the inhibition of first phase transfer after blocking with soluble langerin (Nasr et al., 2014). 
However, the CD1a+Langerin- epidermal DCs expressed the widest range of CLRs, similar to 
CD1a+ dermal DCs, including MR which is known to bind HIV. Therefore, these too may 
significantly contribute to first phase transfer. CD1a+Langerin- DCs were also the only 
epidermal subset that expressed the HIV entry receptors required for productive replication, 
which suggests that these cells are the main contributor for the second phase transfer 
observed. Also, binding to langerin has been shown to promote degradation of HIV (de Witte 
et al., 2007), which further suggests the langerin+ subsets play a minor role in second phase 
transfer. Similar to first phase, blocking with soluble langerin also inhibited the second phase 
of transfer, which may indicate that langerin can serve as an entry receptor, or blocking may 
have resulted in steric hindrance inhibiting optimal binding to the HIV entry receptors. Each 
epidermal subset will therefore now need to be investigated separately in future; however, this 
may be difficult due to the low frequency of the novel epidermal subsets. 
 CLR and Siglec expression differs significantly across dermal mononuclear phagocyte 
subsets, which may influence their ability to transfer HIV in the first phase. CD1a+ DCs and 
CD14+ (autofluorescent and non-autofluorescent) cells transferred virus within 24 hours of 
infection. High level of transfer within 2 hours of infection implies that first phase transfer from 
occurs at the site of infection. This may be further enhanced in the case of inflammation or 
secondary infection in which large numbers of CD4+ T cells have infiltrated (Bebell et al., 2008; 
Clark, 2015; Masson et al., 2015; Shey et al., 2016). CD1a+ DCs were most efficient at first 
phase transfer in 4/6 experiments, and were more consistent in their kinetic profile across 
experiments than CD14+ cells (Figure 5.9). At the time of these experiments, non-
autofluorescent CD14+ cells were not known to be a mixed population, as such it will be 
important to investigate MDMs and CD14+ DCs as separate subsets. Similarly, the ability of 
Langerin+ DDCs to transfer HIV is of interest, especially due to the evidence of HIV interaction 
with langerin (de Jong et al., 2010a; de Witte et al., 2007; Nasr et al., 2014). Due to the difficulty 
in obtaining cell numbers sufficient for investigating CD141+ DCs, they were only successfully 
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included once and at a single timepoint, for which no transfer was observed. This needs to be 
repeated, and second phase transfer also needs to be investigated. Lack of first phase transfer 
may be because fewer HIV-binding CLRs are expressed on this subset, and adds further 
evidence to suggest they play a minor role in pathogen detection. The differences in surface 
expression and first phase transfer between subsets indicates that development of an effective 
microbicide to HIV may require the inclusion of blocking agents to multiple surface receptors 
to cover all the subsets and probable redundancy of surface molecules. 
 The host lab has shown that infected MDDCs have enhanced migratory capacity 
(Harman et al., 2006); therefore, unlike first phase transfer, second phase transfer may occur 
in the lymph nodes rather than the site of infection. This phenomenon may be enhanced by 
secondary infection or inflammation may drive the maturation process and migratory capacity 
of these cells. Second phase transfer of HIV from ex vivo mononuclear phagocytes to T cells 
was far more restricted than observed during first phase. Similar to epidermal DCs, CD1a+ 
DCs and CD14+ cells expressed CD4 and CCR5; however only CD1a+ DCs were observed 
to transfer HIV in both phases. This may indicate that CD14+ cells express higher levels of 
restriction factors, such as SAMHD1 and APOBEC3, which are known to be expressed in 
myeloid cells and inhibit replication of HIV-1 (Malim and Bieniasz, 2012; McLaren et al., 2015; 
Peng et al., 2007). This explains why replication of HIV in DCs and macrophages is far less 
efficient than CD4+ T cells. Reported restriction factors should therefore be investigated by 
QPCR. Furthermore, viability of the cells in culture may be a contributing factor. Future 
investigation of the ability to transfer virus in the second phase will require optimisation of the 
culture conditions in order to ensure maximum cell viability. Infection also needs to be 
confirmed by PCR, which is far more sensitive.  
Unlike CD1a+ DCs and CD14+ cells, CD141+ DCs have so far only been investigated for 
first phase transfer due to low cell numbers; however, they do not express CCR5 and are 
therefore not likely to transfer virus in the second phase. Despite lacking CCR5, 
autofluorescent macrophages were observed to transfer HIV in second phase (Figure 5.9.C), 
which indicates they were productively infected; however, this was only seen once and needs 
to be repeated. Unlike DCs, macrophages remain within the tissue and as such, second phase 
transfer by these cells may indicate they contribute to persistent transfer as the site of 
infection. Similar to macrophages, mature epidermal DCs and CD1a+ DCs isolated by the 
crawl-out method that lacked CCR5 were able to transfer HIV in two phases, indicative of 
replicative infection. This may suggest that although CCR5 was below the level of detection, 
enough was retained on the surface to allow HIV entry. It may also indicate that other CLRs 
and/or Siglecs may act as co-receptors for HIV entry. Although transfer was observed in cells 
isolated by the crawl-out method, it is unknown how relevant these cells are as a model of 
infection. Crawl-out DCs resemble those most likely found in or en route to the lymph nodes, 
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and therefore are not likely to be present as the site of infection. Furthermore, just as skin 
mononuclear subsets differ from in vitro MDMs and MDDCs, it important to determine whether 
the subsets found in skin differ from those in the anogenital tract where the majority of HIV 
transmission occurs. 
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6.1. Introduction 
The skin and mucosae form the first line of defence against the external environment 
and potential pathogens. They form a physical and biochemical barrier, and also contain 
various immune cell types to detect incoming pathogens and mediate an appropriate immune 
response, including tolerance. The function of each surface is reflected in its structure. Skin 
consists of a keratinised, stratified squamous epithelium (epidermis) and underlying dermis 
(Marieb and Hoehn, 2007b; Nestle et al., 2009; Porth, 2007). The multi-layered epidermis is 
resistant to water loss and mechanical damage (Feingold, 2012; Marieb and Hoehn, 2007b; 
Storm and Elder, 2008), which is essential for the outer covering of the body. Mucosal surfaces 
line cavities that are exposed to the external environment, and are covered in a layer of 
mucous and classified as either type I or type II mucosa (Iwasaki, 2007). Similar to skin, type 
II mucosa functions as a physical barrier and therefore contains a stratified squamous 
epithelium (Iwasaki, 2010); however, it lacks the same level of keratinisation as skin (Hladik 
and McElrath, 2008). Type I mucosa consists of a monolayer epithelium that is optimal for 
absorption, excretion and respiration (Iwasaki, 2007). Both mucosa types are underlain with 
lamina propria. 
Mononuclear phagocytes reside in skin and mucosa, where one of their main functions 
is to detect invading pathogens. In the epithelial layer, a single subset called an LC, has been 
reported, which is observed in both skin (Nestle et al., 2009; Romani et al., 2012) and type II 
mucosa (Duluc et al., 2014; Gervaz et al., 1995; Pudney et al., 2005; Shen et al., 2014). The 
dermis in abdominal skin contains CD141+ DCs, CD1a+ DCs, Langerin+ DCs, CD14+ DCs, 
and two subsets of macrophages (Haniffa et al., 2015b). Less is known about the subsets that 
reside in the lamina propria underlying mucosal surfaces, especially in regards to the recently 
identified Langerin+ dermal DC and monocyte-derived macrophage subsets. This represents 
a critical gap in our knowledge, especially in the anogenital tract that is exposed to sexually 
transmitted pathogens which interact with these cells.  
The anogenital tract consists of multiple sites and surfaces, each of which presents a 
unique barrier against sexually transmitted pathogens. Surfaces transition from skin at the 
external orifices, to type II mucosa and finally type I mucosa, as illustrated in Figure 6.1. for 
the anorectal tract. In the anorectal tract, the anal verge in lined with skin, that transitions to 
type II mucosa in the anal canal, and then to type I mucosa at the anal transitional zone leading 
into the rectum (Iwasaki, 2010). Similarly, in the female genital tract, skin transitions to type II 
mucosa from the labia to vagina, and to type I mucosa from the ectocervix to endocervix 
(Ildgruben et al., 2003; Iwasaki, 2010; Marieb and Hoehn, 2007c; Pudney et al., 2005; 
Sabiston and Townsend, 2012). Finally, in the male genital tract, the foreskin, glans and shaft 
are covered with skin, which at the opening to the glans urethra (fossa navicularis) transitions 
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to type II and then type I mucosa of the penile urethra (Dinh et al., 2015; Ganor and Bomsel, 
2011; Ganor et al., 2013; Iwasaki, 2010; Marieb and Hoehn, 2007c). The different epithelial 
surfaces across each tract may render different sites more or less susceptible to invading 
pathogens. 
Important for homeostasis in the anogenital tracts is the balance between tolerance 
and protection against the multitude of immunogenic stimuli, most of which is encountered 
during normal function (reproduction and excretion). Determining which mononuclear 
phagocytes are present and predominant in each site may be key to understanding the 
pathogenesis of these infections, including HIV and HSV. Specifically, understanding how they 
are detected, and how they then manipulate mononuclear phagocytes to aid their 
transmission. This has significant implications for the development of novel strategies to treat 
and prevent these and other sexually transmitted infections. 
Today, HIV transmissions occurs almost exclusively via sexual intercourse (McGregor 
et al., 2015; UNAIDS, 2015), which requires HIV to cross skin and mucosal surfaces of the 
anogenital tracts, and interact with the immune subsets that reside within them (Royce et al., 
1997; Shattock and Moore, 2003). The skin and type II mucosa are most commonly studied, 
and HIV penetration and infection across these surfaces has been demonstrated in human ex 
vivo genital tissue explants from the vagina (Hladik et al., 2007; Maher et al., 2005), ectocervix 
(Maher et al., 2005) and foreskin (Ganor et al., 2010). Little is known about transmission 
across the anus, which is likely to be more efficient. This is because the anus is more 
susceptible to mechanical abrasions as it lacks natural lubrication (Marieb and Hoehn, 2007a) 
(unlike the vagina (Lai et al., 2009b)) and the external anal sphincter restricts the flexibility of 
the tissue (Mahadevan, 2014; Marieb and Hoehn, 2007a).  
LCs have been shown to play a critical role in HIV penetration and infection, and in the 
inner foreskin have been shown to transfer HIV to T cells within 1 hour of exposure (Ganor et 
al., 2010), and in vagina within 15 minutes (Shen et al., 2014). Far less is known about what 
role dermal and/or lamina propria DCs may play in the sexual transmission of HIV. Most 
studies use DC-SIGN as a DC marker (Cavarelli et al., 2013; Jameson et al., 2002; Liu et al., 
2014), which is also known to bind HIV (Geijtenbeek and van Kooyk, 2003; Gringhuis et al., 
2009a; Gringhuis et al., 2010; Pöhlmann et al., 2001a), although as established in Chapter 5, 
it is predominantly a macrophages marker. DC-SIGN+ cells have been observed in foreskin 
(Hirbod et al., 2010), vagina (Jameson et al., 2002) and cervix (Hirbod et al., 2011; Hirbod et 
al., 2009), and may enhance HIV transmission at these sites. Furthermore, DC-SIGN+ cells in 
the colon have been observed to extend processes into the lumen to capture virus (Cavarelli 
et al., 2013), and in the rectal mucosa bind and transfer virus (Gurney et al., 2005). Therefore, 
the interaction between HIV and mononuclear phagocytes in anogenital tissue could be a 
critical target for prevention strategies.  
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As well as understanding which pathogens are detected by mononuclear phagocytes, 
it is important to determine how pathogens manipulate mononuclear phagocytes to aid survival 
and transmission. Two examples are HIV and HSV, which have evolved different mechanisms 
to evade destruction and enhance transmission by mononuclear phagocytes. HIV has been 
shown to evade lysosomal destruction by DCs (Harman et al., 2009), and simultaneously 
promote their migration to lymph nodes (Harman et al., 2006). Furthermore, HIV to T cell 
interactions are enhanced (Harman et al., 2006; Mercier et al., 2013), allowing more efficient 
transfer of virus to their primary target, CD4+ T cells. The converse is seen for HSV, which 
inhibits DC and T cell interactions by downregulation of co-stimulatory markers (Bosnjak et 
al., 2005). Identifying which mononuclear phagocytes play a role in this, and how the viruses 
manipulate them, is crucial to developing effective prevention strategies. 
A recent study by the host lab revealed HSV is transported through DCs in the skin by 
a relay system (Kim et al., 2015). Specifically, LCs infected with HSV undergo apoptosis and 
migrate into the dermis where they are subsequently taken up by dermal CD141+ DCs and 
DC-SIGN+ cells for antigen presentation (Kim et al., 2015). This highlights the importance of 
identifying which mononuclear phagocyte subsets reside in each site, as effective protection 
against invading pathogens may rely on multiple subsets working together. Therefore, 
mononuclear phagocytes represent a key target for strategies aiming to prevent sexually 
transmitted infections. It was the aim of this chapter to determine which mononuclear 
phagocyte subsets reside in the various tissues HIV may encounter during sexual 
transmission, and how this relates to the susceptibility of each tissue to HIV infection based 
on the efficiencies of transfer by specific subsets observed in Chapter 5.
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Figure 6.1. Tissue composition of the anorectal tract. A schematic (left) and photographic (right) illustration of the anorectal tract is shown 
with the different skin and mucosal surfaces outlined. The anal verge is comprised of skin, which contains a keratinised, stratified epithelium. The 
anal canal is comprised of a type II mucosal surface containing a non-keratinised, stratified squamous epithelium. The rectum is comprised of a 
type I mucosal surface containing a columnar epithelium. Each of these surfaces are also present in the female and male genital tracts.
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6.2. Results 
6.2.1. Anogenital tissue sources 
The various surfaces of the male and female anogenital tracts represent unique 
barriers and opportunities for transmission of invading pathogens. In order to investigate which 
mononuclear phagocyte subsets reside in each specific tissue, a wide range of specimens 
composed of different surfaces (Table 6.1.) were obtained after surgical removal (Figure 6.2.). 
Labia minora (hereafter referred to as labia) and vaginal specimens were obtained from 
healthy individuals undergoing cosmetic surgery. Healthy adult foreskins were obtained after 
circumcision, while healthy glans, shaft, urethra and fossa navicularis were obtained from sex 
reassignment surgery. Rectum, anal canal and anal verge were obtained during cancer or 
haemorrhoid removal. In the case of cancer, the specimens obtained were those outside the 
border of cancerous tissue. Note that cervical tissue was not included in this study as the host 
laboratory has yet to source this tissue. Skin and type II mucosal tissues were treated with 
dispase to separate the epithelial layer from the underlying dermis/lamina propria prior to 
collagenase digestion (summarised in Table 6.1.). Type I mucosal tissues were only digested 
with collagenase to isolate cells.  
 
6.2.2. Identification of novel anogenital epidermal DC subsets 
 Skin and type II mucosa contain a stratified squamous epithelium that can be 
separated from the underlying dermis/lamina propria. The epithelial layer from labia, vagina, 
inner and outer foreskin, and penile glans and shaft skin were therefore investigated for the 
presence of LCs and the novel epidermal subsets that were observed in abdominal skin, as 
described in Chapter 2. The subsets were distinguished as per abdominal skin epidermis 
(Figure 6.3.), and three subsets were observed that expressed differential levels of CD11c 
and CD4, consistent with the abdominal subsets. A summary of which subsets were present 
in each site, and the number of times they were observed is presented in Table 6.2. Similar 
to labia, all three subsets were observed in inner and outer foreskin, glans and shaft skin. 
However, the CD1a+Langerin+ epidermal DCs in the shaft and glans expressed CD4 (Figure 
6.4.), unlike those observed in other tissues. The vagina was only observed to contain two 
epidermal subsets that were split based on langerin expression, both of which expressed CD4 
(Figure 6.5.). However, the vagina had only successfully been peeled once, and therefore this 
observation needs to be repeated.  
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Table 6.1. Anogenital tissues investigated 
Tissue Surface Dispase 
(Y/N) 
Labia minora Skin/Type II mucosa Y 
Vagina Type II mucosa Y 
Outer Foreskin Skin Y 
Inner Foreskin Skin/Type II mucosa Y 
Penis Shaft Skin Y 
Glans Skin Y 
Fossa navicularis Type II mucosa Y 
Urethra Type I mucosa N 
Anal verge Skin  Y 
Anal canal Type II mucosa  Y 
Rectum Type I mucosa N 
 
 
 
Table 6.2. Epidermal subsets in anogenital epithelium 
Tissue LC CD1a+ 
Langerin- 
CD1a+ 
Langerin+ 
Labia n = 8 n = 8 n = 3 
Vagina n = 2  n = 1* - 
Outer Foreskin n = 4 n = 3 n = 1 
Inner Foreskin n = 4 n = 3 n = 1 
Penis Shaft n = 2 n = 2 n = 2 
Glans n = 2 n = 2 n = 2 
Fossa navicularis  n = 1# - - 
* See Figure 6.5. ;  # See Figure 6.6.
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Figure 6.2. Human anogenital tissues. Displayed are the array of anogenital tissues investigated throughout this chapter. Female genital tissues 
(A): labia minora (left) and vagina (right). Male urogenital tissues (B): Foreskin top left), penis shaft skin (top middle), glans (top right), fossa 
navicularis (bottom left; marked with dotted lines), and penile urethra (bottom right; dotted line marks incision site). Anorectal tract (C): rectum 
(left) and anal canal (right). 
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Figure 6.3. Epidermal populations isolated from labia. Cells isolated by collagenase digestion of epidermis from the labia were stained with 
live/dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, langerin Vioblue, CD4 BUV496 and CD11c APC. Epidermal DCs were gated within 
live, single cells based on HLA-DR, CD45, CD1a and langerin expression (A). CD1a+langerin+ cells (grey) were identified within the HLA-
DRlowCD45low population. Within the HLA-DR+CD45+ population, Langerhans cells (LCs; teal) were defined as the CD1a++langerin+ population 
and a CD1a + langerin- population (navy) also identified. A representative dot plot of all three populations overlayed on CD1a versus langerin 
(B) and CD11c (D; left), and representative histograms of the relative expression of CD4 (C) and CD11c (D; right) are displayed. n = 3. 
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Figure 6.4. CD4 expression on epidermal subsets from labia and penis. Cells isolated by 
collagenase digestion of epidermis from the labia (A), penis shaft (B) and glans (C) were 
stained with live/dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, langerin Vioblue, 
CD4 BUV496 and CD11c APC. Epidermal DCs were gated within live, single cells based on 
HLA-DR, CD45, CD1a and langerin expression. A histogram of the relative expression of CD4 
on LCs (teal), CD1a+Langerin- DCs (navy) and CD1a+langerin+ DCs (grey) is displayed. 
Labia; n = 3. Shaft; n = 2. Glans; n = 3. 
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Figure 6.5. Vagina epidermal DC populations. Cells isolated by collagenase digestion of 
epidermis from the vagina were stained with live/dead NIR, HLA-DR BUV395, CD45 BV786, 
CD1a BV510, langerin Vioblue, CD4 BUV496 and CD11c APC. Epidermal DCs were gated 
within live, single cells based on HLA-DR, CD45, CD1a and langerin expression. Within the 
HLA-DR+CD45+ population, Langerhans cells (LCs; teal) were defined as the CD1a++langerin+ 
population and a CD1a + langerin- population (navy) also identified (A). A histogram of the 
relative expression of CD4 on the epidermal populations and isotype (clear) is displayed (B). 
n =1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6. Penile fossa navicularis Langerhans cells. Cells isolated by collagenase 
digestion of the penile fossa navicularis were stained with live/dead NIR, HLA-DR BUV395, 
CD45 BV786, CD1a BV510, CD14 BUV737, CD141 BV711, CD1c PE.Vio770, langerin 
Vioblue, CD4 BUV496 and CD11c APC. LCs (teal) were defined as the CD1a++langerin+ 
population within the live, single, HLA-DR+CD14+autofluorescent-CD141-CD1a++ population 
(A). A histogram of CD11c expression on LCs compared the dermal CD1a+ DCs (blue) and 
CD1a+langerin+ dermal DCs (dark blue) is displayed (B).  
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The anal canal and anal verge also contain a stratified squamous epithelial layer, but 
separation from the lamina propria was unsuccessful. Similarly, the penile fossa navicularis 
epithelial layer was not separated from the underlying lamina propria, but a CD1ahighCD11clow 
population consistent with an LC was observed within the cells isolated from the whole 
specimen (Figure 6.6.). 
 
6.2.3. Anogenital tissues are enriched for CD141+ DCs 
 Mononuclear phagocyte subsets were classified based on the gating strategy in 
Chapter 5 (Figure 5.1.). Therefore, CD141+ DCs were defined as the non-autofluorescent 
CD141+CD14- population, and were observed in all anogenital tissues (Figure 6.7.A). 
Furthermore, CD141+ DCs tended to be present at a higher frequency in anogenital tissues 
compared to abdomen, excluding the fossa navicularis and anal verge; however, the percent 
in vagina, urethra and anal canal did not reach statistical significance (Figure 6.7.B). Unlike 
abdomen, CD141 was also expressed at notable levels on the non-autofluorescent CD14+ 
population in the shaft, glans, fossa navicularis and rectum. 
 See Figure 6.13. for an overview of the frequency of each mononuclear phagocyte 
subset within HLA-DR+CD45+ population from each tissue. 
 
6.2.4. Abdominal skin is enriched for CD1a+ DCs, but contains fewer Langerin+ 
dermal DCs 
 Similar to CD141+ DCs, the presence and frequency of CD1a+ and Langerin+ 
dermal/lamina propria DCs were investigated in the anogenital tissues. The subsets were 
defined within the CD1a+ population (Figure 6.8.A) for all tissues, excluding vagina and 
rectum in which no CD1a+ cells were observed (Figure 6.8.B). CD1a+ DCs and Langerin+ 
dermal DCs were observed in all other tissues (Figure 6.8.C), and the frequency of each 
subset was determined. Abdominal skin contained more than double the frequency of CD1a+ 
DCs than any other tissue investigated (Figure 6.8.D), but a much lower frequency of 
Langerin+ dermal DCs (Figure 6.8.E). Labia, foreskin, glans and shaft dermis were observed 
to contain 5 – 10 times more CD1a+ DCs than the anal verge, and type I and type II mucosae, 
but only the frequency in labia and outer foreskin reached statistical significance. Langerin+ 
dermal/lamina propria DCs were 2 times more frequent (Figure 6.8.E) and represented a 
significantly higher proportion of CD1a+ cells (Figure 6.8.F) in anogenital skin than abdominal 
skin. Similarly, the anal verge, and type I and type II mucosal surfaces contained half the 
number of Langerin+ dermal/lamina propria DCs than anogenital skin, but due to the low 
frequency of CD1a+ DCs, this represented a higher proportion of the CD1a+ cells than in 
anogenital skin. 
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Figure 6.7. Frequency of CD141+ DCs isolated from abdomen and anogenital tissues. 
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Figure 6.7. Frequency of CD141+ DCs isolated from abdomen and anogenital tissues. 
Cells were isolated by collagenase digestion of anal verge, anal canal, the dermis from 
abdomen, labia, outer and inner foreskin, glans and shaft skin, and lamina propria of the 
vagina, penile fossa navicularis, urethra, and rectum. Cells were stained with Live/Dead NIR, 
HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 BV711, langerin 
Vioblue, CD1c PE.Vio770, and CD11c APC, and run on the BDFortessa flow cytometer. 
CD141+ DCs were defined according to the gating strategy in Figure 5.1., and a 
representative plot from each tissue with the mean percent frequency of the CD45+HLA-DR+ 
displayed (A). The frequency of CD141+ DCs was determined as a percentage of the 
CD45+HLA-DR+ population and plotted as mean +/- standard deviation (B). Statistics were 
generated using the Kruskal-Wallis test and Dunn’s multiple comparison post hoc test. * 
p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001; x: n < 3, therefore omitted from statistical 
analysis. Abdomen n = 21; Labia n = 11; Vagina n = 9; Outer foreskin n = 7; Inner foreskin n 
= 7; Shaft n = 3; Glans n = 3; Fossa navicularis n = 3; Urethra n = 3; Anal verge n = 1; Anal 
canal n = 7; Rectum n = 9. 
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Figure 6.8. Frequency of CD1a+ DCs and CD1a+langerin+ DDCs isolated from abdomen 
and anogenital tissues. Cells were isolated by collagenase digestion of anal verge, anal 
canal, the dermis from abdomen, labia, outer and inner foreskin, glans and shaft skin, and 
lamina propria of the vagina, penile fossa navicularis, urethra, and rectum. Cells were stained 
with Live/Dead NIR, HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 
BV711, langerin Vioblue, CD1c PE.Vio770, and CD11c APC, and run on the BDFortessa flow 
cytometer. CD1a+ cells were defined according to the gating strategy in Figure 5.1., and a 
representative plot from abdomen (A), vagina (B; left) and rectum (B; right) displayed. CD1a+ 
cells were further split into langerin- CD1a+ DCs (blue) and CD1a+langerin+ dermal DCs 
(dark blue) (A), and a representative plot from each tissue with the mean percent frequency 
of CD45+HLA-DR+ population displayed (C). The frequency of CD1a+ DCs (D) and 
CD1a+langerin+ DDCs (E) was determined as a percentage of the CD45+HLA-DR+ population 
and plotted as mean +/- standard deviation. The ratio of CD1a+langerin+ DDCs to CD1a+ 
DCs was determined for each tissue and expressed as mean +/- standard deviation (F). 
Statistics were generated using the Kruskal-Wallis test and Dunn’s multiple comparison post 
hoc test. * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001; x: n < 3, therefore omitted from 
statistical analysis.  #:   ratio could not be determined due to lack of CD1a+ DCs and/or 
CD1a+langerin+ DDCs. Abdomen n = 15; Labia n = 12; Vagina n = 10; Outer foreskin n = 4; 
Inner foreskin n = 3; Shaft n = 3; Glans n = 3; Fossa navicularis n = 3; Urethra n = 3; Anal 
verge n = 1; Anal canal n = 3; Rectum n = 9. 
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Figure 6.9. Frequency of macrophages isolated from abdomen and anogenital tissues.
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Figure 6.9. Frequency of macrophages isolated from abdomen and anogenital tissues. 
Cells were isolated by collagenase digestion of anal verge, anal canal, the dermis from 
abdomen, labia, outer and inner foreskin, glans and shaft skin, and lamina propria of the 
vagina, penile fossa navicularis, urethra, and rectum. Cells were stained with Live/Dead NIR, 
HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 BV711, langerin 
Vioblue, CD1c PE.Vio770, and CD11c APC, and run on the BDFortessa flow cytometer. The 
macrophage population was defined according to the gating strategy in Figure 5.1., and a 
representative plot from each tissue with the mean percent frequency of the CD45+HLA-DR+ 
displayed (A). The frequency of macrophages was determined as a percentage of the 
CD45+HLA-DR+ population and plotted as mean +/- standard deviation (B). Statistics were 
generated using the Kruskal-Wallis test and Dunn’s multiple comparison post hoc test. * 
p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001; x: n < 3, therefore omitted from statistical 
analysis. Abdomen n = 23; Labia n = 12; Vagina n = 7; Outer foreskin n = 7; Inner foreskin n 
= 7; Shaft n = 3; Glans n = 3; Fossa navicularis n = 3; Urethra n = 3; Anal verge n = 1; Anal 
canal n = 5; Rectum n = 9. 
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Figure 6.10. Frequency of MDMs and CD14+ DCs isolated from abdomen and anogenital 
tissues. 
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tissues. 
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Figure 6.10. Frequency of MDMs and CD14+ DCs isolated from abdomen and anogenital 
tissues. Cells were isolated by collagenase digestion of anal verge, anal canal, the dermis 
from abdomen, labia, outer and inner foreskin, glans and shaft skin, and lamina propria of the 
vagina, penile fossa navicularis, urethra, and rectum. Cells were stained with Live/Dead NIR, 
HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 BV711, langerin 
Vioblue, CD1c PE.Vio770, and CD11c APC, and run on the BDFortessa flow cytometer. 
CD14+ cells were defined according to the gating strategy in Figure 5.1., and a representative 
plot from abdomen of the split into CD1c- monocyte-derived macrophages (MDMs; red) and 
CD1c+ CD14+ DCs (orange) displayed (A). A representative plot from each tissue with the 
mean percent frequency of CD45+HLA-DR+ population displayed (B). The frequency of CD14+ 
DCs (C) and MDMs (D) was determined as a percentage of the CD45+HLA-DR+ population 
and plotted as mean +/- standard deviation. The ratio of MDMs to CD14+ DCs was determined 
for each tissue and expressed as mean +/- standard deviation (E). Statistics were generated 
using the Kruskal-Wallis test and Dunn’s multiple comparison post hoc test. * p<0.05; ** 
p<0.01; *** p<0.001; **** p<0.0001; x: n < 3, therefore omitted from statistical analysis. 
Abdomen n = 18; Labia n = 7; Vagina n = 2; Outer foreskin n = 1; Inner foreskin n = 1; Shaft 
n = 3; Glans n = 3; Fossa navicularis n = 3; Urethra n = 3; Anal verge n = 1; Anal canal n = 3; 
Rectum n = 5. 
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6.2.5. Anogenital tissues are enriched for CD14+ cells 
 The CD14+ population was split into three populations based on autofluorescence and 
CD1c expression. Macrophages were classified as the autofluorescent CD14+ population, and 
within the non-autofluorescent CD14+ cells, CD14+ DCs and MDMs were classified as the 
CD1c+ and CD1c- cells respectively (Figure 6.10.A). All three populations were observed in 
all anogenital tissues (Figure 6.10.B and Figure 6.9.A). The highest frequencies of 
autofluorescent macrophages were observed in the penile tissues, excluding the outer 
foreskin (Figure 6.9.B). A similar frequency of CD14+ DCs were observed across all tissues 
(Figure 6.10.C), but MDMs were significantly more frequent in the anorectal tract and penis, 
excluding the shaft skin, compared to abdominal skin (Figure 6.10.D). Furthermore, Type I 
and Type II mucosa contained a higher frequency of MDMs in the CD14+ population (Figure 
6.10.E).  
 
6.2.6. Anogenital tissues are enriched for two potentially novel CD11c+ populations 
 In anogenital tissues, a notably large population of cells was observed that did not 
express the other population-defining markers (CD141, CD14 and CD1a), but did express 
CD11c (Figure 6.11.). This population could be further divided into two populations based on 
CD1c expression, hereafter referred to as CD11c+CD1c+ and CD11c+CD1c- cells. The 
CD11c+CD1c+ population were observed at the same or greater frequency than the 
CD11c+CD1c- population in all tissues (Figure 6.12.A). The abdomen and anal verge 
contained the fewest CD11c+CD1c+ and CD11c+CD1c- cells (Figure 6.12.B and C). The 
highest frequencies of CD1c- cells were observed in Type I and Type II mucosal surfaces, and 
the labia and glans. Similarly, CD1c+ cells comprise the highest proportion of the CD11c+ 
population in the anorectal tract and penis, including the foreskin, but excluding the shaft. 
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Figure 6.11. Novel CD11c+CD1c+ and CD11c+CD1c- populations in dermis. Cells isolated 
by collagenase digestion of dermis/lamina propria were stained with Live/Dead NIR, HLA-DR 
BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 BV711, langerin Vioblue, CD1c 
PE.Vio770, and CD11c APC, and run on a BDFortessa flow cytometer. Within the live, single, 
CD45+HLA-DR+autofluorescent-CD141-CD14-CD1a- population, was a CD11c+ population 
that could be further split into a CD1c- (dark pink) and CD1c+ (pink). A representative gating 
strategy on the dermis of outer foreskin is shown. 
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Figure 6.12. Frequency of CD11c+CD1c+/- cells isolated from abdomen and anogenital 
tissues.  
Chapter 6: Comparison of epidermal, dermal and lamia propria macrophage Rachel Botting 
                  and dendritic cell subsets in human skin and anogenital tissues 
225 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.12. Frequency of CD11c+CD1c+/- cells isolated from abdomen and anogenital 
tissues. 
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Figure 6.12. Frequency of CD11c+CD1c+/- cells isolated from abdomen and anogenital 
tissues. Cells were isolated by collagenase digestion of anal verge, anal canal, the dermis 
from abdomen, labia, outer and inner foreskin, glans and shaft skin, and lamina propria of the 
vagina, penile fossa navicularis, urethra, and rectum. Cells were stained with Live/Dead NIR, 
HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 BV711, langerin 
Vioblue, CD1c PE.Vio770, and CD11c APC, and run on the BDFortessa flow cytometer. 
CD11c+CD1c- cells (dark pink) and CD11c+CD1c+ cells (pink) were gated within the CD1a-
CD14- population according to Figure 6.14. A representative plot from each tissue with the 
mean percent frequency of CD45+HLA-DR+ population displayed (A). The frequency of 
CD11c+CD1c- cells (B) and CD11c+CD1c+ cells (C) was determined as a percentage of the 
CD45+HLA-DR+ population and plotted as mean +/- standard deviation. The ratio of CD1c+ to 
CD1c- CD11c+ cells was determined for each tissue and expressed as mean +/- standard 
deviation (D). Statistics were generated using the Kruskal-Wallis test and Dunn’s multiple 
comparison post hoc test. * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001; x: n < 3, therefore 
omitted from statistical analysis. Abdomen n = 5; Labia n = 1; Vagina n = 1; Outer foreskin n 
= 1; Inner foreskin n = 1; Shaft n = 3; Glans n = 3; Fossa navicularis n = 3; Urethra n = 3; Anal 
verge n = 1; Anal canal n = 3; Rectum n = 2. 
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Figure 6.13. Summary of the macrophage and DC subset frequencies within the 
CD45+HLA-DR+ population isolated from human abdominal and anogenital tissues. 
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Figure 6.13. Summary of the macrophage and DC subset frequencies within the 
CD45+HLA-DR+ population isolated from human abdominal and anogenital tissues. 
Cells were isolated by collagenase digestion of anal verge, anal canal, the dermis from 
abdomen, labia, outer and inner foreskin, glans and shaft skin, and lamina propria of the 
vagina, penile fossa navicularis, urethra, and rectum. Cells were stained with Live/Dead NIR, 
HLA-DR BUV395, CD45 BV786, CD1a BV510, CD14 BUV737, CD141 BV711, langerin 
Vioblue, CD1c PE.Vio770, and CD11c APC, and run on the BDFortessa flow cytometer. The 
frequency of CD141+ DCs (purple), CD1a+ DCs (blue), CD1a+langerin+ dermal DCs (dark 
blue), CD14+ DCs (orange), monocyte-derived macrophages (MDMs; red), macrophages 
(green), CD11c+CD1c+ cells (pink) and CD11c+CD1c- cells (dark pink) was determined as a 
percent of the CD45+HLA-DR+ population. The mean frequencies of each subset within the 
CD45+HLA-DR+ population, including the undefined population (grey), are shown in a 
representative pie chart for each tissue. 
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6.3. Discussion 
 There were approximately 2 million new HIV infections in 2014 alone, almost all of 
which occurred via sexual transmission (UNAIDS, 2015). Furthermore, prior exposure to HSV 
is known to increase HIV acquisition by up to four-fold, even in asymptomatic patients 
(Freeman et al., 2006; Wald and Link, 2002). This highlights the importance of developing 
novel strategies to prevent new infections of both these viruses, which are both known to 
manipulate DC biology to aid their transmission (Harman et al., 2013b; Kim et al., 2015). 
Development of microbicides to block these viruses from interacting with mononuclear 
phagocytes, which could be applied topically to the surfaces of the anogenital tract, is of 
particular interest. Key to developing effective prevention strategies is understanding the 
different surfaces HIV encounters in the anogenital tract, and which cells it interacts with, 
especially DCs. HIV is only one of a number of sexually transmitted infections, which plague 
more than 800 million people worldwide. Determining which mononuclear phagocytes reside 
in the various tissues that make up the anogenital tracts therefore has widespread relevance 
in understanding these infections and how they may be prevented. 
 There is some knowledge on the mononuclear phagocyte subsets that reside in the 
female and male genital tracts, specifically LCs and macrophages, but a lot remains unknown 
regarding dermal/lamina propria DCs, and even less is known about the subsets that reside 
in the anorectal tract (Iijima et al., 2008; Iwasaki, 2010). This represents a critical gap in 
knowledge, especially for HIV transmission, where acquisition via unprotected anal 
intercourse is 10-100 times more efficient than vaginal intercourse (Powers et al., 2008), and 
is by far the most common mode of HIV transmission in western countries (McGregor et al., 
2015). Accordingly, the percentage of both men and women who practice receptive anal 
intercourse has increased over the last 10 years (de Visser et al., 2014), and associated 
condom usage is decreasing (de Visser et al., 2014; McGregor et al., 2015). Given that 
mononuclear phagocyte subsets are key target cells for HIV (Cunningham et al., 2013a; 
Cunningham et al., 2013b; Harman et al., 2013b), the composition of mononuclear phagocyte 
subsets was investigated in the anorectum and genital tract of both sexes; specifically, labia, 
vagina, foreskin, glans, penile shaft and urethra, rectum and anal canal. The cervix is also of 
interest, but it is often damaged during removal and rendered unusable. Furthermore, it is 
difficult to distinguish between the ecto- and endocervix as the squamocolumnar junction can 
be difficult to identify, and has been shown to contain unique subsets (Pudney et al., 2005). 
Therefore, microscopy is probably a more relevant tool to investigate the subsets that reside 
in specific sites of the cervix, and single-cell RNA sequencing an ideal tool to determine the 
range of subsets overall. 
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The genital tissues investigated here were removed for cosmetic purposes, and thus 
were clinically healthy. It will be important in future to confirm this by histology and/or the 
absence of inflammatory markers by QPCR. Anorectal tissues were taken during surgical 
treatment, and despite being separated from clinically abnormal regions, may be affected by 
the diseased state of the tissue. This could not be avoided, as these tissues are not removed 
cosmetically. However, the results are still relevant as they give an indication of the subsets 
that may reside in the anorectum. Furthermore, sexually transmitted infections such as HIV 
often occur in the case of inflammation or a secondary infection, as shown in a recent study 
demonstrating a strong association of genital inflammation and sexual transmission of HIV in 
South African Women (Masson et al., 2015). Therefore, it will be of interest to obtain biopsies 
from inflamed and/or infected anogenital tissues in future to see which mononuclear 
phagocyte subsets are present, and whether they differ from those that reside in a healthy 
state. As well as the mononuclear phagocytes already investigated, it will also be important to 
determine the presence and abundance of pDCs and other immune subsets, including T cells, 
B cells, NK cells and granulocytes in these tissues. 
All epidermal and dermal subsets that were observed in skin from the abdomen, were 
investigated in each of the anogenital tissues obtained using the same flow cytometry gating 
strategy. The epidermis was successfully separated from dermis of anogenital skin (labia, 
foreskin, glans and shaft), and consistent with previous reports (Dinh et al., 2015; Donoval et 
al., 2006; Ganor et al., 2010; Hussain and Lehner, 1995; Liu et al., 2014; McCoombe and 
Short, 2006; Patterson et al., 2002), LCs were observed in each. Furthermore, similar to 
abdominal skin, the two novel epidermal subsets were also observed in each of these sites 
(Table 6.2.). Interestingly however, the CD1a+Langerin+ DCs in the epidermis of the glans 
and shaft expressed CD4, unlike those found in other tissues. Therefore, this subset of cells 
in these sites they may be more permissive to HIV infection. Type II mucosa also contains an 
epidermal layer; however, it was far more difficult to separate from the lamina propria. This 
may be because the basement membrane in these tissues may differ and be less susceptible 
to dispase, or because the tissues were thicker resulting in restricted access of this enzyme. 
LCs were identified in the vagina and fossa navicularis, which was consistent with literature 
(Duluc et al., 2013; Edwards and Morris, 1985; Ganor et al., 2013; Hladik et al., 2007; Hussain 
and Lehner, 1995; Pudney and Anderson, 1995; Pudney et al., 2005; Shen et al., 2014), but 
this has yet to be investigated in the anal canal, as obtaining large enough healthy specimens 
of anal tissue to carry out flow cytometry is very difficult. CD1a+Langerin- DCs were also 
observed in the epidermal layer from vagina; however, this was only in one of two specimens. 
No CD1a+Langerin+ epidermal DCs were observed in type II mucosal tissue, which may 
indicate that the epidermal subsets present in this tissue type differ from those in skin. 
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Figure 6.14. Summary of mononuclear phagocyte subset frequencies in skin, and type I and type II mucosa of human anogenital tissue. 
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Figure 6.14. Summary of mononuclear phagocyte subset frequencies in skin, and type 
I and type II mucosa of human anogenital tissue and abdomen. The mononuclear 
phagocyte subsets observed within the epidermal and dermal/lamina propria for each tissue 
are displayed. The colour of each bar correlates to the same coloured mononuclear phagocyte 
subset, and the size of the bar indicates the frequency of the subset relative to each tissue. 
For example, a level bar indicates no differences between tissues, while the small end of a 
segment points to the tissue with fewer of that subset than the tissue with the wider end. 
Similar to abdominal skin, all three epidermal DC subsets were observed in anogenital skin. 
LCs were also observed in vagina and penile fossal navicularis, but CD1a+Langerin- 
epidermal DCs were only observed in the vagina. CD1a+ DCs were most abundant in 
abdominal skin, and more abundant in skin of the anogenital tissue than type I or type II 
mucosa. Langerin+ dermal DCs were most abundant in anogenital skin, and macrophages, 
CD141+ DCs and CD11c+CD1c+/- cells were more abundant in anogenital tissues than 
abdominal skin. CD14+ DCs were present at the same frequency across all tissues and sites. 
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Due to the difficulty in separating the epidermal layer from the underlying dermis/lamina 
propria, and the difficulty in obtaining specimens, the epidermal data were limited. Therefore, 
more specimens are required to determine whether the frequency of subsets differs between 
tissues. It will also now be important to visualise these subsets in situ by immunofluorescence 
microscopy. 
The HLA-DR+CD45+ population in abdominal dermis differed significantly from 
anogenital skin dermis and mucosal lamina propria in the relative proportions of mononuclear 
phagocyte subsets, as summarised in Figure 6.13 and Figure 6.14. CD141+ DCs were 
observed in all sites, which have previously only been observed in the rectum (Watchmaker 
et al., 2014). Furthermore, they were more abundant in anogenital tissues than abdominal 
skin. Their role as efficient cross-presenters has been utilised for vaccine strategies 
(Caminschi et al., 2009; Caminschi et al., 2008; Crozat and Dalod, 2011), and therefore their 
higher abundance in anogenital tissues may indicate this is a prime site for vaccination against 
pathogens encountered in these sites. 
 Macrophages were present in all anogenital tissues, which is consistent with the 
literature (Anderson et al., 2011; Gervaz et al., 1995; McCoombe and Short, 2006; Patyka et 
al., 2015; Reis Machado et al., 2014; Wira et al., 2005), and were observed to be more 
abundant in these tissues than in abdominal skin. The discovery that macrophages 
predominate over DCs is highly novel as, unlike DCs the role of tissue resident macrophages 
in HIV transmission has yet to be investigated, and therefore represents a key gap in literature. 
Recently however, model MDMs were shown to engulf HIV-infected T cells (Baxter et al., 
2014), and despite the recent discovery that latently infected memory CD4+ T cells are key 
viral reservoirs (Lee and Lichterfeld, 2016), macrophages are still believed to act as an 
important viral reservoir (Waki and Freed, 2010), and they play a significant role in immune 
dysfunction (Kuroda, 2010). Furthermore, macrophages in the vagina, rectum, foreskin, penis 
and urethra have been shown to express CCR5 (Duluc et al., 2014; Ganor et al., 2013; 
McCoombe and Short, 2006; McElrath et al., 2013; Shen et al., 2009), unlike intestinal 
macrophages (McElrath et al., 2013; Shen et al., 2009) or macrophages that reside in 
abdominal skin (as shown in Chapter 5 Figure 5.2.). As such, macrophages in these tissues 
are likely to be more permissive to HIV infection. Therefore, it will be crucial to determine if 
tissue-specific subsets of these cells exist, which CLRs they express, whether they bind and 
take up HIV, and what the subsequent fate of the virus is. It will also be important to repeat 
transfer assays on macrophages from these tissues to determine whether they transfer virus 
to CD4+ T cells.  
DC-SIGN has commonly been used as a marker for DCs in these tissues, which have 
been observed in foreskin (Hirbod et al., 2010; Kim et al., 2015; Soilleux and Coleman, 2004), 
vagina (Jameson et al., 2002), cervix (Jameson et al., 2002; Rivera-Morales et al., 2012) and 
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rectum (Gurney et al., 2005), and shown to interact with HIV (Gurney et al., 2005). DC-SIGN 
expression in abdominal subsets is limited to CD14-expressing cell subsets (autofluorescent 
macrophages, MDMs and CD14+ DCs); therefore, it will be important to determine which of 
these are involved in HIV transmission in the anogenital tracts, and whether DC-SIGN is 
expressed on any of the other dermal DC subsets in these sites. CD14+CD1c+ cells (CD14+ 
DCs), which had previously only been observed in vagina (Duluc et al., 2014), were also 
observed in all tissues; however, unlike macrophages their frequency was independent of site. 
Furthermore, due to the observation that non-autofluorescent CD14+ cells transfer HIV in the 
first phase, it will be critical to determine whether anogenital MDMs and CD14+ DCs transfer 
HIV, and whether this is linked to their CLR profile, which is yet to be determined. 
The most significant difference between abdomen and anogenital tissue was in the 
frequency of CD1a+ DCs, which was two times more abundant in abdominal skin. In turn, 
CD1a+ DCs were generally more abundant in the skin found in anogenital tracts compared 
with type I and type II mucosal tissues. Despite reports in literature (Duluc et al., 2014; Pudney 
et al., 2005), CD1a+ DCs were not observed in the lamina propria of vagina, which will be 
important to confirm by microscopy.  Similarly, CD1a+ DCs were absent from rectal lamina 
propria; however, these and other anogenital tissues contained CD11c+CD1c+ cells, which 
may be the equivalent of CD1a+ DCs that lack CD1a expression, as is seen in the liver (Haniffa 
et al., 2012). This has significant implications for HIV transfer, as CD1a+ DCs were shown to 
be the most efficient subset at transmitting HIV, and they expressed a wide range of CLRs 
and Siglecs known to bind HIV. It will therefore be crucial to investigate the CD11c+CD1c+ 
cells from anogenital tissues to determine how they relate to CD1a+ DCs by transcriptomics, 
expression of HIV entry receptors and CLRs, and whether they transfer virus to T cells and 
are permissive to HIV infection. 
 During normal reproductive and excretory function of anogenital tissues, a multitude of 
immunogenic stimuli are encountered, including commensal pathogens. CD14+ cells in the 
shaft, glans, fossa navicularis and rectum expressed relatively higher levels of CD141 than 
other tissues. This may indicate the cells in these sites are more activated/mature than in the 
abdomen and other anogenital tissues, or that surface expression is influenced by the cytokine 
environment in tissue. Similar to resident memory T cells, which have been shown to have 
specificity for commonly encountered site-dependent pathogens (Clark, 2015; Mackay et al., 
2013; Watanabe et al., 2015), mononuclear phagocytes may also be primed for the pathogens 
they encounter regularly. Importantly, the subsequent response may be tolerance in order to 
prevent a constant and pathogenic activated immune state. Of particular interest is the role 
macrophages may play in this, as they can be divided into pro-inflammatory (M1) and anti-
inflammatory (M2) subsets (Martinez and Gordon, 2014; Varol et al., 2015), and therefore 
have distinct functions. The frequency of these and other mononuclear phagocytes in different 
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anogenital tissues may be influenced by the cytokine environment in each site. Therefore, it 
is important to now investigate what cytokines are present in each tissue, and whether they 
correlate with the distribution of any of the constitutive immune cell subsets. The next step will 
also involve comparing the transcriptome of each subset, independent of surface expression, 
to see how the subsets relate between sites. 
 Importantly, these results show unique repertoires of DC and macrophages subsets at 
different anogenital sites, which differed considerably from abdominal skin, the most 
commonly studied model epithelium. This may have profound implications for the efficiency of 
transmission of HIV and other sexually transmitted pathogens across different anogenital 
tissues. Furthermore, this data forms a base layer of knowledge for rational design of 
microbicides, which perhaps need to be tailored to each anogenital tissue.
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7.1. Overview 
The skin and mucosae cover the body forming the first line of defence against the 
external environment and potential pathogens. Each surface has a structure that reflects its 
function, and each represents a unique barrier and opportunity for invading pathogens. This 
is highlighted by the abundance of resident immune cells in these tissues, many of which are 
present at frequencies far greater than those observed in blood (Clark et al., 2006; Wang et 
al., 2014). Significant for the detection of pathogens are the DCs and macrophages, which are 
professional antigen detectors, destroyers and presenters (Guilliams et al., 2014; Haniffa et 
al., 2015a; Schlitzer et al., 2015). DCs are particularly efficient at antigen presentation to T 
cells, and potent immune stimulators (Haniffa et al., 2015b; Jin et al., 2004; Schlitzer et al., 
2015), which has made them an ideal vehicle for vaccine delivery. It is crucial to determine 
which subsets are present in different tissues and the range of receptors expressed on their 
surface, through which they interact with antigens, to understand what role these cells may 
play in vaccine-induced responses and infectious disease pathogenesis. A particular focus of 
this thesis was the role these cells may play in HIV pathogenesis, which infects more than 2 
million new individuals per year (UNAIDS, 2015). Most transmission occurs as a result of 
sexual intercourse (McGregor et al., 2015; UNAIDS, 2015), and as such, understanding which 
mononuclear phagocytes reside in anogenital tissue, and which HIV-binding receptors they 
express could provide the key to developing new strategies to prevent transmission. 
Furthermore, this could be extended to aid the development of prevention strategies for any 
number of other sexually transmitted pathogens known to interact with DCs and macrophages, 
such as herpes simplex virus (HSV). 
 In order to investigate the role mononuclear phagocytes may play in the sexual 
transmission of HIV, pathogen binding receptor surface expression profiles were determined 
for each known subset, and their relative ability to transfer HIV to CD4+ T cells was studied 
using ex vivo-derived skin subsets. The relative abundance of each subset in specific 
anogenital tissues was then determined. Different methods of isolation were investigated in 
order to do this, and collagenase digestion was found to be superior for isolating all subsets 
in an immature state. Next, a flow cytometry gating strategy for accurate classification of each 
subset was optimised, and subsets isolated by collagenase digestion were compared to those 
isolated by spontaneous migration in terms of the expression of discriminatory surface marker 
expression. This revealed two potentially novel epidermal DC subsets. Pathogen binding 
receptor expression was examined on all mature and immature epidermal and dermal skin 
subsets, and distinct expression patterns were identified between individual ex vivo-derived 
subsets and in vitro-derived model cells. Thus highlighting the need for careful interpretation 
of results obtained from functional assays using the latter models. Furthermore, each subset 
differed in its ability to transfer HIV to T cells, with the CD1a+ dermal DC population proving to 
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be the most efficient. Finally, the relative frequency of each mononuclear phagocyte subset 
was investigated in anogenital tissues, and was found to differ significantly from those in 
abdominal skin. Furthermore, differences were observed in the subset ratios between some 
anogenital tissue types. This highlights a significant gap in the understanding of the biology of 
these tissues and shows that the use of ex vivo subsets derived from abdominal skin may 
have limitations to studying transmission of HIV across anogenital tissues. 
 
7.2. Access to human anogenital tissue 
 A highly innovative aspect of this research was the use of actual human anogenital 
tissues that make up the portals of entry for sexually transmitted infections. No other studies 
have as comprehensively investigated the immune subsets that reside in as wide a range of 
human anogenital tissues. As such, a lot remains unknown about how sexually transmitted 
pathogens interact with the various immune subsets that reside in these sites. The host lab is 
in a unique position to perform these studies, with access to a wide range of anogenital tissues. 
However, access to these specimens did present a limitation, as certain specimens were 
rarely available and limited the subsets that statistical analysis could be applied to. Abdomen, 
labia, vagina and rectum could be obtained multiple times throughout the year, while penis 
and anal specimens could only be obtained once or twice per year due to circumstances 
determining the surgery. The anal verge in particular is very rarely removed due to the severe 
complications associated with removal, and as such only one specimen was obtained within 
the duration of this PhD research. Therefore, the data obtained from these sites is novel and 
adds significantly to the knowledge of immune responses within these tissues. Investigation 
of anogenital tissues revealed the frequency of mononuclear phagocyte subsets differed 
significantly from those observed in abdominal skin. Furthermore, just as in vitro-derived 
MDMs and MDDCs were shown to differ significantly from mononuclear phagocytes isolated 
from skin, abdominal subsets may also differ significantly from those that reside in the 
anogenital tracts. Transcriptomic, functional and phenotypic comparisons will therefore be 
crucial to determine how similar these subsets are to those in abdomen. This has significant 
implications for whether mononuclear phagocytes from abdominal skin provide a suitable 
model for those present in anogenital tissues, especially as abdominal skin is easier to obtain, 
and generally the cell yield is higher. Therefore, functional assays to investigate how sexually 
transmitted pathogens interact with mononuclear phagocytes that may otherwise have been 
impossible, may become a reality. 
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7.3. Isolation and classification of mononuclear phagocytes has significant 
implications on function 
 Across the literature, multiple isolation techniques and classification strategies are 
used for the identification of tissue mononuclear phagocytes (Haniffa et al., 2015b). Unlike in 
blood, tissue mononuclear phagocyte subsets have overlapping expression of key 
discriminating surface molecules, which is further complicated by the influence of the isolation 
method. Ultimately this has led to inconsistencies and confusion in the literature in regard to 
the subsets present and their function, which is most apparent in the study of tissue CD141+ 
DCs. Chu et al. investigated CD141+ DCs after spontaneous migration and showed they were 
the main producers of IL-10 (Chu et al., 2012), while the converse was reported by Haniffa et 
al. using cells isolated by collagenase digestion (Haniffa et al., 2012). Results from this thesis 
have shown that CD141+ DCs cannot be confidently identified using the crawl-out method 
due to the upregulation of CD141 on both CD1a+ DCs and CD14+ cells, which gives credence 
to the functional observations made by Haniffa et al. Furthermore, the findings of this study 
highlight the importance of using the appropriate isolation method of ex vivo tissue DCs for 
the functional assays that will be performed. Collagenase digestion liberates cells in an 
immature phenotype closely resembling the state they are in in tissue when they encounter 
pathogens. Therefore, this method should be used to liberate cells used for the determination 
of pathogen binding receptor expression, and for pathogen binding and processing assays. 
Conversely, the spontaneous migration (or crawl-out) method liberates mature cells that are 
more phenotypical of cells after migration to the lymph nodes. This technique may therefore 
be more suited, for example, to experiments where DCs have been exposed to a stimulus in 
situ and are then collected for analysis of their antigen presentation capacity in vitro. 
 
7.4. Identification of novel epidermal DC subsets 
 Within recent years there have been several additions to the human tissue 
mononuclear phagocyte system, including CD141+ DCs (Haniffa et al., 2012), monocyte-
derived macrophages (MDM) (McGovern et al., 2014b), and langerin+ dermal DCs (Bigley et 
al., 2015). Here, through thorough examination of mononuclear phagocyte subsets from 
human skin using complex multicolour flow cytometry it was revealed that, in addition to LCs, 
two further epidermal subsets (CD1a+Langerin+ DCs and CD1a+Langerin- DCs) were 
present that have not previously been described in healthy skin. Each subset could be 
distinguished by differential surface expression of HLA-DR, CD1a and langerin. 
CD1a+Langerin- DCs were successfully distinguished from LCs in situ by 
immunofluorescence microscopy. However, this technique is limited in its ability to detect 
subtle differences in receptor expression, and as such the CD1a+Langerin+ DCs were not 
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able to be distinguished from LCs. CLR profiling revealed that CLEC4A, Siglec-3 and Siglec-
9 could be reliably used to distinguish between these two langerin+ epidermal subsets by flow 
cytometry. Unfortunately, this could not be confirmed by immunofluorescence microscopy due 
to lack of commercially available antibodies that are compatible with this technique. Of interest, 
all three subsets were also detected in anogenital tissue by flow cytometry. 
 In order to conclude that there are indeed three separate CD1a-expressing epidermal 
subsets, further investigation is needed to more fully characterise these cells and investigate 
whether they are functionally distinct. Firstly, their cellular morphology should be examined 
using Geimsa staining, and they should be analysed by electron microscopy for Birbeck 
granules – a hallmark of true LCs thought to be involved in antigen degradation (de Witte et 
al., 2007; Valladeau et al., 2003; Valladeau et al., 2000). It will also be important to determine 
which TLRs each subset expresses, as this will indicate which pathogens they specialise in 
detecting. Functional assays should then be carried out, such as determining which cytokines 
each cell type produces using both intracellular cytokine assays and cytometric bead arrays. 
It will also be important to investigate their relative ability to stimulate T cell proliferation, as 
this may provide an indication of whether these cells are more functionally similar to DCs, 
which are more efficient at stimulating naïve T cells than macrophages and monocytes 
(Guilliams et al., 2014; Haniffa et al., 2015a). Furthermore, as the combined CD1a-expressing 
epidermal cell population has been shown to transfer HIV to CD4+ T cells (Nasr et al., 2014), 
it is now crucial to investigate which of the specific subsets are able to perform this function. 
Interestingly, the CD1a+Langerin- epidermal DCs closely resemble dermal CD1a+ 
DCs in terms of CLR expression, and therefore indicates the dermal subset may migrate into 
the epidermis. Furthermore, in inflamed skin, a subset resembling the CD1a+Langerin- DCs, 
called an inflammatory dendritic epidermal cell (IDEC) has previously been reported 
(Wollenberg et al., 1996; Wollenberg et al., 2002a). Ultimately transcriptomic investigation will 
be required to conclusively determine whether these cells represent distinct subsets, and how 
closely they relate to other known subsets, within the epidermis, dermis, blood and other 
tissues. 
 
7.5. Implications for HIV transmission 
 Since its discovery more than 30 years ago, there is still no cure or vaccine for 
HIV/AIDS. There are approximately 37 million people living with this disease worldwide, 2 
million of which are newly infected each year (UNAIDS, 2015). Due to the high mutation rate 
of HIV, current treatments rely on a combination of drugs that target multiple stages of the 
virus’ lifecycle. Although combination antiviral therapy (cART) has dramatically changed 
outcomes, it is still failing to contain the epidemic (McGregor et al., 2015; UNAIDS, 2015). 
Furthermore, cART is lifelong, carries significant drug toxicity issues, and is a substantial 
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burden to healthcare systems. Despite the efficiency of cART in significantly reducing the risk 
of transmitted HIV, acquisition is still a major problem as more than half of HIV+ people fail to 
take cART or are unaware they are HIV+ (UNAIDS, 2015). Thus, there is still a critical need to 
develop strategies to block the spread of the virus at the time of acquisition. Sexual 
transmission is by far the most common route of transfer (McGregor et al., 2015; Powers et 
al., 2008; UNAIDS, 2010), therefore it is crucial to understand how HIV crosses anogenital 
tissues. Efforts to develop an effective vaccine and/or microbicide have so far failed, but 
understanding which potential HIV target cells reside in anogenital tissues, and whether they 
express HIV binding receptors, may provide the key for novel targets.  
Anogenital tissues differ significantly depending on site, and tissue-specific 
combinations of microbicides may therefore be required for effective treatments to block 
acquisition. Apart from CD1a+ DCs, which were more abundant in anogenital skin than type I 
and type II mucosa, other subsets were relatively evenly distributed throughout the anogenital 
tracts. Interestingly, CD1a+ DCs were the subset observed to be by far the most efficient at 
transferring HIV to CD4+ T cells; therefore, they are likely to play a key role in sexual 
transmission of HIV. However, CD1a+ cells were present in much lower numbers in anogenital 
tissues compared with abdominal skin, and were entirely absent from others. This coincided 
with the appearance of a population of CD11c+CD1c+ cells in anogenital tissues that did not 
express any other DC subset-discriminating markers (CD1a, CD14, CD141 or langerin), and 
are very likely the equivalent of skin CD1a+ DCs that have downregulated or stopped 
expressing CD1a. Therefore, it will be important to investigate this population further, 
specifically to determine their transcriptomic relationship to CD1a+ skin DCs, and also to 
investigate their role in HIV transmission. Firstly, it will be important to determine whether 
these cells express HIV entry receptors (CD4, CCR5 and CXCR4) and are permissive to HIV 
infection, and also whether they can transfer the virus to T cells. Secondly, it will be of 
significance to examine the CLR expression profile on these cells, which may indicate which 
pathogens they interact with, including HIV, and reveal potential targets to prevent these 
interactions. 
 
7.5.1. Strategies to block HIV transmission 
The search for effective microbicides to block HIV transmission remains an important 
approach to prevent infection. Currently the most effective inhibitor of de novo viral infection 
is Tenofovir, which only offers a 39% block in infection rates (Karim et al., 2010). Similar to 
cART, it is likely that a combination approach will be required to prevent HIV binding to 
mucosal DCs and macrophages. A potential strategy for microbicide development is targeting 
surface receptors than bind HIV (Frank and Robbiani, 2011; Kawamura et al., 2004). Pre-
treatment of HIV with soluble langerin and pre-treatment of LCs with monoclonal antibodies 
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against langerin has been shown to significantly inhibit both phases of LC-mediated HIV 
transfer to T cells (Nasr et al., 2014), which demonstrates a proof of principal that targeting 
HIV-binding receptors may be effective for microbicide development. Unfortunately, soluble 
DC-SIGN only weakly blocks transfer of SIV to vaginal DCs in macaques (Burton et al., 2011). 
Given the results shown here that DC-SIGN is not expressed by the DC subset that most 
efficiently mediated transfer of HIV in both phases (CD1a+ DCs), this is perhaps not surprising. 
Thus it is important to define if blocking other CLRs is effective in blocking HIV 
uptake/infection, particularly in DC subsets that do not express DC-SIGN. Targeting an HIV-
binding CLR that is highly expressed on all subsets (especially CD1a+ DCs), such as 
CLEC4A/DCIR, may be more effective; however, there are multiple HIV-binding receptors 
expressed on mononuclear phagocytes, which may provide redundancy. The majority of 
studies investigating the role of CLRs and Siglecs in HIV binding or transmission have used 
model DCs or cell lines (Geijtenbeek et al., 2000a; Gringhuis et al., 2009a; Gringhuis et al., 
2009b; Izquierdo-Useros et al., 2012; Lambert et al., 2008; Puryear et al., 2013; Trujillo et al., 
2007; Zou et al., 2011). Therefore, it will be important to determine what role they play on the 
interaction of HIV with tissue mononuclear phagocytes. Furthermore, there were a number of 
CLRs highly expressed on mononuclear phagocytes that have not been investigated for HIV 
binding, such as CLEC4D and CLEC5A. It is therefore of importance to investigate whether 
they are able to bind HIV, and as with the other CLRs such as langerin, whether blocking 
attenuates HIV infection and/or transmission. 
 
7.5.2. Transmission of HIV across genital skin and type II mucosa 
The anogenital tract of both sexes is lined with different surfaces, each which represent 
a unique barrier and opportunity for invading pathogens. The tightly packed cells of the 
stratified squamous epithelial layers of skin and type II mucosa represent a significant physical 
barrier for HIV. However, HIV penetration and infection across this surface has been 
demonstrated in human ex vivo genital tissue explants from the vagina, ectocervix and 
foreskin (Ganor et al., 2010; Hladik et al., 2007; Maher et al., 2005). Furthermore, the 
significant role of the foreskin in HIV transmission is highlighted by reduced rates of infection 
with circumcision (Auvert et al., 2005; Gray et al., 2007; MacLaren et al., 2015). The similarities 
between the foreskin and labia minora, both in their skin structure and the mononuclear 
phagocyte subsets that reside in each, may indicate that the labia minora has been an 
underappreciated site for HIV infection. As such, microbicides may need to be applied to the 
surrounding area and not just within the vagina, especially in a setting of inflammation or skin 
abrasions.  
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7.5.3. Transmission of HIV via anal intercourse 
Transmission of HIV via unprotected anal intercourse is 10-100 times more efficient 
than vaginal intercourse (Powers et al., 2008), and is by far the most common mode of HIV 
acquisition in western countries (McGregor et al., 2015). Accordingly, the percentage of both 
men and women who practice receptive anal intercourse has increased over the last 10 years 
(de Visser et al., 2014), and associated condom usage is decreasing (de Visser et al., 2014; 
McGregor et al., 2015). Despite this, surprisingly little is known about how HIV crosses the 
anorectal mucosa (Harman et al., 2013b), and a better understanding of the mechanisms 
involved may enable the targeted development of strategies to block the spread of the virus 
at the time of acquisition. Unlike the vagina and ectocervix, the anus is less flexible due to the 
external anal sphincter and lacks natural lubrication (Marieb and Hoehn, 2007a), and therefore 
may be more susceptible to mechanical abrasion. The thin and fragile columnar epithelial 
surface of the adjacent rectum may present a pathway of lesser resistance for HIV 
transmission, however this surface may undergo less mechanical damage as it is a more 
flexible and voluminous cavity. Although the frequency of subsets did not differ significantly 
between these sites, the phenotype and/or function may, which will need to be investigated to 
successfully target cells susceptible to HIV infection. 
 
7.5.4. The role of inflammation in HIV transmission 
Secondary infection and inflammation may increase the rate of transmission, and 
therefore consideration needs to be given to the disease state of the tissue obtained. This is 
specifically apparent in the case of HSV infection, which increases the risk of HIV acquisition 
by 3-4 fold (Freeman et al., 2006; Wald and Link, 2002). Bacterial infection, inflammation and 
ulceration also increase the risk of infection via vaginal intercourse (Masson et al., 2015; 
Mehta et al., 2012). In the case of anal intercourse, it is likely that many factors associated 
with this practice traumatise and inflame the anorectal mucosa, including mechanical 
abrasion, lubricants, recreational drugs, douching and semen. Indeed, douching agents have 
been shown to cause osmotic stress to the anorectal mucosa, and many lubricants have been 
shown to cause chemical irritation (Begay et al., 2011; Schmelzer et al., 2004), which may 
induce inflammation and subsequently enhance HIV transmission. As well as increasing the 
risk of infection, these are likely to influence the expression of surface receptors, and in turn 
the effectiveness of microbicides. During inflammation or secondary infection, DCs in these 
sites may be more activated (Qin et al., 2012; Qin et al., 2011), and therefore express a unique 
pathogen receptor profile. Numerous CLRs, including HIV-binding receptors langerin, 
CLEC4A/DCIR, and CLEC13D/MR were downregulated on mature DCs, and as such may not 
be suitable targets for microbicides applied to infected or inflamed areas. Thus, an important 
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future direction of this study will be to investigate anogenital infiltrating cells and their role in 
HIV transmission. 
 
7.6. Implications beyond HIV, including vaccine design 
 An exciting new strategy for vaccine design, is delivering antigen to DCs by targeting 
surface receptors, which have the potential to exert fine control over antigen presentation 
outcomes and subsequent immunity (Caminschi et al., 2009; Caminschi et al., 2008; Lahoud 
et al., 2009; Moffat et al., 2013; Tacken et al., 2005). There is a growing list of DC receptors 
that have been targeted with antigens, most of which are CLRs, such as CLEC4L/DC-SIGN, 
CLEC6A, CLEC7A, CLEC9A, CLEC12A and CEC13B/DEC-205 (reviewed in Caminschi et 
al., 2009). In particular, targeting CLEC13B/DEC-205 has been shown to be highly proficient 
at eliciting immunity (Caminschi et al., 2009; Moffat et al., 2013). Intradermal injection of 
vaccines directly stimulates the dermal mononuclear phagocytes, which have been shown 
here to express a wide range of pathogen binding receptors. CD1a+ dermal DCs were 
observed to be the most abundant DC subset, and also expressed a wide range of CLRs; 
therefore, these may be the ideal target for DC-based vaccines. Furthermore, CLEC4A/DCIR, 
CLEC4E, CLEC4M, CLEC5A and CLEC13D/MR are highly expressed on this subset, and 
may therefore be of interest as potential targets. 
There are over 800 million people infected with a sexually transmitted disease 
worldwide. A better understanding of how these are transmitted may provide the key to 
developing prevention strategies. The pathogens regularly encountered by mononuclear 
phagocytes differ between sites, and may influence the magnitude of the immunogenic or 
tolerogenic response. Furthermore, these sites are likely to represent unique cytokine 
environments, which may not only influence the response of each subset, but also their 
surface expression. As such, it will also be important to determine how the microbiome and 
cytokine environment differ across anogenital tissues, and whether either influence which 
subsets are present, along with their phenotype and/or frequency. Of particular interest is the 
expression profile of CLRs, many of which act as pathogen recognition receptors (Dambuza 
and Brown, 2015). As with HIV, numerous CLRs have been shown to interact with sexually 
transmitted pathogens, including HCV and HSV (summarised in Chapter 1 Table 1.3.). 
Furthermore, expression profiles on subsets in abdominal skin has implications for 
transmission of mosquito-borne pathogens. For example, LCs, CD1a+ DCs, CD14+ DCs and 
macrophages have been reported to be productively infected with Dengue virus (Cerny et al., 
2014), which may be linked to expression of a Dengue virus entry receptor, CLEC5A (Chen 
et al., 2008). For these reasons, the surface expression profile on skin mononuclear phagocyte 
subsets has relevance far beyond HIV susceptibility. 
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7.7. Concluding remarks 
 Mononuclear phagocytes in skin and mucosae play a significant role in homeostasis, 
tolerance and immunity, which is largely dependent on antigens binding to surface molecules 
and the subsequent immune response. The examination of mononuclear phagocytes present 
in abdominal skin and anogenital tissues undertaken here has significant implications on which 
subsets may encounter sexually transmitted pathogens, vector-borne pathogens, and 
vaccines. This highly innovative study using human tissue was the first study to 
comprehensively map surface expression of pathogen binding receptors on all skin 
mononuclear phagocytes at the protein level, and has demonstrated the phenotypic difference 
between the subsets in the epidermis and dermis, and in vitro-derived model cells. It also 
identified two novel epidermal DC subsets. The detailed profile of the surface pathogen 
recognition receptor profile on each subset provides key insight into subset-specific 
interactions with pathogens, and a range of targets that could be investigated for DC-based 
vaccines and microbicides. This was also the first study to compare the ability of ex vivo dermal 
DCs to transfer HIV to CD4+ T cells. CD1a+ DCs were shown to transfer HIV to T cells with 
the greatest efficiency of all mononuclear phagocyte subsets, and therefore represents a key 
target for prevention strategies. 
 Anogenital tracts are lined with different skin and mucosal surfaces, which each 
represent a unique barrier and opportunity for transmission of HIV and other sexually 
transmitted pathogens. Tissue was obtained from the human anogenital tract of both sexes, 
and the repertoire of mononuclear phagocyte subsets was observed to differ between 
anogenital sites, and from those present in abdominal skin. A thorough investigation of all 
known mononuclear phagocyte subsets in a wide range of human anogenital tissues had 
never been done before, and as such, the results here contribute significantly to the current 
knowledge of immune recognition within these sites and paves the way for microbicide and 
vaccine development for mucosae. 
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  The Role of Microvesicles in Establishing HIV Infection 
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